id	sid	tid	token	lemma	pos
hls-12723	1	1	hrev_master	hrev_master	NOUN
hls-12723	1	2	healthcare	healthcare	NOUN
hls-12723	1	3	in	in	ADP
hls-12723	1	4	low	low	ADJ
hls-12723	1	5	-	-	PUNCT
hls-12723	1	6	resource	resource	NOUN
hls-12723	1	7	settings	setting	NOUN
hls-12723	1	8	2025	2025	NUM
hls-12723	1	9	;	;	PUNCT
hls-12723	1	10	volume	volume	NOUN
hls-12723	1	11	13:12723	13:12723	NUM
hls-12723	1	12	the	the	DET
hls-12723	1	13	effectiveness	effectiveness	NOUN
hls-12723	1	14	of	of	ADP
hls-12723	1	15	risperidone	risperidone	NOUN
hls-12723	1	16	on	on	ADP
hls-12723	1	17	panss	pans	NOUN
hls-12723	1	18	score	score	NOUN
hls-12723	1	19	and	and	CCONJ
hls-12723	1	20	il-6	il-6	NOUN
hls-12723	1	21	in	in	ADP
hls-12723	1	22	confirmed	confirm	VERB
hls-12723	1	23	covid-19	covid-19	PROPN
hls-12723	1	24	schizophrenic	schizophrenic	ADJ
hls-12723	1	25	patients	patient	NOUN
hls-12723	1	26	sonny	sonny	PROPN
hls-12723	1	27	teddy	teddy	PROPN
hls-12723	1	28	lisal,1	lisal,1	VERB
hls-12723	1	29	hawaidah,1	hawaidah,1	PROPN
hls-12723	1	30	dessy	dessy	ADJ
hls-12723	1	31	natalia,1	natalia,1	NOUN
hls-12723	1	32	arifin	arifin	PROPN
hls-12723	1	33	seweng,2	seweng,2	PROPN
hls-12723	1	34	yuyun	yuyun	PROPN
hls-12723	1	35	widaningsih,3	widaningsih,3	VERB
hls-12723	1	36	erlyn	erlyn	PROPN
hls-12723	1	37	limoa,1	limoa,1	PROPN
hls-12723	1	38	saidah	saidah	PROPN
hls-12723	1	39	syamsuddin1	syamsuddin1	NOUN
hls-12723	1	40	1department	1department	NUM
hls-12723	1	41	of	of	ADP
hls-12723	1	42	psychiatry	psychiatry	NOUN
hls-12723	1	43	,	,	PUNCT
hls-12723	1	44	faculty	faculty	NOUN
hls-12723	1	45	of	of	ADP
hls-12723	1	46	medicine	medicine	NOUN
hls-12723	1	47	,	,	PUNCT
hls-12723	1	48	hasanuddin	hasanuddin	VERB
hls-12723	1	49	university	university	NOUN
hls-12723	1	50	,	,	PUNCT
hls-12723	1	51	makassar	makassar	PROPN
hls-12723	1	52	;	;	PUNCT
hls-12723	1	53	2department	2department	NUM
hls-12723	1	54	of	of	ADP
hls-12723	1	55	biostatistics	biostatistic	NOUN
hls-12723	1	56	,	,	PUNCT
hls-12723	1	57	faculty	faculty	NOUN
hls-12723	1	58	of	of	ADP
hls-12723	1	59	public	public	ADJ
hls-12723	1	60	health	health	NOUN
hls-12723	1	61	,	,	PUNCT
hls-12723	1	62	universitas	universita	NOUN
hls-12723	1	63	hasanuddin	hasanuddin	NOUN
hls-12723	1	64	,	,	PUNCT
hls-12723	1	65	makassar	makassar	PROPN
hls-12723	1	66	;	;	PUNCT
hls-12723	2	1	3department	3department	NUM
hls-12723	2	2	of	of	ADP
hls-12723	2	3	clinical	clinical	ADJ
hls-12723	2	4	pathology	pathology	NOUN
hls-12723	2	5	,	,	PUNCT
hls-12723	2	6	faculty	faculty	NOUN
hls-12723	2	7	of	of	ADP
hls-12723	2	8	medicine	medicine	NOUN
hls-12723	2	9	,	,	PUNCT
hls-12723	2	10	hasanuddin	hasanuddin	VERB
hls-12723	2	11	university	university	NOUN
hls-12723	2	12	,	,	PUNCT
hls-12723	2	13	makassar	makassar	PROPN
hls-12723	2	14	,	,	PUNCT
hls-12723	2	15	indonesia	indonesia	PROPN
hls-12723	2	16	abstract	abstract	NOUN
hls-12723	2	17	the	the	DET
hls-12723	2	18	study	study	NOUN
hls-12723	2	19	aimed	aim	VERB
hls-12723	2	20	to	to	PART
hls-12723	2	21	determine	determine	VERB
hls-12723	2	22	the	the	DET
hls-12723	2	23	efficacy	efficacy	NOUN
hls-12723	2	24	of	of	ADP
hls-12723	2	25	risperidone	risperidone	NOUN
hls-12723	2	26	on	on	ADP
hls-12723	2	27	panss	pans	NOUN
hls-12723	2	28	scores	score	NOUN
hls-12723	2	29	and	and	CCONJ
hls-12723	2	30	interleukin	interleukin	NOUN
hls-12723	2	31	6	6	NUM
hls-12723	2	32	(	(	PUNCT
hls-12723	2	33	il-6	il-6	NUM
hls-12723	2	34	)	)	PUNCT
hls-12723	2	35	levels	level	NOUN
hls-12723	2	36	in	in	ADP
hls-12723	2	37	schizophrenia	schizophrenia	NOUN
hls-12723	2	38	patients	patient	NOUN
hls-12723	2	39	with	with	ADP
hls-12723	2	40	confirmed	confirm	VERB
hls-12723	2	41	covid-19	covid-19	PROPN
hls-12723	2	42	.	.	PUNCT
hls-12723	3	1	the	the	DET
hls-12723	3	2	study	study	NOUN
hls-12723	3	3	type	type	NOUN
hls-12723	3	4	was	be	AUX
hls-12723	3	5	analytical	analytical	ADJ
hls-12723	3	6	observational	observational	NOUN
hls-12723	3	7	,	,	PUNCT
hls-12723	3	8	with	with	ADP
hls-12723	3	9	a	a	DET
hls-12723	3	10	prospective	prospective	ADJ
hls-12723	3	11	cohort	cohort	NOUN
hls-12723	3	12	design	design	NOUN
hls-12723	3	13	.	.	PUNCT
hls-12723	4	1	the	the	DET
hls-12723	4	2	subjects	subject	NOUN
hls-12723	4	3	included	include	VERB
hls-12723	4	4	inpatient	inpatient	NOUN
hls-12723	4	5	schizophrenia	schizophrenia	NOUN
hls-12723	4	6	patients	patient	NOUN
hls-12723	4	7	with	with	ADP
hls-12723	4	8	and	and	CCONJ
hls-12723	4	9	without	without	ADP
hls-12723	4	10	covid-19	covid-19	PROPN
hls-12723	4	11	,	,	PUNCT
hls-12723	4	12	mild	mild	ADJ
hls-12723	4	13	-	-	PUNCT
hls-12723	4	14	moderate	moderate	ADJ
hls-12723	4	15	and	and	CCONJ
hls-12723	4	16	asymptomatic	asymptomatic	ADJ
hls-12723	4	17	covid-19	covid-19	PROPN
hls-12723	4	18	,	,	PUNCT
hls-12723	4	19	and	and	CCONJ
hls-12723	4	20	schizophrenic	schizophrenic	ADJ
hls-12723	4	21	patients	patient	NOUN
hls-12723	4	22	without	without	ADP
hls-12723	4	23	covid-19	covid-19	PROPN
hls-12723	4	24	who	who	PRON
hls-12723	4	25	were	be	AUX
hls-12723	4	26	hospitalized	hospitalize	VERB
hls-12723	4	27	and	and	CCONJ
hls-12723	4	28	met	meet	VERB
hls-12723	4	29	the	the	DET
hls-12723	4	30	inclusion	inclusion	NOUN
hls-12723	4	31	and	and	CCONJ
hls-12723	4	32	exclusion	exclusion	NOUN
hls-12723	4	33	criteria	criterion	NOUN
hls-12723	4	34	,	,	PUNCT
hls-12723	4	35	for	for	ADP
hls-12723	4	36	a	a	DET
hls-12723	4	37	total	total	NOUN
hls-12723	4	38	of	of	ADP
hls-12723	4	39	22	22	NUM
hls-12723	4	40	subjects	subject	NOUN
hls-12723	4	41	in	in	ADP
hls-12723	4	42	each	each	DET
hls-12723	4	43	group	group	NOUN
hls-12723	4	44	.	.	PUNCT
hls-12723	5	1	the	the	DET
hls-12723	5	2	positive	positive	ADJ
hls-12723	5	3	and	and	CCONJ
hls-12723	5	4	negative	negative	ADJ
hls-12723	5	5	syndrome	syndrome	NOUN
hls-12723	5	6	scale	scale	NOUN
hls-12723	5	7	(	(	PUNCT
hls-12723	5	8	panss	pans	NOUN
hls-12723	5	9	)	)	PUNCT
hls-12723	5	10	and	and	CCONJ
hls-12723	5	11	elisa	elisa	VERB
hls-12723	5	12	interleukin	interleukin	NOUN
hls-12723	5	13	6	6	NUM
hls-12723	5	14	(	(	PUNCT
hls-12723	5	15	il-6	il-6	NUM
hls-12723	5	16	)	)	PUNCT
hls-12723	5	17	serum	serum	NOUN
hls-12723	5	18	were	be	AUX
hls-12723	5	19	sampled	sample	VERB
hls-12723	5	20	consecutively	consecutively	ADV
hls-12723	5	21	for	for	ADP
hls-12723	5	22	this	this	DET
hls-12723	5	23	study	study	NOUN
hls-12723	5	24	.	.	PUNCT
hls-12723	6	1	in	in	ADP
hls-12723	6	2	the	the	DET
hls-12723	6	3	positive	positive	ADJ
hls-12723	6	4	covid-19	covid-19	PROPN
hls-12723	6	5	group	group	NOUN
hls-12723	6	6	,	,	PUNCT
hls-12723	6	7	the	the	DET
hls-12723	6	8	mean	mean	ADJ
hls-12723	6	9	il-6	il-6	NUM
hls-12723	6	10	post	post	NOUN
hls-12723	6	11	was	be	AUX
hls-12723	6	12	significantly	significantly	ADV
hls-12723	6	13	lower	low	ADJ
hls-12723	6	14	than	than	ADP
hls-12723	6	15	pre	pre	VERB
hls-12723	6	16	(	(	PUNCT
hls-12723	6	17	23.0	23.0	NUM
hls-12723	6	18	vs.	vs.	ADP
hls-12723	6	19	26.1	26.1	NUM
hls-12723	6	20	,	,	PUNCT
hls-12723	6	21	p<0.001	p<0.001	PROPN
hls-12723	6	22	)	)	PUNCT
hls-12723	6	23	,	,	PUNCT
hls-12723	6	24	while	while	SCONJ
hls-12723	6	25	in	in	ADP
hls-12723	6	26	the	the	DET
hls-12723	6	27	control	control	NOUN
hls-12723	6	28	group	group	NOUN
hls-12723	6	29	,	,	PUNCT
hls-12723	6	30	the	the	DET
hls-12723	6	31	mean	mean	ADJ
hls-12723	6	32	il-6	il-6	CCONJ
hls-12723	6	33	post	post	NOUN
hls-12723	6	34	(	(	PUNCT
hls-12723	6	35	four	four	NUM
hls-12723	6	36	weeks	week	NOUN
hls-12723	6	37	)	)	PUNCT
hls-12723	6	38	was	be	AUX
hls-12723	6	39	significantly	significantly	ADV
hls-12723	6	40	lower	low	ADJ
hls-12723	6	41	than	than	ADP
hls-12723	6	42	pre	pre	X
hls-12723	6	43	(	(	PUNCT
hls-12723	6	44	baseline	baseline	NOUN
hls-12723	6	45	)	)	PUNCT
hls-12723	6	46	,	,	PUNCT
hls-12723	6	47	with	with	ADP
hls-12723	6	48	19.3	19.3	NUM
hls-12723	6	49	vs.	vs.	ADP
hls-12723	6	50	21.0	21.0	NUM
hls-12723	6	51	(	(	PUNCT
hls-12723	6	52	p<0.001	p<0.001	PROPN
hls-12723	6	53	)	)	PUNCT
hls-12723	6	54	.	.	PUNCT
hls-12723	7	1	serum	serum	PROPN
hls-12723	7	2	il-6	il-6	NOUN
hls-12723	7	3	levels	level	NOUN
hls-12723	7	4	appeared	appear	VERB
hls-12723	7	5	to	to	PART
hls-12723	7	6	be	be	AUX
hls-12723	7	7	an	an	DET
hls-12723	7	8	effective	effective	ADJ
hls-12723	7	9	prognostic	prognostic	ADJ
hls-12723	7	10	biomarker	biomarker	NOUN
hls-12723	7	11	in	in	ADP
hls-12723	7	12	covid-19	covid-19	PROPN
hls-12723	7	13	patients	patient	NOUN
hls-12723	7	14	.	.	PUNCT
hls-12723	8	1	the	the	DET
hls-12723	8	2	35	35	NUM
hls-12723	8	3	pg	pg	NOUN
hls-12723	8	4	/	/	SYM
hls-12723	8	5	ml	ml	X
hls-12723	8	6	cutoff	cutoff	NOUN
hls-12723	8	7	point	point	NOUN
hls-12723	8	8	could	could	AUX
hls-12723	8	9	distinguish	distinguish	VERB
hls-12723	8	10	mild	mild	ADJ
hls-12723	8	11	-	-	PUNCT
hls-12723	8	12	moderate	moderate	ADJ
hls-12723	8	13	patients	patient	NOUN
hls-12723	8	14	from	from	ADP
hls-12723	8	15	more	more	ADV
hls-12723	8	16	severe	severe	ADJ
hls-12723	8	17	ones	one	NOUN
hls-12723	8	18	.	.	PUNCT
hls-12723	9	1	we	we	PRON
hls-12723	9	2	discovered	discover	VERB
hls-12723	9	3	that	that	SCONJ
hls-12723	9	4	schizophrenia	schizophrenia	NOUN
hls-12723	9	5	patients	patient	NOUN
hls-12723	9	6	with	with	ADP
hls-12723	9	7	verified	verify	VERB
hls-12723	9	8	positive	positive	ADJ
hls-12723	9	9	covid-19	covid-19	PROPN
hls-12723	9	10	received	receive	VERB
hls-12723	9	11	covid-19	covid-19	PROPN
hls-12723	9	12	therapy	therapy	NOUN
hls-12723	9	13	in	in	ADP
hls-12723	9	14	the	the	DET
hls-12723	9	15	form	form	NOUN
hls-12723	9	16	of	of	ADP
hls-12723	9	17	a	a	DET
hls-12723	9	18	combination	combination	NOUN
hls-12723	9	19	of	of	ADP
hls-12723	9	20	antipsychotic	antipsychotic	ADJ
hls-12723	9	21	and	and	CCONJ
hls-12723	9	22	antivirals	antiviral	NOUN
hls-12723	9	23	had	have	VERB
hls-12723	9	24	il-6	il-6	NUM
hls-12723	9	25	levels	level	NOUN
hls-12723	9	26	lower	low	ADJ
hls-12723	9	27	than	than	ADP
hls-12723	9	28	35	35	NUM
hls-12723	9	29	pg	pg	NOUN
hls-12723	9	30	/	/	SYM
hls-12723	9	31	ml	ml	PROPN
hls-12723	9	32	,	,	PUNCT
hls-12723	9	33	indicating	indicate	VERB
hls-12723	9	34	the	the	DET
hls-12723	9	35	role	role	NOUN
hls-12723	9	36	of	of	ADP
hls-12723	9	37	antipsychotic	antipsychotic	ADJ
hls-12723	9	38	(	(	PUNCT
hls-12723	9	39	risperidone	risperidone	NOUN
hls-12723	9	40	)	)	PUNCT
hls-12723	9	41	and	and	CCONJ
hls-12723	9	42	antiviral	antiviral	NOUN
hls-12723	9	43	in	in	ADP
hls-12723	9	44	reducing	reduce	VERB
hls-12723	9	45	il-6	il-6	NUM
hls-12723	9	46	levels	level	NOUN
hls-12723	9	47	.	.	PUNCT
hls-12723	10	1	introduction	introduction	NOUN
hls-12723	10	2	the	the	DET
hls-12723	10	3	covid-19	covid-19	PROPN
hls-12723	10	4	outbreak	outbreak	NOUN
hls-12723	10	5	caused	cause	VERB
hls-12723	10	6	by	by	ADP
hls-12723	10	7	the	the	DET
hls-12723	10	8	severe	severe	ADJ
hls-12723	10	9	acute	acute	ADJ
hls-12723	10	10	respiratory	respiratory	ADJ
hls-12723	10	11	syndrome	syndrome	NOUN
hls-12723	10	12	coronavirus	coronavirus	NOUN
hls-12723	10	13	2	2	NUM
hls-12723	10	14	(	(	PUNCT
hls-12723	10	15	sars	sar	NOUN
hls-12723	10	16	-	-	PUNCT
hls-12723	10	17	cov-2	cov-2	NOUN
hls-12723	10	18	)	)	PUNCT
hls-12723	10	19	was	be	AUX
hls-12723	10	20	detected	detect	VERB
hls-12723	10	21	for	for	ADP
hls-12723	10	22	the	the	DET
hls-12723	10	23	first	first	ADJ
hls-12723	10	24	time	time	NOUN
hls-12723	10	25	in	in	ADP
hls-12723	10	26	wuhan	wuhan	PROPN
hls-12723	10	27	,	,	PUNCT
hls-12723	10	28	china	china	PROPN
hls-12723	10	29	,	,	PUNCT
hls-12723	10	30	spread	spread	VERB
hls-12723	10	31	throughout	throughout	ADP
hls-12723	10	32	the	the	DET
hls-12723	10	33	country	country	NOUN
hls-12723	10	34	since	since	SCONJ
hls-12723	10	35	late	late	ADJ
hls-12723	10	36	december	december	PROPN
hls-12723	10	37	2019	2019	NUM
hls-12723	10	38	,	,	PUNCT
hls-12723	10	39	and	and	CCONJ
hls-12723	10	40	has	have	AUX
hls-12723	10	41	attracted	attract	VERB
hls-12723	10	42	significant	significant	ADJ
hls-12723	10	43	attention	attention	NOUN
hls-12723	10	44	from	from	ADP
hls-12723	10	45	all	all	ADV
hls-12723	10	46	over	over	ADP
hls-12723	10	47	the	the	DET
hls-12723	10	48	world	world	NOUN
hls-12723	10	49	.	.	PUNCT
hls-12723	11	1	the	the	DET
hls-12723	11	2	first	first	ADJ
hls-12723	11	3	case	case	NOUN
hls-12723	11	4	of	of	ADP
hls-12723	11	5	covid-19	covid-19	PROPN
hls-12723	11	6	in	in	ADP
hls-12723	11	7	indonesia	indonesia	PROPN
hls-12723	11	8	was	be	AUX
hls-12723	11	9	reported	report	VERB
hls-12723	11	10	on	on	ADP
hls-12723	11	11	march	march	PROPN
hls-12723	11	12	2	2	NUM
hls-12723	11	13	,	,	PUNCT
hls-12723	11	14	2020	2020	NUM
hls-12723	11	15	,	,	PUNCT
hls-12723	11	16	with	with	ADP
hls-12723	11	17	as	as	ADV
hls-12723	11	18	many	many	ADJ
hls-12723	11	19	as	as	ADP
hls-12723	11	20	2	2	NUM
hls-12723	11	21	cases	case	NOUN
hls-12723	11	22	,	,	PUNCT
hls-12723	11	23	and	and	CCONJ
hls-12723	11	24	until	until	ADP
hls-12723	11	25	now	now	ADV
hls-12723	11	26	,	,	PUNCT
hls-12723	11	27	the	the	DET
hls-12723	11	28	number	number	NOUN
hls-12723	11	29	of	of	ADP
hls-12723	11	30	cases	case	NOUN
hls-12723	11	31	has	have	AUX
hls-12723	11	32	been	be	AUX
hls-12723	11	33	increasing	increase	VERB
hls-12723	11	34	.	.	PUNCT
hls-12723	12	1	it	it	PRON
hls-12723	12	2	was	be	AUX
hls-12723	12	3	reported	report	VERB
hls-12723	12	4	that	that	SCONJ
hls-12723	12	5	until	until	ADP
hls-12723	12	6	march	march	PROPN
hls-12723	12	7	23	23	NUM
hls-12723	12	8	,	,	PUNCT
hls-12723	12	9	2021	2021	NUM
hls-12723	12	10	,	,	PUNCT
hls-12723	12	11	in	in	ADP
hls-12723	12	12	34	34	NUM
hls-12723	12	13	provinces	province	NOUN
hls-12723	12	14	,	,	PUNCT
hls-12723	12	15	there	there	PRON
hls-12723	12	16	were	be	VERB
hls-12723	12	17	1,505,775	1,505,775	NUM
hls-12723	12	18	positive	positive	ADJ
hls-12723	12	19	confirmed	confirm	VERB
hls-12723	12	20	cases	case	NOUN
hls-12723	12	21	,	,	PUNCT
hls-12723	12	22	142,695	142,695	NUM
hls-12723	12	23	recovered	recovered	ADJ
hls-12723	12	24	cases	case	NOUN
hls-12723	12	25	,	,	PUNCT
hls-12723	12	26	and	and	CCONJ
hls-12723	12	27	40,754	40,754	NUM
hls-12723	12	28	people	people	NOUN
hls-12723	12	29	died	die	VERB
hls-12723	12	30	from	from	ADP
hls-12723	12	31	this	this	DET
hls-12723	12	32	disease	disease	NOUN
hls-12723	12	33	.	.	PUNCT
hls-12723	13	1	south	south	ADJ
hls-12723	13	2	sulawesi	sulawesi	PROPN
hls-12723	13	3	was	be	AUX
hls-12723	13	4	ranked	rank	VERB
hls-12723	13	5	fifth	fifth	ADJ
hls-12723	13	6	in	in	ADP
hls-12723	13	7	the	the	DET
hls-12723	13	8	number	number	NOUN
hls-12723	13	9	of	of	ADP
hls-12723	13	10	positive	positive	ADJ
hls-12723	13	11	confirmed	confirm	VERB
hls-12723	13	12	cases	case	NOUN
hls-12723	13	13	,	,	PUNCT
hls-12723	13	14	with	with	ADP
hls-12723	13	15	39,703	39,703	NUM
hls-12723	13	16	(	(	PUNCT
hls-12723	13	17	4.5	4.5	NUM
hls-12723	13	18	%	%	NOUN
hls-12723	13	19	)	)	PUNCT
hls-12723	13	20	,	,	PUNCT
hls-12723	13	21	recovered	recover	VERB
hls-12723	13	22	33,156	33,156	NUM
hls-12723	13	23	cases	case	NOUN
hls-12723	13	24	(	(	PUNCT
hls-12723	13	25	83.5	83.5	NUM
hls-12723	13	26	%	%	NOUN
hls-12723	13	27	)	)	PUNCT
hls-12723	13	28	,	,	PUNCT
hls-12723	13	29	and	and	CCONJ
hls-12723	13	30	675	675	NUM
hls-12723	13	31	cases	case	NOUN
hls-12723	13	32	died	die	VERB
hls-12723	13	33	(	(	PUNCT
hls-12723	13	34	1.7%).1	1.7%).1	NUM
hls-12723	13	35	the	the	DET
hls-12723	13	36	most	most	ADV
hls-12723	13	37	common	common	ADJ
hls-12723	13	38	clinical	clinical	ADJ
hls-12723	13	39	manifestations	manifestation	NOUN
hls-12723	13	40	of	of	ADP
hls-12723	13	41	covid-19	covid-19	PROPN
hls-12723	13	42	infection	infection	NOUN
hls-12723	13	43	are	be	AUX
hls-12723	13	44	cough	cough	NOUN
hls-12723	13	45	and	and	CCONJ
hls-12723	13	46	fever	fever	NOUN
hls-12723	13	47	;	;	PUNCT
hls-12723	13	48	about	about	ADV
hls-12723	13	49	8	8	NUM
hls-12723	13	50	-	-	SYM
hls-12723	13	51	19	19	NUM
hls-12723	13	52	%	%	NOUN
hls-12723	13	53	progress	progress	NOUN
hls-12723	13	54	to	to	PART
hls-12723	13	55	acute	acute	VERB
hls-12723	13	56	respiratory	respiratory	ADJ
hls-12723	13	57	distress	distress	NOUN
hls-12723	13	58	syndrome	syndrome	NOUN
hls-12723	13	59	(	(	PUNCT
hls-12723	13	60	ards	ard	NOUN
hls-12723	13	61	)	)	PUNCT
hls-12723	13	62	,	,	PUNCT
hls-12723	13	63	especially	especially	ADV
hls-12723	13	64	in	in	ADP
hls-12723	13	65	the	the	DET
hls-12723	13	66	elderly	elderly	ADJ
hls-12723	13	67	and	and	CCONJ
hls-12723	13	68	patients	patient	NOUN
hls-12723	13	69	with	with	ADP
hls-12723	13	70	multiple	multiple	ADJ
hls-12723	13	71	comorbidities	comorbiditie	NOUN
hls-12723	13	72	.	.	PUNCT
hls-12723	14	1	there	there	PRON
hls-12723	14	2	have	have	AUX
hls-12723	14	3	also	also	ADV
hls-12723	14	4	been	be	AUX
hls-12723	14	5	reports	report	NOUN
hls-12723	14	6	of	of	ADP
hls-12723	14	7	lymphopenia	lymphopenia	NOUN
hls-12723	14	8	,	,	PUNCT
hls-12723	14	9	elevated	elevated	ADJ
hls-12723	14	10	c	c	NOUN
hls-12723	14	11	-	-	ADJ
hls-12723	14	12	reactive	reactive	ADJ
hls-12723	14	13	protein	protein	NOUN
hls-12723	14	14	(	(	PUNCT
hls-12723	14	15	crp	crp	PROPN
hls-12723	14	16	)	)	PUNCT
hls-12723	14	17	,	,	PUNCT
hls-12723	14	18	proinflammatory	proinflammatory	ADJ
hls-12723	14	19	cytokines	cytokine	NOUN
hls-12723	14	20	,	,	PUNCT
hls-12723	14	21	ferritin	ferritin	ADJ
hls-12723	14	22	,	,	PUNCT
hls-12723	14	23	and	and	CCONJ
hls-12723	14	24	d	d	NOUN
hls-12723	14	25	-	-	PUNCT
hls-12723	14	26	dimer	dimer	ADJ
hls-12723	14	27	,	,	PUNCT
hls-12723	14	28	and	and	CCONJ
hls-12723	14	29	histopathological	histopathological	ADJ
hls-12723	14	30	findings	finding	NOUN
hls-12723	14	31	show	show	VERB
hls-12723	14	32	an	an	DET
hls-12723	14	33	infiltrate	infiltrate	NOUN
hls-12723	14	34	of	of	ADP
hls-12723	14	35	monocytes	monocyte	NOUN
hls-12723	14	36	,	,	PUNCT
hls-12723	14	37	macrophages	macrophage	NOUN
hls-12723	14	38	,	,	PUNCT
hls-12723	14	39	lymphocytes	lymphocyte	NOUN
hls-12723	14	40	,	,	PUNCT
hls-12723	14	41	vasculitis	vasculitis	NOUN
hls-12723	14	42	,	,	PUNCT
hls-12723	14	43	and	and	CCONJ
hls-12723	14	44	hypercoagulability	hypercoagulability	NOUN
hls-12723	14	45	in	in	ADP
hls-12723	14	46	the	the	DET
hls-12723	14	47	lung	lung	NOUN
hls-12723	14	48	tissue	tissue	NOUN
hls-12723	14	49	.	.	PUNCT
hls-12723	15	1	diffuse	diffuse	VERB
hls-12723	15	2	alveolar	alveolar	ADJ
hls-12723	15	3	damage	damage	NOUN
hls-12723	15	4	,	,	PUNCT
hls-12723	15	5	focal	focal	ADJ
hls-12723	15	6	hyperplasia	hyperplasia	NOUN
hls-12723	15	7	of	of	ADP
hls-12723	15	8	pneumocytes	pneumocyte	NOUN
hls-12723	15	9	with	with	ADP
hls-12723	15	10	infiltration	infiltration	NOUN
hls-12723	15	11	of	of	ADP
hls-12723	15	12	proinflammatory	proinflammatory	ADJ
hls-12723	15	13	cells	cell	NOUN
hls-12723	15	14	,	,	PUNCT
hls-12723	15	15	and	and	CCONJ
hls-12723	15	16	intravascular	intravascular	ADJ
hls-12723	15	17	thrombosis	thrombosis	NOUN
hls-12723	15	18	lead	lead	VERB
hls-12723	15	19	to	to	ADP
hls-12723	15	20	impaired	impair	VERB
hls-12723	15	21	pulmonary	pulmonary	ADJ
hls-12723	15	22	alveolar	alveolar	ADJ
hls-12723	15	23	gas	gas	NOUN
hls-12723	15	24	exchange.2	exchange.2	ADP
hls-12723	15	25	coronavirus	coronavirus	NOUN
hls-12723	15	26	particles	particle	NOUN
hls-12723	15	27	can	can	AUX
hls-12723	15	28	be	be	AUX
hls-12723	15	29	found	find	VERB
hls-12723	15	30	in	in	ADP
hls-12723	15	31	macrophages	macrophage	NOUN
hls-12723	15	32	,	,	PUNCT
hls-12723	15	33	but	but	CCONJ
hls-12723	15	34	it	it	PRON
hls-12723	15	35	is	be	AUX
hls-12723	15	36	still	still	ADV
hls-12723	15	37	unknown	unknown	ADJ
hls-12723	15	38	whether	whether	SCONJ
hls-12723	15	39	it	it	PRON
hls-12723	15	40	is	be	AUX
hls-12723	15	41	due	due	ADJ
hls-12723	15	42	to	to	ADP
hls-12723	15	43	direct	direct	ADJ
hls-12723	15	44	infection	infection	NOUN
hls-12723	15	45	by	by	ADP
hls-12723	15	46	the	the	DET
hls-12723	15	47	virus	virus	NOUN
hls-12723	15	48	or	or	CCONJ
hls-12723	15	49	the	the	DET
hls-12723	15	50	phagocytosis	phagocytosis	NOUN
hls-12723	15	51	process.3	process.3	NOUN
hls-12723	15	52	this	this	PRON
hls-12723	15	53	will	will	AUX
hls-12723	15	54	activate	activate	VERB
hls-12723	15	55	the	the	DET
hls-12723	15	56	nlrp3	nlrp3	NOUN
hls-12723	15	57	inflammasome	inflammasome	NOUN
hls-12723	15	58	receptor	receptor	NOUN
hls-12723	15	59	on	on	ADP
hls-12723	15	60	monocytes	monocyte	NOUN
hls-12723	15	61	/	/	SYM
hls-12723	15	62	macrophages	macrophage	NOUN
hls-12723	15	63	,	,	PUNCT
hls-12723	15	64	releasing	release	VERB
hls-12723	15	65	many	many	ADJ
hls-12723	15	66	proinflammatory	proinflammatory	ADJ
hls-12723	15	67	cytokines	cytokine	NOUN
hls-12723	15	68	(	(	PUNCT
hls-12723	15	69	il-6	il-6	NUM
hls-12723	15	70	,	,	PUNCT
hls-12723	15	71	gm	gm	PROPN
hls-12723	15	72	-	-	PUNCT
hls-12723	15	73	csf	csf	PROPN
hls-12723	15	74	,	,	PUNCT
hls-12723	15	75	il-1b	il-1b	PROPN
hls-12723	15	76	,	,	PUNCT
hls-12723	15	77	tnf	tnf	PROPN
hls-12723	15	78	,	,	PUNCT
hls-12723	15	79	cxcl8	cxcl8	PROPN
hls-12723	15	80	,	,	PUNCT
hls-12723	15	81	ccl-3	ccl-3	PRON
hls-12723	15	82	)	)	PUNCT
hls-12723	15	83	,	,	PUNCT
hls-12723	15	84	causing	cause	VERB
hls-12723	15	85	a	a	DET
hls-12723	15	86	cytokine	cytokine	NOUN
hls-12723	15	87	storm.4	storm.4	NOUN
hls-12723	15	88	a	a	DET
hls-12723	15	89	study	study	NOUN
hls-12723	15	90	by	by	ADP
hls-12723	15	91	gao	gao	PROPN
hls-12723	15	92	et	et	PROPN
hls-12723	15	93	al	al	PROPN
hls-12723	15	94	.	.	PROPN
hls-12723	15	95	showed	show	VERB
hls-12723	15	96	increased	increase	VERB
hls-12723	15	97	levels	level	NOUN
hls-12723	15	98	of	of	ADP
hls-12723	15	99	cytokines	cytokine	NOUN
hls-12723	15	100	,	,	PUNCT
hls-12723	15	101	especially	especially	ADV
hls-12723	15	102	il-6	il-6	NUM
hls-12723	15	103	,	,	PUNCT
hls-12723	15	104	which	which	PRON
hls-12723	15	105	is	be	AUX
hls-12723	15	106	directly	directly	ADV
hls-12723	15	107	related	relate	VERB
hls-12723	15	108	to	to	ADP
hls-12723	15	109	the	the	DET
hls-12723	15	110	severity	severity	NOUN
hls-12723	15	111	of	of	ADP
hls-12723	15	112	the	the	DET
hls-12723	15	113	discorrespondence	discorrespondence	NOUN
hls-12723	15	114	:	:	PUNCT
hls-12723	15	115	dessy	dessy	ADJ
hls-12723	15	116	natalia	natalia	PROPN
hls-12723	15	117	,	,	PUNCT
hls-12723	15	118	department	department	NOUN
hls-12723	15	119	of	of	ADP
hls-12723	15	120	psychiatry	psychiatry	NOUN
hls-12723	15	121	,	,	PUNCT
hls-12723	15	122	faculty	faculty	NOUN
hls-12723	15	123	of	of	ADP
hls-12723	15	124	medicine	medicine	NOUN
hls-12723	15	125	,	,	PUNCT
hls-12723	15	126	hasanuddin	hasanuddin	VERB
hls-12723	15	127	universitas	universita	NOUN
hls-12723	15	128	,	,	PUNCT
hls-12723	15	129	90245	90245	NUM
hls-12723	15	130	makassar	makassar	NOUN
hls-12723	15	131	,	,	PUNCT
hls-12723	15	132	indonesia	indonesia	PROPN
hls-12723	15	133	.	.	PUNCT
hls-12723	16	1	tel	tel	PROPN
hls-12723	16	2	.	.	PROPN
hls-12723	16	3	:	:	PUNCT
hls-12723	17	1	+628114615988	+628114615988	NUM
hls-12723	17	2	.	.	PUNCT
hls-12723	18	1	e	e	X
hls-12723	18	2	-	-	NOUN
hls-12723	18	3	mail	mail	NOUN
hls-12723	18	4	:	:	PUNCT
hls-12723	18	5	dessynatalia.psychiatry@gmail.com	dessynatalia.psychiatry@gmail.com	NOUN
hls-12723	18	6	key	key	ADJ
hls-12723	18	7	words	word	NOUN
hls-12723	18	8	:	:	PUNCT
hls-12723	18	9	covid-19	covid-19	PROPN
hls-12723	18	10	;	;	PUNCT
hls-12723	18	11	risperidone	risperidone	NOUN
hls-12723	18	12	;	;	PUNCT
hls-12723	18	13	schizophrenia	schizophrenia	NOUN
hls-12723	18	14	;	;	PUNCT
hls-12723	18	15	positive	positive	ADJ
hls-12723	18	16	and	and	CCONJ
hls-12723	18	17	negative	negative	ADJ
hls-12723	18	18	syndrome	syndrome	NOUN
hls-12723	18	19	scale	scale	NOUN
hls-12723	18	20	;	;	PUNCT
hls-12723	18	21	interleukin-6	interleukin-6	X
hls-12723	18	22	.	.	PUNCT
hls-12723	19	1	conflict	conflict	NOUN
hls-12723	19	2	of	of	ADP
hls-12723	19	3	interest	interest	NOUN
hls-12723	19	4	:	:	PUNCT
hls-12723	19	5	the	the	DET
hls-12723	19	6	authors	author	NOUN
hls-12723	19	7	declare	declare	VERB
hls-12723	19	8	no	no	DET
hls-12723	19	9	potential	potential	ADJ
hls-12723	19	10	conflict	conflict	NOUN
hls-12723	19	11	of	of	ADP
hls-12723	19	12	interest	interest	NOUN
hls-12723	19	13	,	,	PUNCT
hls-12723	19	14	and	and	CCONJ
hls-12723	19	15	all	all	DET
hls-12723	19	16	authors	author	NOUN
hls-12723	19	17	confirm	confirm	VERB
hls-12723	19	18	accuracy	accuracy	NOUN
hls-12723	19	19	.	.	PUNCT
hls-12723	20	1	ethics	ethic	NOUN
hls-12723	20	2	approval	approval	NOUN
hls-12723	20	3	:	:	PUNCT
hls-12723	20	4	the	the	DET
hls-12723	20	5	research	research	NOUN
hls-12723	20	6	has	have	AUX
hls-12723	20	7	been	be	AUX
hls-12723	20	8	granted	grant	VERB
hls-12723	20	9	ethical	ethical	ADJ
hls-12723	20	10	clearance	clearance	NOUN
hls-12723	20	11	by	by	ADP
hls-12723	20	12	the	the	DET
hls-12723	20	13	biomedical	biomedical	ADJ
hls-12723	20	14	research	research	PROPN
hls-12723	20	15	ethics	ethic	NOUN
hls-12723	20	16	commission	commission	PROPN
hls-12723	20	17	of	of	ADP
hls-12723	20	18	the	the	DET
hls-12723	20	19	faculty	faculty	NOUN
hls-12723	20	20	of	of	ADP
hls-12723	20	21	medicine	medicine	NOUN
hls-12723	20	22	at	at	ADP
hls-12723	20	23	hasanuddin	hasanuddin	VERB
hls-12723	20	24	university	university	NOUN
hls-12723	20	25	,	,	PUNCT
hls-12723	20	26	under	under	ADP
hls-12723	20	27	certificate	certificate	NOUN
hls-12723	20	28	number	number	NOUN
hls-12723	20	29	492	492	NUM
hls-12723	20	30	/	/	SYM
hls-12723	20	31	un4.6.4.5.31/	un4.6.4.5.31/	PROPN
hls-12723	20	32	pp36/2021	pp36/2021	PROPN
hls-12723	20	33	.	.	PUNCT
hls-12723	21	1	the	the	DET
hls-12723	21	2	study	study	NOUN
hls-12723	21	3	is	be	AUX
hls-12723	21	4	conformed	conform	VERB
hls-12723	21	5	with	with	ADP
hls-12723	21	6	the	the	DET
hls-12723	21	7	helsinki	helsinki	PROPN
hls-12723	21	8	declaration	declaration	NOUN
hls-12723	21	9	of	of	ADP
hls-12723	21	10	1964	1964	NUM
hls-12723	21	11	,	,	PUNCT
hls-12723	21	12	as	as	SCONJ
hls-12723	21	13	revised	revise	VERB
hls-12723	21	14	in	in	ADP
hls-12723	21	15	2013	2013	NUM
hls-12723	21	16	,	,	PUNCT
hls-12723	21	17	concerning	concern	VERB
hls-12723	21	18	human	human	ADJ
hls-12723	21	19	and	and	CCONJ
hls-12723	21	20	animal	animal	NOUN
hls-12723	21	21	rights	right	NOUN
hls-12723	21	22	.	.	PUNCT
hls-12723	22	1	informed	informed	ADJ
hls-12723	22	2	consent	consent	NOUN
hls-12723	22	3	:	:	PUNCT
hls-12723	22	4	all	all	DET
hls-12723	22	5	patients	patient	NOUN
hls-12723	22	6	participating	participate	VERB
hls-12723	22	7	in	in	ADP
hls-12723	22	8	this	this	DET
hls-12723	22	9	study	study	NOUN
hls-12723	22	10	signed	sign	VERB
hls-12723	22	11	a	a	DET
hls-12723	22	12	written	write	VERB
hls-12723	22	13	informed	inform	VERB
hls-12723	22	14	consent	consent	NOUN
hls-12723	22	15	form	form	NOUN
hls-12723	22	16	for	for	ADP
hls-12723	22	17	participating	participate	VERB
hls-12723	22	18	in	in	ADP
hls-12723	22	19	this	this	DET
hls-12723	22	20	study	study	NOUN
hls-12723	22	21	.	.	PUNCT
hls-12723	23	1	patient	patient	ADJ
hls-12723	23	2	consent	consent	NOUN
hls-12723	23	3	for	for	ADP
hls-12723	23	4	publication	publication	NOUN
hls-12723	23	5	:	:	PUNCT
hls-12723	23	6	written	write	VERB
hls-12723	23	7	informed	informed	ADJ
hls-12723	23	8	consent	consent	NOUN
hls-12723	23	9	was	be	AUX
hls-12723	23	10	obtained	obtain	VERB
hls-12723	23	11	from	from	ADP
hls-12723	23	12	a	a	DET
hls-12723	23	13	legally	legally	ADV
hls-12723	23	14	authorized	authorize	VERB
hls-12723	23	15	representative(s	representative(s	NOUN
hls-12723	23	16	)	)	PUNCT
hls-12723	23	17	for	for	ADP
hls-12723	23	18	anonymized	anonymize	VERB
hls-12723	23	19	patient	patient	ADJ
hls-12723	23	20	information	information	NOUN
hls-12723	23	21	to	to	PART
hls-12723	23	22	be	be	AUX
hls-12723	23	23	published	publish	VERB
hls-12723	23	24	in	in	ADP
hls-12723	23	25	this	this	DET
hls-12723	23	26	article	article	NOUN
hls-12723	23	27	.	.	PUNCT
hls-12723	24	1	availability	availability	NOUN
hls-12723	24	2	of	of	ADP
hls-12723	24	3	data	datum	NOUN
hls-12723	24	4	and	and	CCONJ
hls-12723	24	5	materials	material	NOUN
hls-12723	24	6	:	:	PUNCT
hls-12723	24	7	all	all	DET
hls-12723	24	8	data	datum	NOUN
hls-12723	24	9	generated	generate	VERB
hls-12723	24	10	or	or	CCONJ
hls-12723	24	11	analyzed	analyze	VERB
hls-12723	24	12	during	during	ADP
hls-12723	24	13	this	this	DET
hls-12723	24	14	study	study	NOUN
hls-12723	24	15	are	be	AUX
hls-12723	24	16	included	include	VERB
hls-12723	24	17	in	in	ADP
hls-12723	24	18	this	this	DET
hls-12723	24	19	published	publish	VERB
hls-12723	24	20	article	article	NOUN
hls-12723	24	21	.	.	PUNCT
hls-12723	25	1	received	receive	VERB
hls-12723	25	2	:	:	PUNCT
hls-12723	25	3	15	15	NUM
hls-12723	25	4	june	june	PROPN
hls-12723	25	5	2024	2024	NUM
hls-12723	25	6	.	.	PUNCT
hls-12723	26	1	accepted	accept	VERB
hls-12723	26	2	:	:	PUNCT
hls-12723	26	3	10	10	NUM
hls-12723	26	4	july	july	PROPN
hls-12723	26	5	2024	2024	NUM
hls-12723	26	6	.	.	PUNCT
hls-12723	27	1	early	early	ADJ
hls-12723	27	2	access	access	NOUN
hls-12723	27	3	:	:	PUNCT
hls-12723	27	4	22	22	NUM
hls-12723	27	5	july	july	PROPN
hls-12723	27	6	2024	2024	NUM
hls-12723	27	7	.	.	PUNCT
hls-12723	28	1	this	this	DET
hls-12723	28	2	work	work	NOUN
hls-12723	28	3	is	be	AUX
hls-12723	28	4	licensed	license	VERB
hls-12723	28	5	under	under	ADP
hls-12723	28	6	a	a	DET
hls-12723	28	7	creative	creative	ADJ
hls-12723	28	8	commons	common	NOUN
hls-12723	28	9	attribution	attribution	NOUN
hls-12723	28	10	4.0	4.0	NUM
hls-12723	28	11	license	license	NOUN
hls-12723	28	12	(	(	PUNCT
hls-12723	28	13	by	by	ADP
hls-12723	28	14	-	-	PUNCT
hls-12723	28	15	nc	nc	PROPN
hls-12723	28	16	4.0	4.0	NUM
hls-12723	28	17	)	)	PUNCT
hls-12723	28	18	.	.	PUNCT
hls-12723	29	1	©	©	PROPN
hls-12723	29	2	copyright	copyright	NOUN
hls-12723	29	3	:	:	PUNCT
hls-12723	29	4	the	the	DET
hls-12723	29	5	author(s	author(s	PROPN
hls-12723	29	6	)	)	PUNCT
hls-12723	29	7	,	,	PUNCT
hls-12723	29	8	2025	2025	NUM
hls-12723	29	9	licensee	licensee	NOUN
hls-12723	29	10	pagepress	pagepress	NOUN
hls-12723	29	11	,	,	PUNCT
hls-12723	29	12	italy	italy	PROPN
hls-12723	29	13	healthcare	healthcare	PROPN
hls-12723	29	14	in	in	ADP
hls-12723	29	15	low	low	ADJ
hls-12723	29	16	-	-	PUNCT
hls-12723	29	17	resource	resource	NOUN
hls-12723	29	18	settings	setting	NOUN
hls-12723	29	19	2025	2025	NUM
hls-12723	29	20	;	;	PUNCT
hls-12723	29	21	13:12723	13:12723	NUM
hls-12723	29	22	doi:10.4081	doi:10.4081	NOUN
hls-12723	29	23	/	/	SYM
hls-12723	29	24	hls.2024.12723	hls.2024.12723	PROPN
hls-12723	29	25	publisher	publisher	NOUN
hls-12723	29	26	's	's	PART
hls-12723	29	27	note	note	NOUN
hls-12723	29	28	:	:	PUNCT
hls-12723	29	29	all	all	DET
hls-12723	29	30	claims	claim	NOUN
hls-12723	29	31	expressed	express	VERB
hls-12723	29	32	in	in	ADP
hls-12723	29	33	this	this	DET
hls-12723	29	34	article	article	NOUN
hls-12723	29	35	are	be	AUX
hls-12723	29	36	solely	solely	ADV
hls-12723	29	37	those	those	PRON
hls-12723	29	38	of	of	ADP
hls-12723	29	39	the	the	DET
hls-12723	29	40	authors	author	NOUN
hls-12723	29	41	and	and	CCONJ
hls-12723	29	42	do	do	AUX
hls-12723	29	43	not	not	PART
hls-12723	29	44	necessarily	necessarily	ADV
hls-12723	29	45	represent	represent	VERB
hls-12723	29	46	those	those	PRON
hls-12723	29	47	of	of	ADP
hls-12723	29	48	their	their	PRON
hls-12723	29	49	affiliated	affiliated	ADJ
hls-12723	29	50	organizations	organization	NOUN
hls-12723	29	51	,	,	PUNCT
hls-12723	29	52	or	or	CCONJ
hls-12723	29	53	those	those	PRON
hls-12723	29	54	of	of	ADP
hls-12723	29	55	the	the	DET
hls-12723	29	56	publisher	publisher	NOUN
hls-12723	29	57	,	,	PUNCT
hls-12723	29	58	the	the	DET
hls-12723	29	59	editors	editor	NOUN
hls-12723	29	60	and	and	CCONJ
hls-12723	29	61	the	the	DET
hls-12723	29	62	reviewers	reviewer	NOUN
hls-12723	29	63	.	.	PUNCT
hls-12723	30	1	any	any	DET
hls-12723	30	2	product	product	NOUN
hls-12723	30	3	that	that	PRON
hls-12723	30	4	may	may	AUX
hls-12723	30	5	be	be	AUX
hls-12723	30	6	evaluated	evaluate	VERB
hls-12723	30	7	in	in	ADP
hls-12723	30	8	this	this	DET
hls-12723	30	9	article	article	NOUN
hls-12723	30	10	or	or	CCONJ
hls-12723	30	11	claim	claim	NOUN
hls-12723	30	12	that	that	PRON
hls-12723	30	13	may	may	AUX
hls-12723	30	14	be	be	AUX
hls-12723	30	15	made	make	VERB
hls-12723	30	16	by	by	ADP
hls-12723	30	17	its	its	PRON
hls-12723	30	18	manufacturer	manufacturer	NOUN
hls-12723	30	19	is	be	AUX
hls-12723	30	20	not	not	PART
hls-12723	30	21	guaranteed	guarantee	VERB
hls-12723	30	22	or	or	CCONJ
hls-12723	30	23	endorsed	endorse	VERB
hls-12723	30	24	by	by	ADP
hls-12723	30	25	the	the	DET
hls-12723	30	26	publisher	publisher	NOUN
hls-12723	30	27	.	.	PUNCT
hls-12723	31	1	[	[	X
hls-12723	31	2	healthcare	healthcare	NOUN
hls-12723	31	3	in	in	ADP
hls-12723	31	4	low	low	ADJ
hls-12723	31	5	-	-	PUNCT
hls-12723	31	6	resource	resource	NOUN
hls-12723	31	7	settings	setting	NOUN
hls-12723	31	8	2025;13:12723	2025;13:12723	NUM
hls-12723	31	9	]	]	X
hls-12723	32	1	[	[	X
hls-12723	32	2	page	page	NOUN
hls-12723	32	3	99	99	NUM
hls-12723	32	4	]	]	PUNCT
hls-12723	32	5	ease.5	ease.5	ADJ
hls-12723	32	6	another	another	DET
hls-12723	32	7	study	study	NOUN
hls-12723	32	8	showed	show	VERB
hls-12723	32	9	that	that	SCONJ
hls-12723	32	10	il-6	il-6	NOUN
hls-12723	32	11	is	be	AUX
hls-12723	32	12	an	an	DET
hls-12723	32	13	effective	effective	ADJ
hls-12723	32	14	biomarker	biomarker	NOUN
hls-12723	32	15	of	of	ADP
hls-12723	32	16	sars	sar	NOUN
hls-12723	32	17	-	-	PUNCT
hls-12723	32	18	cov-2	cov-2	PUNCT
hls-12723	32	19	and	and	CCONJ
hls-12723	32	20	may	may	AUX
hls-12723	32	21	predict	predict	VERB
hls-12723	32	22	respiratory	respiratory	ADJ
hls-12723	32	23	failure	failure	NOUN
hls-12723	32	24	with	with	ADP
hls-12723	32	25	a	a	DET
hls-12723	32	26	high	high	ADJ
hls-12723	32	27	degree	degree	NOUN
hls-12723	32	28	of	of	ADP
hls-12723	32	29	accuracy	accuracy	NOUN
hls-12723	32	30	and	and	CCONJ
hls-12723	32	31	help	help	VERB
hls-12723	32	32	clinicians	clinician	NOUN
hls-12723	32	33	allocate	allocate	VERB
hls-12723	32	34	patients	patient	NOUN
hls-12723	32	35	correctly	correctly	ADV
hls-12723	32	36	at	at	ADP
hls-12723	32	37	an	an	DET
hls-12723	32	38	early	early	ADJ
hls-12723	32	39	stage	stage	NOUN
hls-12723	32	40	.	.	PUNCT
hls-12723	33	1	serum	serum	NOUN
hls-12723	33	2	il-6	il-6	NOUN
hls-12723	33	3	levels	level	NOUN
hls-12723	33	4	are	be	AUX
hls-12723	33	5	a	a	DET
hls-12723	33	6	valuable	valuable	ADJ
hls-12723	33	7	prognostic	prognostic	ADJ
hls-12723	33	8	biomarker	biomarker	NOUN
hls-12723	33	9	in	in	ADP
hls-12723	33	10	patients	patient	NOUN
hls-12723	33	11	diagnosed	diagnose	VERB
hls-12723	33	12	with	with	ADP
hls-12723	33	13	covid-19	covid-19	PROPN
hls-12723	33	14	disease	disease	NOUN
hls-12723	33	15	.	.	PUNCT
hls-12723	34	1	the	the	PRON
hls-12723	34	2	35	35	NUM
hls-12723	34	3	pg	pg	NOUN
hls-12723	34	4	/	/	SYM
hls-12723	34	5	ml	ml	VERB
hls-12723	34	6	cut	cut	VERB
hls-12723	34	7	-	-	PUNCT
hls-12723	34	8	off	off	ADP
hls-12723	34	9	point	point	NOUN
hls-12723	34	10	can	can	AUX
hls-12723	34	11	differentiate	differentiate	VERB
hls-12723	34	12	patients	patient	NOUN
hls-12723	34	13	with	with	ADP
hls-12723	34	14	more	more	ADV
hls-12723	34	15	severe	severe	ADJ
hls-12723	34	16	conditions.6	conditions.6	PROPN
hls-12723	34	17	covid-19	covid-19	PROPN
hls-12723	34	18	is	be	AUX
hls-12723	34	19	characterized	characterize	VERB
hls-12723	34	20	by	by	ADP
hls-12723	34	21	complexities	complexity	NOUN
hls-12723	34	22	,	,	PUNCT
hls-12723	34	23	including	include	VERB
hls-12723	34	24	humanto	humanto	ADP
hls-12723	34	25	-	-	PUNCT
hls-12723	34	26	human	human	ADJ
hls-12723	34	27	transmission	transmission	NOUN
hls-12723	34	28	,	,	PUNCT
hls-12723	34	29	the	the	DET
hls-12723	34	30	transmission	transmission	NOUN
hls-12723	34	31	of	of	ADP
hls-12723	34	32	asymptomatic	asymptomatic	ADJ
hls-12723	34	33	carriers	carrier	NOUN
hls-12723	34	34	,	,	PUNCT
hls-12723	34	35	and	and	CCONJ
hls-12723	34	36	high	high	ADJ
hls-12723	34	37	transmission	transmission	NOUN
hls-12723	34	38	efficiency	efficiency	NOUN
hls-12723	34	39	,	,	PUNCT
hls-12723	34	40	leading	lead	VERB
hls-12723	34	41	to	to	ADP
hls-12723	34	42	a	a	DET
hls-12723	34	43	worldwide	worldwide	ADJ
hls-12723	34	44	pandemic.7	pandemic.7	PROPN
hls-12723	34	45	patients	patient	NOUN
hls-12723	34	46	with	with	ADP
hls-12723	34	47	severe	severe	ADJ
hls-12723	34	48	mental	mental	ADJ
hls-12723	34	49	disorders	disorder	NOUN
hls-12723	34	50	are	be	AUX
hls-12723	34	51	more	more	ADV
hls-12723	34	52	susceptible	susceptible	ADJ
hls-12723	34	53	to	to	ADP
hls-12723	34	54	infection	infection	NOUN
hls-12723	34	55	for	for	ADP
hls-12723	34	56	various	various	ADJ
hls-12723	34	57	reasons	reason	NOUN
hls-12723	34	58	,	,	PUNCT
hls-12723	34	59	some	some	PRON
hls-12723	34	60	related	related	ADJ
hls-12723	34	61	to	to	ADP
hls-12723	34	62	the	the	DET
hls-12723	34	63	presence	presence	NOUN
hls-12723	34	64	of	of	ADP
hls-12723	34	65	an	an	DET
hls-12723	34	66	underlying	underlie	VERB
hls-12723	34	67	disease	disease	NOUN
hls-12723	34	68	and	and	CCONJ
hls-12723	34	69	some	some	PRON
hls-12723	34	70	due	due	ADJ
hls-12723	34	71	to	to	ADP
hls-12723	34	72	environmental	environmental	ADJ
hls-12723	34	73	factors	factor	NOUN
hls-12723	34	74	,	,	PUNCT
hls-12723	34	75	including	include	VERB
hls-12723	34	76	housing	housing	NOUN
hls-12723	34	77	insecurity	insecurity	NOUN
hls-12723	34	78	,	,	PUNCT
hls-12723	34	79	smoking	smoking	NOUN
hls-12723	34	80	,	,	PUNCT
hls-12723	34	81	poor	poor	ADJ
hls-12723	34	82	access	access	NOUN
hls-12723	34	83	to	to	ADP
hls-12723	34	84	health	health	NOUN
hls-12723	34	85	facilities	facility	NOUN
hls-12723	34	86	,	,	PUNCT
hls-12723	34	87	and	and	CCONJ
hls-12723	34	88	the	the	DET
hls-12723	34	89	effects	effect	NOUN
hls-12723	34	90	of	of	ADP
hls-12723	34	91	medications	medication	NOUN
hls-12723	34	92	used	use	VERB
hls-12723	34	93	to	to	PART
hls-12723	34	94	treat	treat	VERB
hls-12723	34	95	the	the	DET
hls-12723	34	96	disorder	disorder	NOUN
hls-12723	34	97	.	.	PUNCT
hls-12723	35	1	this	this	PRON
hls-12723	35	2	increased	increase	VERB
hls-12723	35	3	susceptibility	susceptibility	NOUN
hls-12723	35	4	to	to	ADP
hls-12723	35	5	respiratory	respiratory	ADJ
hls-12723	35	6	tract	tract	NOUN
hls-12723	35	7	infections	infection	NOUN
hls-12723	35	8	may	may	AUX
hls-12723	35	9	contribute	contribute	VERB
hls-12723	35	10	to	to	ADP
hls-12723	35	11	the	the	DET
hls-12723	35	12	risk	risk	NOUN
hls-12723	35	13	of	of	ADP
hls-12723	35	14	covid-19	covid-19	PROPN
hls-12723	35	15	in	in	ADP
hls-12723	35	16	patients	patient	NOUN
hls-12723	35	17	with	with	ADP
hls-12723	35	18	severe	severe	ADJ
hls-12723	35	19	mental	mental	ADJ
hls-12723	35	20	illness	illness	NOUN
hls-12723	35	21	or	or	CCONJ
hls-12723	35	22	who	who	PRON
hls-12723	35	23	are	be	AUX
hls-12723	35	24	in	in	ADP
hls-12723	35	25	inpatient	inpatient	NOUN
hls-12723	35	26	care.8	care.8	NOUN
hls-12723	35	27	dadi	dadi	NOUN
hls-12723	35	28	regional	regional	ADJ
hls-12723	35	29	special	special	ADJ
hls-12723	35	30	hospital	hospital	NOUN
hls-12723	35	31	,	,	PUNCT
hls-12723	35	32	south	south	PROPN
hls-12723	35	33	sulawesi	sulawesi	PROPN
hls-12723	35	34	province	province	PROPN
hls-12723	35	35	,	,	PUNCT
hls-12723	35	36	reported	report	VERB
hls-12723	35	37	that	that	SCONJ
hls-12723	35	38	80	80	NUM
hls-12723	35	39	patients	patient	NOUN
hls-12723	35	40	with	with	ADP
hls-12723	35	41	schizophrenia	schizophrenia	NOUN
hls-12723	35	42	positively	positively	ADV
hls-12723	35	43	exposed	expose	VERB
hls-12723	35	44	to	to	ADP
hls-12723	35	45	covid-19	covid-19	PROPN
hls-12723	35	46	since	since	SCONJ
hls-12723	35	47	december	december	PROPN
hls-12723	35	48	2020	2020	NUM
hls-12723	35	49	were	be	AUX
hls-12723	35	50	generally	generally	ADV
hls-12723	35	51	asymptomatic	asymptomatic	ADJ
hls-12723	35	52	.	.	PUNCT
hls-12723	36	1	these	these	DET
hls-12723	36	2	patients	patient	NOUN
hls-12723	36	3	received	receive	VERB
hls-12723	36	4	typical	typical	ADJ
hls-12723	36	5	and	and	CCONJ
hls-12723	36	6	atypical	atypical	ADJ
hls-12723	36	7	antipsychotic	antipsychotic	ADJ
hls-12723	36	8	therapies	therapy	NOUN
hls-12723	36	9	,	,	PUNCT
hls-12723	36	10	including	include	VERB
hls-12723	36	11	haloperidol	haloperidol	NOUN
hls-12723	36	12	,	,	PUNCT
hls-12723	36	13	chlorpromazine	chlorpromazine	NOUN
hls-12723	36	14	,	,	PUNCT
hls-12723	36	15	risperidone	risperidone	NOUN
hls-12723	36	16	,	,	PUNCT
hls-12723	36	17	and	and	CCONJ
hls-12723	36	18	clozapine	clozapine	NOUN
hls-12723	36	19	.	.	PUNCT
hls-12723	37	1	schizophrenia	schizophrenia	PROPN
hls-12723	37	2	is	be	AUX
hls-12723	37	3	a	a	DET
hls-12723	37	4	chronic	chronic	ADJ
hls-12723	37	5	mental	mental	ADJ
hls-12723	37	6	disorder	disorder	NOUN
hls-12723	37	7	characterized	characterize	VERB
hls-12723	37	8	by	by	ADP
hls-12723	37	9	many	many	ADJ
hls-12723	37	10	symptoms	symptom	NOUN
hls-12723	37	11	,	,	PUNCT
hls-12723	37	12	such	such	ADJ
hls-12723	37	13	as	as	ADP
hls-12723	37	14	hallucinations	hallucination	NOUN
hls-12723	37	15	,	,	PUNCT
hls-12723	37	16	delusions	delusion	NOUN
hls-12723	37	17	,	,	PUNCT
hls-12723	37	18	confused	confused	ADJ
hls-12723	37	19	thoughts	thought	NOUN
hls-12723	37	20	,	,	PUNCT
hls-12723	37	21	and	and	CCONJ
hls-12723	37	22	impaired	impaired	ADJ
hls-12723	37	23	cognitive	cognitive	NOUN
hls-12723	37	24	function.9	function.9	X
hls-12723	37	25	the	the	DET
hls-12723	37	26	etiology	etiology	NOUN
hls-12723	37	27	of	of	ADP
hls-12723	37	28	schizophrenia	schizophrenia	NOUN
hls-12723	37	29	itself	itself	PRON
hls-12723	37	30	is	be	AUX
hls-12723	37	31	not	not	PART
hls-12723	37	32	well	well	ADV
hls-12723	37	33	understood	understand	VERB
hls-12723	37	34	.	.	PUNCT
hls-12723	38	1	the	the	DET
hls-12723	38	2	hypothesis	hypothesis	NOUN
hls-12723	38	3	that	that	PRON
hls-12723	38	4	often	often	ADV
hls-12723	38	5	arises	arise	VERB
hls-12723	38	6	is	be	AUX
hls-12723	38	7	that	that	SCONJ
hls-12723	38	8	biological	biological	ADJ
hls-12723	38	9	mechanisms	mechanism	NOUN
hls-12723	38	10	such	such	ADJ
hls-12723	38	11	as	as	ADP
hls-12723	38	12	the	the	DET
hls-12723	38	13	metabolic	metabolic	NOUN
hls-12723	38	14	system	system	NOUN
hls-12723	38	15	or	or	CCONJ
hls-12723	38	16	the	the	DET
hls-12723	38	17	immune	immune	ADJ
hls-12723	38	18	system	system	NOUN
hls-12723	38	19	are	be	AUX
hls-12723	38	20	involved	involve	VERB
hls-12723	38	21	in	in	ADP
hls-12723	38	22	the	the	DET
hls-12723	38	23	pathophysiology	pathophysiology	NOUN
hls-12723	38	24	of	of	ADP
hls-12723	38	25	schizophrenia	schizophrenia	NOUN
hls-12723	38	26	.	.	PUNCT
hls-12723	39	1	several	several	ADJ
hls-12723	39	2	processes	process	NOUN
hls-12723	39	3	,	,	PUNCT
hls-12723	39	4	such	such	ADJ
hls-12723	39	5	as	as	ADP
hls-12723	39	6	inflammation	inflammation	NOUN
hls-12723	39	7	,	,	PUNCT
hls-12723	39	8	oxidative	oxidative	ADJ
hls-12723	39	9	stress	stress	NOUN
hls-12723	39	10	,	,	PUNCT
hls-12723	39	11	and	and	CCONJ
hls-12723	39	12	complex	complex	ADJ
hls-12723	39	13	interactions	interaction	NOUN
hls-12723	39	14	of	of	ADP
hls-12723	39	15	neurotransmitters	neurotransmitter	NOUN
hls-12723	39	16	,	,	PUNCT
hls-12723	39	17	are	be	AUX
hls-12723	39	18	concerned	concern	VERB
hls-12723	39	19	with	with	ADP
hls-12723	39	20	the	the	DET
hls-12723	39	21	pathophysiology	pathophysiology	NOUN
hls-12723	39	22	of	of	ADP
hls-12723	39	23	schizophrenia.10	schizophrenia.10	VERB
hls-12723	39	24	the	the	DET
hls-12723	39	25	release	release	NOUN
hls-12723	39	26	of	of	ADP
hls-12723	39	27	proinflammatory	proinflammatory	ADJ
hls-12723	39	28	cytokines	cytokine	NOUN
hls-12723	39	29	and	and	CCONJ
hls-12723	39	30	free	free	ADJ
hls-12723	39	31	radicals	radical	NOUN
hls-12723	39	32	associated	associate	VERB
hls-12723	39	33	with	with	ADP
hls-12723	39	34	activated	activate	VERB
hls-12723	39	35	microglia	microglia	NOUN
hls-12723	39	36	is	be	AUX
hls-12723	39	37	associated	associate	VERB
hls-12723	39	38	with	with	ADP
hls-12723	39	39	the	the	DET
hls-12723	39	40	pathophysiology	pathophysiology	NOUN
hls-12723	39	41	of	of	ADP
hls-12723	39	42	schizophrenia	schizophrenia	NOUN
hls-12723	39	43	.	.	PUNCT
hls-12723	40	1	it	it	PRON
hls-12723	40	2	is	be	AUX
hls-12723	40	3	also	also	ADV
hls-12723	40	4	found	find	VERB
hls-12723	40	5	in	in	ADP
hls-12723	40	6	postmortem	postmortem	NOUN
hls-12723	40	7	examination	examination	NOUN
hls-12723	40	8	of	of	ADP
hls-12723	40	9	brain	brain	NOUN
hls-12723	40	10	tissue.11	tissue.11	VERB
hls-12723	40	11	an	an	DET
hls-12723	40	12	increase	increase	NOUN
hls-12723	40	13	in	in	ADP
hls-12723	40	14	several	several	ADJ
hls-12723	40	15	markers	marker	NOUN
hls-12723	40	16	of	of	ADP
hls-12723	40	17	inflammation	inflammation	NOUN
hls-12723	40	18	in	in	ADP
hls-12723	40	19	serum	serum	NOUN
hls-12723	40	20	and	and	CCONJ
hls-12723	40	21	csf	csf	PROPN
hls-12723	40	22	,	,	PUNCT
hls-12723	40	23	such	such	ADJ
hls-12723	40	24	as	as	ADP
hls-12723	40	25	prostaglandin	prostaglandin	NOUN
hls-12723	40	26	e2	e2	PROPN
hls-12723	40	27	(	(	PUNCT
hls-12723	40	28	pge2	pge2	PROPN
hls-12723	40	29	)	)	PUNCT
hls-12723	40	30	,	,	PUNCT
hls-12723	40	31	creative	creative	ADJ
hls-12723	40	32	protein	protein	NOUN
hls-12723	40	33	(	(	PUNCT
hls-12723	40	34	crp	crp	PROPN
hls-12723	40	35	)	)	PUNCT
hls-12723	40	36	,	,	PUNCT
hls-12723	40	37	and	and	CCONJ
hls-12723	40	38	several	several	ADJ
hls-12723	40	39	proinflammatory	proinflammatory	ADJ
hls-12723	40	40	cytokines	cytokine	NOUN
hls-12723	40	41	such	such	ADJ
hls-12723	40	42	as	as	ADP
hls-12723	40	43	interleukin	interleukin	NOUN
hls-12723	40	44	(	(	PUNCT
hls-12723	40	45	il)-1β	il)-1β	PROPN
hls-12723	40	46	,	,	PUNCT
hls-12723	40	47	il-6	il-6	PRON
hls-12723	40	48	,	,	PUNCT
hls-12723	40	49	il-8	il-8	NOUN
hls-12723	40	50	,	,	PUNCT
hls-12723	40	51	and	and	CCONJ
hls-12723	40	52	tumor	tumor	NOUN
hls-12723	40	53	necrosis	necrosis	NOUN
hls-12723	40	54	factor	factor	NOUN
hls-12723	40	55	(	(	PUNCT
hls-12723	40	56	tnf)α	tnf)α	PROPN
hls-12723	40	57	also	also	ADV
hls-12723	40	58	observed	observe	VERB
hls-12723	40	59	in	in	ADP
hls-12723	40	60	schizophrenic	schizophrenic	ADJ
hls-12723	40	61	patients.12	patients.12	NOUN
hls-12723	40	62	involvement	involvement	NOUN
hls-12723	40	63	of	of	ADP
hls-12723	40	64	the	the	DET
hls-12723	40	65	immune	immune	ADJ
hls-12723	40	66	system	system	NOUN
hls-12723	40	67	is	be	AUX
hls-12723	40	68	thought	think	VERB
hls-12723	40	69	to	to	PART
hls-12723	40	70	be	be	AUX
hls-12723	40	71	related	relate	VERB
hls-12723	40	72	to	to	ADP
hls-12723	40	73	the	the	DET
hls-12723	40	74	pathogenesis	pathogenesis	NOUN
hls-12723	40	75	of	of	ADP
hls-12723	40	76	schizophrenia	schizophrenia	NOUN
hls-12723	40	77	,	,	PUNCT
hls-12723	40	78	especially	especially	ADV
hls-12723	40	79	in	in	ADP
hls-12723	40	80	negative	negative	ADJ
hls-12723	40	81	symptoms	symptom	NOUN
hls-12723	40	82	and	and	CCONJ
hls-12723	40	83	cognitive	cognitive	ADJ
hls-12723	40	84	dysfunction.13	dysfunction.13	NOUN
hls-12723	40	85	this	this	DET
hls-12723	40	86	immune	immune	ADJ
hls-12723	40	87	system	system	NOUN
hls-12723	40	88	dysregulation	dysregulation	NOUN
hls-12723	40	89	can	can	AUX
hls-12723	40	90	be	be	AUX
hls-12723	40	91	connected	connect	VERB
hls-12723	40	92	to	to	ADP
hls-12723	40	93	events	event	NOUN
hls-12723	40	94	,	,	PUNCT
hls-12723	40	95	risk	risk	NOUN
hls-12723	40	96	factors	factor	NOUN
hls-12723	40	97	,	,	PUNCT
hls-12723	40	98	or	or	CCONJ
hls-12723	40	99	responses	response	NOUN
hls-12723	40	100	to	to	ADP
hls-12723	40	101	therapy	therapy	NOUN
hls-12723	40	102	in	in	ADP
hls-12723	40	103	schizophrenic	schizophrenic	ADJ
hls-12723	40	104	patients.14	patients.14	PROPN
hls-12723	40	105	antipsychotic	antipsychotic	ADJ
hls-12723	40	106	medication	medication	NOUN
hls-12723	40	107	is	be	AUX
hls-12723	40	108	the	the	DET
hls-12723	40	109	treatment	treatment	NOUN
hls-12723	40	110	of	of	ADP
hls-12723	40	111	choice	choice	NOUN
hls-12723	40	112	for	for	ADP
hls-12723	40	113	schizophrenia	schizophrenia	NOUN
hls-12723	40	114	.	.	PUNCT
hls-12723	41	1	risperidone	risperidone	NOUN
hls-12723	41	2	is	be	AUX
hls-12723	41	3	a	a	DET
hls-12723	41	4	second	second	ADJ
hls-12723	41	5	-	-	PUNCT
hls-12723	41	6	generation	generation	NOUN
hls-12723	41	7	antipsychotic	antipsychotic	ADJ
hls-12723	41	8	drug	drug	NOUN
hls-12723	41	9	that	that	PRON
hls-12723	41	10	is	be	AUX
hls-12723	41	11	effective	effective	ADJ
hls-12723	41	12	for	for	ADP
hls-12723	41	13	positive	positive	ADJ
hls-12723	41	14	and	and	CCONJ
hls-12723	41	15	negative	negative	ADJ
hls-12723	41	16	symptoms	symptom	NOUN
hls-12723	41	17	of	of	ADP
hls-12723	41	18	schizophrenia	schizophrenia	NOUN
hls-12723	41	19	.	.	PUNCT
hls-12723	42	1	side	side	ADJ
hls-12723	42	2	effects	effect	NOUN
hls-12723	42	3	of	of	ADP
hls-12723	42	4	these	these	DET
hls-12723	42	5	drugs	drug	NOUN
hls-12723	42	6	are	be	AUX
hls-12723	42	7	mild	mild	ADJ
hls-12723	42	8	and	and	CCONJ
hls-12723	42	9	generally	generally	ADV
hls-12723	42	10	do	do	AUX
hls-12723	42	11	not	not	PART
hls-12723	42	12	interfere	interfere	VERB
hls-12723	42	13	with	with	ADP
hls-12723	42	14	cognitive	cognitive	ADJ
hls-12723	42	15	function	function	NOUN
hls-12723	42	16	.	.	PUNCT
hls-12723	43	1	there	there	PRON
hls-12723	43	2	are	be	VERB
hls-12723	43	3	several	several	ADJ
hls-12723	43	4	mechanisms	mechanism	NOUN
hls-12723	43	5	by	by	ADP
hls-12723	43	6	which	which	PRON
hls-12723	43	7	risperidone	risperidone	NOUN
hls-12723	43	8	may	may	AUX
hls-12723	43	9	decrease	decrease	VERB
hls-12723	43	10	il-6	il-6	PRON
hls-12723	43	11	levels	level	NOUN
hls-12723	43	12	.	.	PUNCT
hls-12723	44	1	accumulating	accumulate	VERB
hls-12723	44	2	evidence	evidence	NOUN
hls-12723	44	3	has	have	AUX
hls-12723	44	4	shown	show	VERB
hls-12723	44	5	that	that	SCONJ
hls-12723	44	6	astrocytes	astrocyte	NOUN
hls-12723	44	7	can	can	AUX
hls-12723	44	8	amplify	amplify	VERB
hls-12723	44	9	the	the	DET
hls-12723	44	10	cns	cns	NOUN
hls-12723	44	11	’s	’s	PART
hls-12723	44	12	inflammatory	inflammatory	ADJ
hls-12723	44	13	response	response	NOUN
hls-12723	44	14	,	,	PUNCT
hls-12723	44	15	a	a	DET
hls-12723	44	16	phenomenon	phenomenon	NOUN
hls-12723	44	17	closely	closely	ADV
hls-12723	44	18	related	relate	VERB
hls-12723	44	19	to	to	ADP
hls-12723	44	20	the	the	DET
hls-12723	44	21	neurobiology	neurobiology	NOUN
hls-12723	44	22	and	and	CCONJ
hls-12723	44	23	development	development	NOUN
hls-12723	44	24	of	of	ADP
hls-12723	44	25	neuropsychiatric	neuropsychiatric	ADJ
hls-12723	44	26	disorders	disorder	NOUN
hls-12723	44	27	.	.	PUNCT
hls-12723	45	1	quincozes	quincoze	NOUN
hls-12723	45	2	-	-	PUNCT
hls-12723	45	3	santos	santos	NUM
hls-12723	45	4	et	et	PROPN
hls-12723	45	5	al	al	PROPN
hls-12723	45	6	.	.	PROPN
hls-12723	45	7	observed	observe	VERB
hls-12723	45	8	that	that	SCONJ
hls-12723	45	9	risperidone	risperidone	NOUN
hls-12723	45	10	had	have	VERB
hls-12723	45	11	anti	anti	ADJ
hls-12723	45	12	-	-	ADJ
hls-12723	45	13	inflammatory	inflammatory	ADJ
hls-12723	45	14	action	action	NOUN
hls-12723	45	15	on	on	ADP
hls-12723	45	16	c6	c6	PROPN
hls-12723	45	17	astroglia	astroglia	PROPN
hls-12723	45	18	,	,	PUNCT
hls-12723	45	19	decreasing	decrease	VERB
hls-12723	45	20	il-6	il-6	NOUN
hls-12723	45	21	release.15	release.15	NOUN
hls-12723	45	22	people	people	NOUN
hls-12723	45	23	with	with	ADP
hls-12723	45	24	schizophrenia	schizophrenia	NOUN
hls-12723	45	25	and	and	CCONJ
hls-12723	45	26	people	people	NOUN
hls-12723	45	27	who	who	PRON
hls-12723	45	28	have	have	VERB
hls-12723	45	29	sars	sar	NOUN
hls-12723	45	30	-	-	PUNCT
hls-12723	45	31	cov-2	cov-2	NOUN
hls-12723	45	32	both	both	PRON
hls-12723	45	33	have	have	VERB
hls-12723	45	34	an	an	DET
hls-12723	45	35	inflammatory	inflammatory	ADJ
hls-12723	45	36	response	response	NOUN
hls-12723	45	37	that	that	PRON
hls-12723	45	38	includes	include	VERB
hls-12723	45	39	higher	high	ADJ
hls-12723	45	40	levels	level	NOUN
hls-12723	45	41	of	of	ADP
hls-12723	45	42	cytokines	cytokine	NOUN
hls-12723	45	43	and	and	CCONJ
hls-12723	45	44	inflammatory	inflammatory	ADJ
hls-12723	45	45	markers	marker	NOUN
hls-12723	45	46	like	like	ADP
hls-12723	45	47	il-1β	il-1β	PROPN
hls-12723	45	48	,	,	PUNCT
hls-12723	45	49	il-6	il-6	NOUN
hls-12723	45	50	,	,	PUNCT
hls-12723	45	51	il-8	il-8	NOUN
hls-12723	45	52	,	,	PUNCT
hls-12723	45	53	and	and	CCONJ
hls-12723	45	54	tnf	tnf	PROPN
hls-12723	45	55	.	.	PUNCT
hls-12723	46	1	so	so	ADV
hls-12723	46	2	,	,	PUNCT
hls-12723	46	3	this	this	DET
hls-12723	46	4	study	study	NOUN
hls-12723	46	5	aims	aim	VERB
hls-12723	46	6	to	to	PART
hls-12723	46	7	explore	explore	VERB
hls-12723	46	8	the	the	DET
hls-12723	46	9	relationship	relationship	NOUN
hls-12723	46	10	between	between	ADP
hls-12723	46	11	il-6	il-6	NOUN
hls-12723	46	12	levels	level	NOUN
hls-12723	46	13	,	,	PUNCT
hls-12723	46	14	the	the	DET
hls-12723	46	15	efficacy	efficacy	NOUN
hls-12723	46	16	of	of	ADP
hls-12723	46	17	risperidone	risperidone	NOUN
hls-12723	46	18	therapy	therapy	NOUN
hls-12723	46	19	,	,	PUNCT
hls-12723	46	20	and	and	CCONJ
hls-12723	46	21	the	the	DET
hls-12723	46	22	panss	pans	NOUN
hls-12723	46	23	score	score	NOUN
hls-12723	46	24	in	in	ADP
hls-12723	46	25	schizophrenia	schizophrenia	NOUN
hls-12723	46	26	patients	patient	NOUN
hls-12723	46	27	diagnosed	diagnose	VERB
hls-12723	46	28	with	with	ADP
hls-12723	46	29	covid-19	covid-19	PROPN
hls-12723	46	30	.	.	PUNCT
hls-12723	46	31	materials	material	NOUN
hls-12723	46	32	and	and	CCONJ
hls-12723	46	33	methods	method	NOUN
hls-12723	46	34	study	study	NOUN
hls-12723	46	35	design	design	NOUN
hls-12723	46	36	this	this	DET
hls-12723	46	37	study	study	NOUN
hls-12723	46	38	was	be	AUX
hls-12723	46	39	an	an	DET
hls-12723	46	40	analytical	analytical	ADJ
hls-12723	46	41	observational	observational	ADJ
hls-12723	46	42	study	study	NOUN
hls-12723	46	43	with	with	ADP
hls-12723	46	44	a	a	DET
hls-12723	46	45	prospective	prospective	ADJ
hls-12723	46	46	cohort	cohort	NOUN
hls-12723	46	47	approach	approach	NOUN
hls-12723	46	48	.	.	PUNCT
hls-12723	47	1	a	a	DET
hls-12723	47	2	cohort	cohort	NOUN
hls-12723	47	3	study	study	NOUN
hls-12723	47	4	examines	examine	VERB
hls-12723	47	5	the	the	DET
hls-12723	47	6	relationship	relationship	NOUN
hls-12723	47	7	between	between	ADP
hls-12723	47	8	exposure	exposure	NOUN
hls-12723	47	9	and	and	CCONJ
hls-12723	47	10	disease	disease	NOUN
hls-12723	47	11	by	by	ADP
hls-12723	47	12	selecting	select	VERB
hls-12723	47	13	two	two	NUM
hls-12723	47	14	or	or	CCONJ
hls-12723	47	15	more	more	ADJ
hls-12723	47	16	study	study	NOUN
hls-12723	47	17	groups	group	NOUN
hls-12723	47	18	based	base	VERB
hls-12723	47	19	on	on	ADP
hls-12723	47	20	exposure	exposure	NOUN
hls-12723	47	21	status	status	NOUN
hls-12723	47	22	and	and	CCONJ
hls-12723	47	23	then	then	ADV
hls-12723	47	24	following	follow	VERB
hls-12723	47	25	them	they	PRON
hls-12723	47	26	for	for	ADP
hls-12723	47	27	a	a	DET
hls-12723	47	28	certain	certain	ADJ
hls-12723	47	29	period	period	NOUN
hls-12723	47	30	to	to	PART
hls-12723	47	31	identify	identify	VERB
hls-12723	47	32	and	and	CCONJ
hls-12723	47	33	calculate	calculate	VERB
hls-12723	47	34	the	the	DET
hls-12723	47	35	magnitude	magnitude	NOUN
hls-12723	47	36	of	of	ADP
hls-12723	47	37	the	the	DET
hls-12723	47	38	disease	disease	NOUN
hls-12723	47	39	.	.	PUNCT
hls-12723	48	1	population	population	NOUN
hls-12723	48	2	and	and	CCONJ
hls-12723	48	3	sample	sample	VERB
hls-12723	48	4	the	the	DET
hls-12723	48	5	population	population	NOUN
hls-12723	48	6	in	in	ADP
hls-12723	48	7	this	this	DET
hls-12723	48	8	study	study	NOUN
hls-12723	48	9	were	be	AUX
hls-12723	48	10	schizophrenic	schizophrenic	ADJ
hls-12723	48	11	subjects	subject	NOUN
hls-12723	48	12	with	with	ADP
hls-12723	48	13	and	and	CCONJ
hls-12723	48	14	without	without	ADP
hls-12723	48	15	covid-19	covid-19	PROPN
hls-12723	48	16	,	,	PUNCT
hls-12723	48	17	mild	mild	ADJ
hls-12723	48	18	-	-	PUNCT
hls-12723	48	19	moderate	moderate	ADJ
hls-12723	48	20	and	and	CCONJ
hls-12723	48	21	asymptomatic	asymptomatic	ADJ
hls-12723	48	22	covid-19	covid-19	PROPN
hls-12723	48	23	,	,	PUNCT
hls-12723	48	24	and	and	CCONJ
hls-12723	48	25	schizophrenic	schizophrenic	ADJ
hls-12723	48	26	subjects	subject	NOUN
hls-12723	48	27	without	without	ADP
hls-12723	48	28	covid-19	covid-19	PROPN
hls-12723	48	29	who	who	PRON
hls-12723	48	30	were	be	AUX
hls-12723	48	31	hospitalized	hospitalize	VERB
hls-12723	48	32	and	and	CCONJ
hls-12723	48	33	met	meet	VERB
hls-12723	48	34	the	the	DET
hls-12723	48	35	inclusion	inclusion	NOUN
hls-12723	48	36	and	and	CCONJ
hls-12723	48	37	exclusion	exclusion	NOUN
hls-12723	48	38	criteria	criterion	NOUN
hls-12723	48	39	.	.	PUNCT
hls-12723	49	1	the	the	DET
hls-12723	49	2	research	research	NOUN
hls-12723	49	3	sought	seek	VERB
hls-12723	49	4	individuals	individual	NOUN
hls-12723	49	5	aged	age	VERB
hls-12723	49	6	20	20	NUM
hls-12723	49	7	-	-	SYM
hls-12723	49	8	50	50	NUM
hls-12723	49	9	diagnosed	diagnose	VERB
hls-12723	49	10	with	with	ADP
hls-12723	49	11	both	both	PRON
hls-12723	49	12	covid-19	covid-19	PROPN
hls-12723	49	13	and	and	CCONJ
hls-12723	49	14	schizophrenia	schizophrenia	NOUN
hls-12723	49	15	,	,	PUNCT
hls-12723	49	16	actively	actively	ADV
hls-12723	49	17	taking	take	VERB
hls-12723	49	18	risperidone	risperidone	NOUN
hls-12723	49	19	at	at	ADP
hls-12723	49	20	a	a	DET
hls-12723	49	21	daily	daily	ADJ
hls-12723	49	22	dosage	dosage	NOUN
hls-12723	49	23	of	of	ADP
hls-12723	49	24	2	2	NUM
hls-12723	49	25	-	-	SYM
hls-12723	49	26	6	6	NUM
hls-12723	49	27	mg	mg	NOUN
hls-12723	49	28	for	for	ADP
hls-12723	49	29	at	at	ADV
hls-12723	49	30	least	least	ADV
hls-12723	49	31	four	four	NUM
hls-12723	49	32	weeks	week	NOUN
hls-12723	49	33	,	,	PUNCT
hls-12723	49	34	confirmed	confirm	VERB
hls-12723	49	35	with	with	ADP
hls-12723	49	36	an	an	DET
hls-12723	49	37	rt	rt	ADJ
hls-12723	49	38	-	-	PUNCT
hls-12723	49	39	pcr	pcr	PROPN
hls-12723	49	40	swab	swab	NOUN
hls-12723	49	41	test	test	NOUN
hls-12723	49	42	to	to	PART
hls-12723	49	43	have	have	VERB
hls-12723	49	44	mild	mild	ADJ
hls-12723	49	45	to	to	ADP
hls-12723	49	46	moderate	moderate	ADJ
hls-12723	49	47	symptoms	symptom	NOUN
hls-12723	49	48	or	or	CCONJ
hls-12723	49	49	be	be	AUX
hls-12723	49	50	asymptomatic	asymptomatic	ADJ
hls-12723	49	51	and	and	CCONJ
hls-12723	49	52	have	have	VERB
hls-12723	49	53	a	a	DET
hls-12723	49	54	panss	pans	NOUN
hls-12723	49	55	total	total	NOUN
hls-12723	49	56	score	score	NOUN
hls-12723	49	57	of	of	ADP
hls-12723	49	58	less	less	ADJ
hls-12723	49	59	than	than	ADP
hls-12723	49	60	95	95	NUM
hls-12723	49	61	,	,	PUNCT
hls-12723	49	62	indicating	indicate	VERB
hls-12723	49	63	significant	significant	ADJ
hls-12723	49	64	illness	illness	NOUN
hls-12723	49	65	.	.	PUNCT
hls-12723	50	1	the	the	DET
hls-12723	50	2	control	control	PROPN
hls-12723	50	3	group	group	NOUN
hls-12723	50	4	included	include	VERB
hls-12723	50	5	individuals	individual	NOUN
hls-12723	50	6	with	with	ADP
hls-12723	50	7	schizophrenia	schizophrenia	NOUN
hls-12723	50	8	,	,	PUNCT
hls-12723	50	9	negative	negative	ADJ
hls-12723	50	10	for	for	ADP
hls-12723	50	11	covid-19	covid-19	PROPN
hls-12723	50	12	,	,	PUNCT
hls-12723	50	13	also	also	ADV
hls-12723	50	14	taking	take	VERB
hls-12723	50	15	risperidone	risperidone	NOUN
hls-12723	50	16	at	at	ADP
hls-12723	50	17	a	a	DET
hls-12723	50	18	similar	similar	ADJ
hls-12723	50	19	dosage	dosage	NOUN
hls-12723	50	20	for	for	ADP
hls-12723	50	21	at	at	ADV
hls-12723	50	22	least	least	ADV
hls-12723	50	23	four	four	NUM
hls-12723	50	24	weeks	week	NOUN
hls-12723	50	25	,	,	PUNCT
hls-12723	50	26	and	and	CCONJ
hls-12723	50	27	a	a	DET
hls-12723	50	28	panss	pans	NOUN
hls-12723	50	29	total	total	NOUN
hls-12723	50	30	score	score	NOUN
hls-12723	50	31	of	of	ADP
hls-12723	50	32	less	less	ADJ
hls-12723	50	33	than	than	ADP
hls-12723	50	34	95	95	NUM
hls-12723	50	35	.	.	PUNCT
hls-12723	51	1	exclusion	exclusion	NOUN
hls-12723	51	2	criteria	criterion	NOUN
hls-12723	51	3	involved	involve	VERB
hls-12723	51	4	individuals	individual	NOUN
hls-12723	51	5	abusing	abuse	VERB
hls-12723	51	6	drugs	drug	NOUN
hls-12723	51	7	or	or	CCONJ
hls-12723	51	8	alcohol	alcohol	NOUN
hls-12723	51	9	,	,	PUNCT
hls-12723	51	10	taking	take	VERB
hls-12723	51	11	specific	specific	ADJ
hls-12723	51	12	medications	medication	NOUN
hls-12723	51	13	,	,	PUNCT
hls-12723	51	14	or	or	CCONJ
hls-12723	51	15	having	have	VERB
hls-12723	51	16	severe	severe	ADJ
hls-12723	51	17	unrelated	unrelated	ADJ
hls-12723	51	18	physical	physical	ADJ
hls-12723	51	19	illnesses	illness	NOUN
hls-12723	51	20	.	.	PUNCT
hls-12723	52	1	drop	drop	VERB
hls-12723	52	2	-	-	PUNCT
hls-12723	52	3	out	out	ADP
hls-12723	52	4	criteria	criterion	NOUN
hls-12723	52	5	included	include	VERB
hls-12723	52	6	individuals	individual	NOUN
hls-12723	52	7	leaving	leave	VERB
hls-12723	52	8	the	the	DET
hls-12723	52	9	hospital	hospital	NOUN
hls-12723	52	10	before	before	ADP
hls-12723	52	11	four	four	NUM
hls-12723	52	12	weeks	week	NOUN
hls-12723	52	13	or	or	CCONJ
hls-12723	52	14	passing	pass	VERB
hls-12723	52	15	away	away	ADV
hls-12723	52	16	.	.	PUNCT
hls-12723	53	1	research	research	NOUN
hls-12723	53	2	instruments	instrument	VERB
hls-12723	53	3	the	the	DET
hls-12723	53	4	data	data	NOUN
hls-12723	53	5	collection	collection	NOUN
hls-12723	53	6	tools	tool	NOUN
hls-12723	53	7	and	and	CCONJ
hls-12723	53	8	study	study	NOUN
hls-12723	53	9	instruments	instrument	NOUN
hls-12723	53	10	utilized	utilize	VERB
hls-12723	53	11	in	in	ADP
hls-12723	53	12	this	this	DET
hls-12723	53	13	research	research	NOUN
hls-12723	53	14	included	include	VERB
hls-12723	53	15	a	a	DET
hls-12723	53	16	demographic	demographic	ADJ
hls-12723	53	17	questionnaire	questionnaire	NOUN
hls-12723	53	18	sheet	sheet	NOUN
hls-12723	53	19	and	and	CCONJ
hls-12723	53	20	the	the	DET
hls-12723	53	21	positive	positive	ADJ
hls-12723	53	22	and	and	CCONJ
hls-12723	53	23	negative	negative	ADJ
hls-12723	53	24	syndrome	syndrome	NOUN
hls-12723	53	25	scale	scale	NOUN
hls-12723	53	26	(	(	PUNCT
hls-12723	53	27	panss	pans	NOUN
hls-12723	53	28	)	)	PUNCT
hls-12723	53	29	,	,	PUNCT
hls-12723	53	30	a	a	DET
hls-12723	53	31	psychometric	psychometric	ADJ
hls-12723	53	32	tool	tool	NOUN
hls-12723	53	33	used	use	VERB
hls-12723	53	34	to	to	PART
hls-12723	53	35	evaluate	evaluate	VERB
hls-12723	53	36	positive	positive	ADJ
hls-12723	53	37	and	and	CCONJ
hls-12723	53	38	negative	negative	ADJ
hls-12723	53	39	symptoms	symptom	NOUN
hls-12723	53	40	as	as	ADV
hls-12723	53	41	well	well	ADV
hls-12723	53	42	as	as	ADP
hls-12723	53	43	general	general	ADJ
hls-12723	53	44	psychopathology	psychopathology	NOUN
hls-12723	53	45	.	.	PUNCT
hls-12723	54	1	each	each	DET
hls-12723	54	2	item	item	NOUN
hls-12723	54	3	on	on	ADP
hls-12723	54	4	the	the	DET
hls-12723	54	5	scale	scale	NOUN
hls-12723	54	6	is	be	AUX
hls-12723	54	7	scored	score	VERB
hls-12723	54	8	from	from	ADP
hls-12723	54	9	1	1	NUM
hls-12723	54	10	(	(	PUNCT
hls-12723	54	11	no	no	DET
hls-12723	54	12	symptoms	symptom	NOUN
hls-12723	54	13	)	)	PUNCT
hls-12723	54	14	to	to	ADP
hls-12723	54	15	7	7	NUM
hls-12723	54	16	(	(	PUNCT
hls-12723	54	17	very	very	ADV
hls-12723	54	18	severe	severe	ADJ
hls-12723	54	19	symptoms	symptom	NOUN
hls-12723	54	20	)	)	PUNCT
hls-12723	54	21	.	.	PUNCT
hls-12723	55	1	in	in	ADP
hls-12723	55	2	addition	addition	NOUN
hls-12723	55	3	,	,	PUNCT
hls-12723	55	4	serum	serum	NOUN
hls-12723	55	5	elisa	elisa	PROPN
hls-12723	55	6	interleukin	interleukin	NOUN
hls-12723	55	7	6	6	NUM
hls-12723	55	8	(	(	PUNCT
hls-12723	55	9	il-6	il-6	NUM
hls-12723	55	10	)	)	PUNCT
hls-12723	55	11	was	be	AUX
hls-12723	55	12	used	use	VERB
hls-12723	55	13	as	as	ADP
hls-12723	55	14	a	a	DET
hls-12723	55	15	proinflammatory	proinflammatory	ADJ
hls-12723	55	16	cytokine	cytokine	NOUN
hls-12723	55	17	marker	marker	NOUN
hls-12723	55	18	of	of	ADP
hls-12723	55	19	inflammation	inflammation	NOUN
hls-12723	55	20	with	with	ADP
hls-12723	55	21	a	a	DET
hls-12723	55	22	limit	limit	NOUN
hls-12723	55	23	point	point	NOUN
hls-12723	55	24	for	for	ADP
hls-12723	55	25	serum	serum	NOUN
hls-12723	55	26	il-6	il-6	NOUN
hls-12723	55	27	levels	level	NOUN
hls-12723	55	28	set	set	VERB
hls-12723	55	29	at	at	ADP
hls-12723	55	30	35	35	NUM
hls-12723	55	31	pg	pg	NOUN
hls-12723	55	32	/	/	SYM
hls-12723	55	33	ml	ml	NOUN
hls-12723	55	34	.	.	PUNCT
hls-12723	56	1	the	the	DET
hls-12723	56	2	normal	normal	ADJ
hls-12723	56	3	range	range	NOUN
hls-12723	56	4	of	of	ADP
hls-12723	56	5	il-6	il-6	NOUN
hls-12723	56	6	concentrations	concentration	NOUN
hls-12723	56	7	is	be	AUX
hls-12723	56	8	between	between	ADP
hls-12723	56	9	0	0	NUM
hls-12723	56	10	-	-	SYM
hls-12723	56	11	7	7	NUM
hls-12723	56	12	pg	pg	NOUN
hls-12723	56	13	/	/	SYM
hls-12723	56	14	ml	ml	ADP
hls-12723	56	15	,	,	PUNCT
hls-12723	56	16	and	and	CCONJ
hls-12723	56	17	the	the	DET
hls-12723	56	18	blood	blood	NOUN
hls-12723	56	19	plasma	plasma	NOUN
hls-12723	56	20	il-6	il-6	NOUN
hls-12723	56	21	levels	level	NOUN
hls-12723	56	22	were	be	AUX
hls-12723	56	23	measured	measure	VERB
hls-12723	56	24	using	use	VERB
hls-12723	56	25	the	the	DET
hls-12723	56	26	elisa	elisa	NOUN
hls-12723	56	27	method	method	NOUN
hls-12723	56	28	.	.	PUNCT
hls-12723	57	1	data	datum	NOUN
hls-12723	57	2	analysis	analysis	NOUN
hls-12723	57	3	data	datum	NOUN
hls-12723	57	4	analysis	analysis	NOUN
hls-12723	57	5	was	be	AUX
hls-12723	57	6	carried	carry	VERB
hls-12723	57	7	out	out	ADP
hls-12723	57	8	after	after	SCONJ
hls-12723	57	9	the	the	DET
hls-12723	57	10	primary	primary	ADJ
hls-12723	57	11	data	datum	NOUN
hls-12723	57	12	had	have	AUX
hls-12723	57	13	been	be	AUX
hls-12723	57	14	collected	collect	VERB
hls-12723	57	15	using	use	VERB
hls-12723	57	16	the	the	DET
hls-12723	57	17	statistical	statistical	ADJ
hls-12723	57	18	package	package	NOUN
hls-12723	57	19	for	for	ADP
hls-12723	57	20	social	social	ADJ
hls-12723	57	21	sciences	science	NOUN
hls-12723	57	22	(	(	PUNCT
hls-12723	57	23	spss	spss	ADJ
hls-12723	57	24	)	)	PUNCT
hls-12723	57	25	program	program	NOUN
hls-12723	57	26	.	.	PUNCT
hls-12723	58	1	if	if	SCONJ
hls-12723	58	2	the	the	DET
hls-12723	58	3	data	datum	NOUN
hls-12723	58	4	was	be	AUX
hls-12723	58	5	normally	normally	ADV
hls-12723	58	6	distributed	distribute	VERB
hls-12723	58	7	,	,	PUNCT
hls-12723	58	8	an	an	DET
hls-12723	58	9	unpaired	unpaired	ADJ
hls-12723	58	10	t	t	NOUN
hls-12723	58	11	-	-	PUNCT
hls-12723	58	12	test	test	NOUN
hls-12723	58	13	was	be	AUX
hls-12723	58	14	applied	apply	VERB
hls-12723	58	15	,	,	PUNCT
hls-12723	58	16	and	and	CCONJ
hls-12723	58	17	if	if	SCONJ
hls-12723	58	18	it	it	PRON
hls-12723	58	19	was	be	AUX
hls-12723	58	20	not	not	PART
hls-12723	58	21	,	,	PUNCT
hls-12723	58	22	mann	mann	PROPN
hls-12723	58	23	-	-	PUNCT
hls-12723	58	24	whitney	whitney	PROPN
hls-12723	58	25	.	.	PUNCT
hls-12723	59	1	results	result	VERB
hls-12723	59	2	this	this	DET
hls-12723	59	3	study	study	NOUN
hls-12723	59	4	was	be	AUX
hls-12723	59	5	conducted	conduct	VERB
hls-12723	59	6	on	on	ADP
hls-12723	59	7	schizophrenic	schizophrenic	ADJ
hls-12723	59	8	patients	patient	NOUN
hls-12723	59	9	who	who	PRON
hls-12723	59	10	confirmed	confirm	VERB
hls-12723	59	11	positive	positive	ADJ
hls-12723	59	12	covid-19	covid-19	PROPN
hls-12723	59	13	and	and	CCONJ
hls-12723	59	14	had	have	AUX
hls-12723	59	15	been	be	AUX
hls-12723	59	16	screened	screen	VERB
hls-12723	59	17	;	;	PUNCT
hls-12723	59	18	these	these	DET
hls-12723	59	19	patients	patient	NOUN
hls-12723	59	20	were	be	AUX
hls-12723	59	21	inpatients	inpatient	NOUN
hls-12723	59	22	at	at	ADP
hls-12723	59	23	the	the	DET
hls-12723	59	24	dadi	dadi	NOUN
hls-12723	59	25	special	special	ADJ
hls-12723	59	26	hospital	hospital	NOUN
hls-12723	59	27	from	from	ADP
hls-12723	59	28	july	july	PROPN
hls-12723	59	29	to	to	ADP
hls-12723	59	30	august	august	PROPN
hls-12723	59	31	2021	2021	NUM
hls-12723	59	32	.	.	PUNCT
hls-12723	60	1	a	a	DET
hls-12723	60	2	total	total	NOUN
hls-12723	60	3	of	of	ADP
hls-12723	60	4	41	41	NUM
hls-12723	60	5	patients	patient	NOUN
hls-12723	60	6	diagnosed	diagnose	VERB
hls-12723	60	7	with	with	ADP
hls-12723	60	8	schizophrenia	schizophrenia	NOUN
hls-12723	60	9	with	with	ADP
hls-12723	60	10	covid-19	covid-19	PROPN
hls-12723	60	11	were	be	AUX
hls-12723	60	12	screened	screen	VERB
hls-12723	60	13	and	and	CCONJ
hls-12723	60	14	22	22	NUM
hls-12723	60	15	subjects	subject	NOUN
hls-12723	60	16	(	(	PUNCT
hls-12723	60	17	53.65	53.65	NUM
hls-12723	60	18	%	%	NOUN
hls-12723	60	19	)	)	PUNCT
hls-12723	60	20	met	meet	VERB
hls-12723	60	21	the	the	DET
hls-12723	60	22	inclusion	inclusion	NOUN
hls-12723	60	23	criteria	criterion	NOUN
hls-12723	60	24	.	.	PUNCT
hls-12723	61	1	similarly	similarly	ADV
hls-12723	61	2	,	,	PUNCT
hls-12723	61	3	22	22	NUM
hls-12723	61	4	subjects	subject	NOUN
hls-12723	61	5	with	with	ADP
hls-12723	61	6	negative	negative	ADJ
hls-12723	61	7	covid-19	covid-19	PROPN
hls-12723	61	8	were	be	AUX
hls-12723	61	9	screened	screen	VERB
hls-12723	61	10	for	for	ADP
hls-12723	61	11	a	a	DET
hls-12723	61	12	control	control	NOUN
hls-12723	61	13	group	group	NOUN
hls-12723	61	14	.	.	PUNCT
hls-12723	62	1	data	datum	NOUN
hls-12723	62	2	analysis	analysis	NOUN
hls-12723	62	3	was	be	AUX
hls-12723	62	4	conducted	conduct	VERB
hls-12723	62	5	on	on	ADP
hls-12723	62	6	44	44	NUM
hls-12723	62	7	subjects	subject	NOUN
hls-12723	62	8	aged	age	VERB
hls-12723	62	9	18	18	NUM
hls-12723	62	10	–	–	SYM
hls-12723	62	11	53	53	NUM
hls-12723	62	12	years	year	NOUN
hls-12723	62	13	with	with	ADP
hls-12723	62	14	a	a	DET
hls-12723	62	15	mean	mean	NOUN
hls-12723	62	16	of	of	ADP
hls-12723	62	17	35.9±9.2	35.9±9.2	NUM
hls-12723	62	18	years	year	NOUN
hls-12723	62	19	.	.	PUNCT
hls-12723	63	1	table	table	NOUN
hls-12723	63	2	1	1	NUM
hls-12723	63	3	shows	show	VERB
hls-12723	63	4	the	the	DET
hls-12723	63	5	data	data	NOUN
hls-12723	63	6	normality	normality	NOUN
hls-12723	63	7	testing	testing	NOUN
hls-12723	63	8	(	(	PUNCT
hls-12723	63	9	n=44	n=44	NOUN
hls-12723	63	10	)	)	PUNCT
hls-12723	63	11	,	,	PUNCT
hls-12723	63	12	which	which	PRON
hls-12723	63	13	highlights	highlight	VERB
hls-12723	63	14	the	the	DET
hls-12723	63	15	distribution	distribution	NOUN
hls-12723	63	16	of	of	ADP
hls-12723	63	17	panss	pans	NOUN
hls-12723	63	18	(	(	PUNCT
hls-12723	63	19	positive	positive	ADJ
hls-12723	63	20	and	and	CCONJ
hls-12723	63	21	negative	negative	ADJ
hls-12723	63	22	syndrome	syndrome	NOUN
hls-12723	63	23	article	article	NOUN
hls-12723	64	1	[	[	X
hls-12723	64	2	page	page	NOUN
hls-12723	64	3	100	100	NUM
hls-12723	64	4	]	]	PUNCT
hls-12723	65	1	[	[	X
hls-12723	65	2	healthcare	healthcare	NOUN
hls-12723	65	3	in	in	ADP
hls-12723	65	4	low	low	ADJ
hls-12723	65	5	-	-	PUNCT
hls-12723	65	6	resource	resource	NOUN
hls-12723	65	7	settings	setting	NOUN
hls-12723	65	8	2025;13:12723	2025;13:12723	NUM
hls-12723	65	9	]	]	SYM
hls-12723	65	10	scale	scale	NOUN
hls-12723	65	11	)	)	PUNCT
hls-12723	65	12	scores	score	NOUN
hls-12723	65	13	and	and	CCONJ
hls-12723	65	14	il-6	il-6	NOUN
hls-12723	65	15	levels	level	NOUN
hls-12723	65	16	before	before	ADP
hls-12723	65	17	and	and	CCONJ
hls-12723	65	18	after	after	ADP
hls-12723	65	19	treatment	treatment	NOUN
hls-12723	65	20	.	.	PUNCT
hls-12723	66	1	it	it	PRON
hls-12723	66	2	reveals	reveal	VERB
hls-12723	66	3	that	that	SCONJ
hls-12723	66	4	while	while	SCONJ
hls-12723	66	5	panss	pans	NOUN
hls-12723	66	6	scores	score	NOUN
hls-12723	66	7	exhibited	exhibit	VERB
hls-12723	66	8	a	a	DET
hls-12723	66	9	non	non	ADJ
hls-12723	66	10	-	-	ADJ
hls-12723	66	11	normal	normal	ADJ
hls-12723	66	12	distribution	distribution	NOUN
hls-12723	66	13	in	in	ADP
hls-12723	66	14	both	both	DET
hls-12723	66	15	pre	pre	ADJ
hls-12723	66	16	-	-	ADJ
hls-12723	66	17	and	and	CCONJ
hls-12723	66	18	post	post	ADJ
hls-12723	66	19	-	-	ADJ
hls-12723	66	20	treatment	treatment	ADJ
hls-12723	66	21	,	,	PUNCT
hls-12723	66	22	il-6	il-6	NUM
hls-12723	66	23	levels	level	NOUN
hls-12723	66	24	were	be	AUX
hls-12723	66	25	normally	normally	ADV
hls-12723	66	26	distributed	distribute	VERB
hls-12723	66	27	after	after	ADP
hls-12723	66	28	treatment	treatment	NOUN
hls-12723	66	29	.	.	PUNCT
hls-12723	67	1	this	this	DET
hls-12723	67	2	table	table	NOUN
hls-12723	67	3	uses	use	VERB
hls-12723	67	4	the	the	DET
hls-12723	67	5	kolmogorov	kolmogorov	ADJ
hls-12723	67	6	-	-	PUNCT
hls-12723	67	7	smirnov	smirnov	ADJ
hls-12723	67	8	test	test	NOUN
hls-12723	67	9	to	to	PART
hls-12723	67	10	assess	assess	VERB
hls-12723	67	11	data	datum	NOUN
hls-12723	67	12	normality	normality	NOUN
hls-12723	67	13	.	.	PUNCT
hls-12723	68	1	the	the	DET
hls-12723	68	2	data	datum	NOUN
hls-12723	68	3	in	in	ADP
hls-12723	68	4	table	table	NOUN
hls-12723	68	5	2	2	NUM
hls-12723	68	6	presents	present	VERB
hls-12723	68	7	the	the	DET
hls-12723	68	8	demographic	demographic	ADJ
hls-12723	68	9	statistics	statistic	NOUN
hls-12723	68	10	of	of	ADP
hls-12723	68	11	the	the	DET
hls-12723	68	12	survey	survey	NOUN
hls-12723	68	13	’s	’s	PART
hls-12723	68	14	44	44	NUM
hls-12723	68	15	respondents	respondent	NOUN
hls-12723	68	16	,	,	PUNCT
hls-12723	68	17	encompassing	encompass	VERB
hls-12723	68	18	gender	gender	NOUN
hls-12723	68	19	,	,	PUNCT
hls-12723	68	20	age	age	NOUN
hls-12723	68	21	,	,	PUNCT
hls-12723	68	22	education	education	NOUN
hls-12723	68	23	,	,	PUNCT
hls-12723	68	24	employment	employment	NOUN
hls-12723	68	25	,	,	PUNCT
hls-12723	68	26	and	and	CCONJ
hls-12723	68	27	pcr	pcr	PROPN
hls-12723	68	28	covid-19	covid-19	PROPN
hls-12723	68	29	test	test	NOUN
hls-12723	68	30	results	result	NOUN
hls-12723	68	31	.	.	PUNCT
hls-12723	69	1	the	the	DET
hls-12723	69	2	analysis	analysis	NOUN
hls-12723	69	3	reveals	reveal	VERB
hls-12723	69	4	that	that	SCONJ
hls-12723	69	5	77.3	77.3	NUM
hls-12723	69	6	%	%	NOUN
hls-12723	69	7	of	of	ADP
hls-12723	69	8	the	the	DET
hls-12723	69	9	respondents	respondent	NOUN
hls-12723	69	10	are	be	AUX
hls-12723	69	11	male	male	ADJ
hls-12723	69	12	,	,	PUNCT
hls-12723	69	13	with	with	ADP
hls-12723	69	14	the	the	DET
hls-12723	69	15	most	most	ADV
hls-12723	69	16	significant	significant	ADJ
hls-12723	69	17	portion	portion	NOUN
hls-12723	69	18	falling	fall	VERB
hls-12723	69	19	within	within	ADP
hls-12723	69	20	the	the	DET
hls-12723	69	21	30	30	NUM
hls-12723	69	22	-	-	SYM
hls-12723	69	23	39	39	NUM
hls-12723	69	24	age	age	NOUN
hls-12723	69	25	bracket	bracket	NOUN
hls-12723	69	26	,	,	PUNCT
hls-12723	69	27	constituting	constitute	VERB
hls-12723	69	28	43.2	43.2	NUM
hls-12723	69	29	%	%	NOUN
hls-12723	69	30	of	of	ADP
hls-12723	69	31	the	the	DET
hls-12723	69	32	sample	sample	NOUN
hls-12723	69	33	.	.	PUNCT
hls-12723	70	1	moreover	moreover	ADV
hls-12723	70	2	,	,	PUNCT
hls-12723	70	3	the	the	DET
hls-12723	70	4	majority	majority	NOUN
hls-12723	70	5	of	of	ADP
hls-12723	70	6	participants	participant	NOUN
hls-12723	70	7	,	,	PUNCT
hls-12723	70	8	totaling	total	VERB
hls-12723	70	9	56.8	56.8	NUM
hls-12723	70	10	%	%	NOUN
hls-12723	70	11	,	,	PUNCT
hls-12723	70	12	have	have	AUX
hls-12723	70	13	attained	attain	VERB
hls-12723	70	14	a	a	DET
hls-12723	70	15	primary	primary	ADJ
hls-12723	70	16	school	school	NOUN
hls-12723	70	17	education	education	NOUN
hls-12723	70	18	,	,	PUNCT
hls-12723	70	19	while	while	SCONJ
hls-12723	70	20	79.5	79.5	NUM
hls-12723	70	21	%	%	NOUN
hls-12723	70	22	reported	report	VERB
hls-12723	70	23	being	be	AUX
hls-12723	70	24	unemployed	unemployed	ADJ
hls-12723	70	25	.	.	PUNCT
hls-12723	71	1	comparison	comparison	NOUN
hls-12723	71	2	of	of	ADP
hls-12723	71	3	panss	pans	NOUN
hls-12723	71	4	and	and	CCONJ
hls-12723	71	5	il-6	il-6	NOUN
hls-12723	71	6	pre	pre	ADJ
hls-12723	71	7	-	-	NOUN
hls-12723	71	8	post	post	ADJ
hls-12723	71	9	demonstrates	demonstrate	VERB
hls-12723	71	10	the	the	DET
hls-12723	71	11	significant	significant	ADJ
hls-12723	71	12	reduction	reduction	NOUN
hls-12723	71	13	in	in	ADP
hls-12723	71	14	both	both	PRON
hls-12723	71	15	panss	pans	NOUN
hls-12723	71	16	scores	score	NOUN
hls-12723	71	17	and	and	CCONJ
hls-12723	71	18	il-6	il-6	NOUN
hls-12723	71	19	levels	level	NOUN
hls-12723	71	20	following	follow	VERB
hls-12723	71	21	the	the	DET
hls-12723	71	22	treatment	treatment	NOUN
hls-12723	71	23	,	,	PUNCT
hls-12723	71	24	with	with	ADP
hls-12723	71	25	respective	respective	ADJ
hls-12723	71	26	p	p	NOUN
hls-12723	71	27	-	-	PUNCT
hls-12723	71	28	values	value	NOUN
hls-12723	71	29	indicating	indicate	VERB
hls-12723	71	30	statistical	statistical	ADJ
hls-12723	71	31	significance	significance	NOUN
hls-12723	71	32	.	.	PUNCT
hls-12723	72	1	this	this	PRON
hls-12723	72	2	suggests	suggest	VERB
hls-12723	72	3	improvements	improvement	NOUN
hls-12723	72	4	in	in	ADP
hls-12723	72	5	the	the	DET
hls-12723	72	6	participants	participant	NOUN
hls-12723	72	7	’	'	PUNCT
hls-12723	72	8	psychiatric	psychiatric	ADJ
hls-12723	72	9	symptoms	symptom	NOUN
hls-12723	72	10	and	and	CCONJ
hls-12723	72	11	inflammatory	inflammatory	ADJ
hls-12723	72	12	status	status	NOUN
hls-12723	72	13	(	(	PUNCT
hls-12723	72	14	table	table	NOUN
hls-12723	72	15	3	3	NUM
hls-12723	72	16	)	)	PUNCT
hls-12723	72	17	.	.	PUNCT
hls-12723	73	1	table	table	NOUN
hls-12723	73	2	4	4	NUM
hls-12723	73	3	shows	show	VERB
hls-12723	73	4	that	that	SCONJ
hls-12723	73	5	the	the	DET
hls-12723	73	6	comparison	comparison	NOUN
hls-12723	73	7	of	of	ADP
hls-12723	73	8	panss	pans	NOUN
hls-12723	73	9	and	and	CCONJ
hls-12723	73	10	il-6	il-6	NOUN
hls-12723	73	11	prepost	prepost	NOUN
hls-12723	73	12	(	(	PUNCT
hls-12723	73	13	by	by	ADP
hls-12723	73	14	gender	gender	NOUN
hls-12723	73	15	)	)	PUNCT
hls-12723	73	16	shows	show	VERB
hls-12723	73	17	the	the	DET
hls-12723	73	18	impact	impact	NOUN
hls-12723	73	19	of	of	ADP
hls-12723	73	20	treatment	treatment	NOUN
hls-12723	73	21	on	on	ADP
hls-12723	73	22	panss	pans	NOUN
hls-12723	73	23	scores	score	NOUN
hls-12723	73	24	and	and	CCONJ
hls-12723	73	25	il-6	il-6	NOUN
hls-12723	73	26	levels	level	NOUN
hls-12723	73	27	,	,	PUNCT
hls-12723	73	28	categorized	categorize	VERB
hls-12723	73	29	by	by	ADP
hls-12723	73	30	gender	gender	NOUN
hls-12723	73	31	.	.	PUNCT
hls-12723	74	1	both	both	DET
hls-12723	74	2	men	man	NOUN
hls-12723	74	3	and	and	CCONJ
hls-12723	74	4	women	woman	NOUN
hls-12723	74	5	showed	show	VERB
hls-12723	74	6	significant	significant	ADJ
hls-12723	74	7	improvements	improvement	NOUN
hls-12723	74	8	post	post	ADJ
hls-12723	74	9	-	-	NOUN
hls-12723	74	10	treatment	treatment	NOUN
hls-12723	74	11	,	,	PUNCT
hls-12723	74	12	underscoring	underscore	VERB
hls-12723	74	13	risperidone	risperidone	NOUN
hls-12723	74	14	’s	’s	PART
hls-12723	74	15	effectiveness	effectiveness	NOUN
hls-12723	74	16	across	across	ADP
hls-12723	74	17	genders	gender	NOUN
hls-12723	74	18	.	.	PUNCT
hls-12723	75	1	in	in	ADP
hls-12723	75	2	table	table	NOUN
hls-12723	75	3	5	5	NUM
hls-12723	75	4	,	,	PUNCT
hls-12723	75	5	the	the	DET
hls-12723	75	6	data	datum	NOUN
hls-12723	75	7	comparing	compare	VERB
hls-12723	75	8	panss	pans	NOUN
hls-12723	75	9	and	and	CCONJ
hls-12723	75	10	il-6	il-6	NOUN
hls-12723	75	11	pre	pre	NOUN
hls-12723	75	12	-	-	NOUN
hls-12723	75	13	post	post	ADJ
hls-12723	75	14	by	by	ADP
hls-12723	75	15	age	age	NOUN
hls-12723	75	16	groups	group	NOUN
hls-12723	75	17	shows	show	VERB
hls-12723	75	18	that	that	SCONJ
hls-12723	75	19	there	there	PRON
hls-12723	75	20	were	be	VERB
hls-12723	75	21	significant	significant	ADJ
hls-12723	75	22	reductions	reduction	NOUN
hls-12723	75	23	in	in	ADP
hls-12723	75	24	panss	pans	NOUN
hls-12723	75	25	scores	score	NOUN
hls-12723	75	26	and	and	CCONJ
hls-12723	75	27	il-6	il-6	NOUN
hls-12723	75	28	levels	level	NOUN
hls-12723	75	29	across	across	ADP
hls-12723	75	30	all	all	DET
hls-12723	75	31	age	age	NOUN
hls-12723	75	32	categories	category	NOUN
hls-12723	75	33	.	.	PUNCT
hls-12723	76	1	this	this	PRON
hls-12723	76	2	suggests	suggest	VERB
hls-12723	76	3	that	that	SCONJ
hls-12723	76	4	the	the	DET
hls-12723	76	5	treatment	treatment	NOUN
hls-12723	76	6	has	have	VERB
hls-12723	76	7	broad	broad	ADJ
hls-12723	76	8	applicability	applicability	NOUN
hls-12723	76	9	across	across	ADP
hls-12723	76	10	different	different	ADJ
hls-12723	76	11	age	age	NOUN
hls-12723	76	12	groups	group	NOUN
hls-12723	76	13	.	.	PUNCT
hls-12723	77	1	in	in	ADP
hls-12723	77	2	table	table	NOUN
hls-12723	77	3	6	6	NUM
hls-12723	77	4	,	,	PUNCT
hls-12723	77	5	the	the	DET
hls-12723	77	6	comparison	comparison	NOUN
hls-12723	77	7	of	of	ADP
hls-12723	77	8	panss	pans	NOUN
hls-12723	77	9	and	and	CCONJ
hls-12723	77	10	il-6	il-6	NOUN
hls-12723	77	11	pre	pre	NOUN
hls-12723	77	12	-	-	NOUN
hls-12723	77	13	post	post	ADJ
hls-12723	77	14	(	(	PUNCT
hls-12723	77	15	by	by	ADP
hls-12723	77	16	pcr	pcr	PROPN
hls-12723	77	17	testing	testing	NOUN
hls-12723	77	18	)	)	PUNCT
hls-12723	77	19	distinguishes	distinguish	VERB
hls-12723	77	20	between	between	ADP
hls-12723	77	21	participants	participant	NOUN
hls-12723	77	22	with	with	ADP
hls-12723	77	23	positive	positive	ADJ
hls-12723	77	24	and	and	CCONJ
hls-12723	77	25	negative	negative	ADJ
hls-12723	77	26	covid-19	covid-19	PROPN
hls-12723	77	27	pcr	pcr	ADJ
hls-12723	77	28	tests	test	NOUN
hls-12723	77	29	.	.	PUNCT
hls-12723	78	1	both	both	DET
hls-12723	78	2	groups	group	NOUN
hls-12723	78	3	showed	show	VERB
hls-12723	78	4	significant	significant	ADJ
hls-12723	78	5	decreases	decrease	NOUN
hls-12723	78	6	in	in	ADP
hls-12723	78	7	panss	pans	NOUN
hls-12723	78	8	scores	score	NOUN
hls-12723	78	9	and	and	CCONJ
hls-12723	78	10	il-6	il-6	NOUN
hls-12723	78	11	levels	level	NOUN
hls-12723	78	12	,	,	PUNCT
hls-12723	78	13	underscoring	underscore	VERB
hls-12723	78	14	the	the	DET
hls-12723	78	15	potential	potential	ADJ
hls-12723	78	16	advantages	advantage	NOUN
hls-12723	78	17	of	of	ADP
hls-12723	78	18	risperidone	risperidone	NOUN
hls-12723	78	19	for	for	ADP
hls-12723	78	20	schizophrenia	schizophrenia	NOUN
hls-12723	78	21	patients	patient	NOUN
hls-12723	78	22	,	,	PUNCT
hls-12723	78	23	irrespective	irrespective	ADV
hls-12723	78	24	of	of	ADP
hls-12723	78	25	their	their	PRON
hls-12723	78	26	covid-19	covid-19	PROPN
hls-12723	78	27	status	status	NOUN
hls-12723	78	28	.	.	PUNCT
hls-12723	79	1	article	article	NOUN
hls-12723	80	1	[	[	X
hls-12723	80	2	healthcare	healthcare	NOUN
hls-12723	80	3	in	in	ADP
hls-12723	80	4	low	low	ADJ
hls-12723	80	5	-	-	PUNCT
hls-12723	80	6	resource	resource	NOUN
hls-12723	80	7	settings	setting	NOUN
hls-12723	80	8	2025;13:12723	2025;13:12723	NUM
hls-12723	80	9	]	]	X
hls-12723	81	1	[	[	X
hls-12723	81	2	page	page	NOUN
hls-12723	81	3	101	101	NUM
hls-12723	81	4	]	]	PUNCT
hls-12723	81	5	table	table	NOUN
hls-12723	81	6	1	1	NUM
hls-12723	81	7	.	.	PUNCT
hls-12723	81	8	data	datum	NOUN
hls-12723	81	9	normality	normality	NOUN
hls-12723	81	10	testing	testing	NOUN
hls-12723	81	11	(	(	PUNCT
hls-12723	81	12	n=44	n=44	NOUN
hls-12723	81	13	)	)	PUNCT
hls-12723	81	14	.	.	PUNCT
hls-12723	82	1	variables	variable	NOUN
hls-12723	82	2	minimum	minimum	ADJ
hls-12723	82	3	maximum	maximum	ADJ
hls-12723	82	4	median	median	ADJ
hls-12723	82	5	mean	mean	NOUN
hls-12723	82	6	sd	sd	ADP
hls-12723	82	7	data	datum	NOUN
hls-12723	82	8	distribution	distribution	NOUN
hls-12723	82	9	*	*	PUNCT
hls-12723	82	10	panss	pans	NOUN
hls-12723	82	11	pre	pre	VERB
hls-12723	82	12	68	68	NUM
hls-12723	82	13	81	81	NUM
hls-12723	82	14	71.0	71.0	NUM
hls-12723	82	15	72.4	72.4	NUM
hls-12723	82	16	3.4	3.4	NUM
hls-12723	82	17	not	not	PART
hls-12723	82	18	normal	normal	ADJ
hls-12723	82	19	panss	pans	NOUN
hls-12723	82	20	post	post	VERB
hls-12723	82	21	43	43	NUM
hls-12723	82	22	69	69	NUM
hls-12723	82	23	58.0	58.0	NUM
hls-12723	82	24	56.9	56.9	NUM
hls-12723	82	25	6.3	6.3	NUM
hls-12723	82	26	not	not	PART
hls-12723	82	27	normal	normal	ADJ
hls-12723	82	28	difference	difference	NOUN
hls-12723	82	29	panss	pans	NOUN
hls-12723	82	30	7	7	NUM
hls-12723	82	31	34	34	NUM
hls-12723	82	32	13.5	13.5	NUM
hls-12723	82	33	15.6	15.6	NUM
hls-12723	82	34	5.9	5.9	NUM
hls-12723	82	35	not	not	PART
hls-12723	82	36	normal	normal	ADJ
hls-12723	82	37	il-6	il-6	NOUN
hls-12723	83	1	pre	pre	ADJ
hls-12723	83	2	(	(	PUNCT
hls-12723	83	3	pg	pg	NOUN
hls-12723	83	4	/	/	SYM
hls-12723	83	5	ml	ml	VERB
hls-12723	83	6	)	)	PUNCT
hls-12723	83	7	16.1	16.1	NUM
hls-12723	83	8	31.0	31.0	NUM
hls-12723	83	9	24.1	24.1	NUM
hls-12723	83	10	23.6	23.6	NUM
hls-12723	83	11	4.1	4.1	NUM
hls-12723	83	12	normal	normal	ADJ
hls-12723	83	13	il-6	il-6	NOUN
hls-12723	83	14	post	post	NOUN
hls-12723	83	15	(	(	PUNCT
hls-12723	83	16	pg	pg	NOUN
hls-12723	83	17	/	/	SYM
hls-12723	83	18	ml	ml	VERB
hls-12723	83	19	)	)	PUNCT
hls-12723	83	20	14.3	14.3	NUM
hls-12723	83	21	27.5	27.5	NUM
hls-12723	83	22	21.5	21.5	NUM
hls-12723	83	23	21.1	21.1	NUM
hls-12723	83	24	3.4	3.4	NUM
hls-12723	83	25	normal	normal	ADJ
hls-12723	83	26	difference	difference	NOUN
hls-12723	83	27	il-6	il-6	NOUN
hls-12723	83	28	(	(	PUNCT
hls-12723	83	29	pg	pg	NOUN
hls-12723	83	30	/	/	SYM
hls-12723	83	31	ml	ml	VERB
hls-12723	83	32	)	)	PUNCT
hls-12723	83	33	0.2	0.2	NUM
hls-12723	83	34	4.9	4.9	NUM
hls-12723	83	35	2.3	2.3	NUM
hls-12723	83	36	2.5	2.5	NUM
hls-12723	83	37	1.2	1.2	NUM
hls-12723	83	38	normal	normal	ADJ
hls-12723	83	39	*	*	PUNCT
hls-12723	83	40	kolmogorov	kolmogorov	ADJ
hls-12723	83	41	-	-	PUNCT
hls-12723	83	42	smirnov	smirnov	ADJ
hls-12723	83	43	test	test	NOUN
hls-12723	83	44	.	.	PUNCT
hls-12723	84	1	table	table	NOUN
hls-12723	84	2	2	2	NUM
hls-12723	84	3	.	.	PUNCT
hls-12723	85	1	characteristics	characteristic	NOUN
hls-12723	85	2	of	of	ADP
hls-12723	85	3	respondents	respondent	NOUN
hls-12723	85	4	(	(	PUNCT
hls-12723	85	5	n=44	n=44	NOUN
hls-12723	85	6	)	)	PUNCT
hls-12723	85	7	.	.	PUNCT
hls-12723	86	1	category	category	NOUN
hls-12723	86	2	variables	variable	NOUN
hls-12723	86	3	n	n	PRON
hls-12723	86	4	percent	percent	NOUN
hls-12723	86	5	(	(	PUNCT
hls-12723	86	6	%	%	INTJ
hls-12723	86	7	)	)	PUNCT
hls-12723	86	8	gender	gender	NOUN
hls-12723	86	9	men	man	NOUN
hls-12723	87	1	34	34	NUM
hls-12723	87	2	77.3	77.3	NUM
hls-12723	87	3	women	woman	NOUN
hls-12723	87	4	10	10	NUM
hls-12723	87	5	22.7	22.7	NUM
hls-12723	87	6	age	age	NOUN
hls-12723	87	7	18	18	NUM
hls-12723	87	8	-	-	SYM
hls-12723	87	9	29	29	NUM
hls-12723	87	10	years	year	NOUN
hls-12723	87	11	12	12	NUM
hls-12723	87	12	27.3	27.3	NUM
hls-12723	87	13	30	30	NUM
hls-12723	87	14	-	-	SYM
hls-12723	87	15	39	39	NUM
hls-12723	87	16	years	year	NOUN
hls-12723	87	17	19	19	NUM
hls-12723	87	18	43.2	43.2	NUM
hls-12723	87	19	40	40	NUM
hls-12723	87	20	-	-	SYM
hls-12723	87	21	53	53	NUM
hls-12723	87	22	years	year	NOUN
hls-12723	87	23	13	13	NUM
hls-12723	87	24	29.5	29.5	NUM
hls-12723	87	25	education	education	NOUN
hls-12723	87	26	primary	primary	ADJ
hls-12723	87	27	school	school	NOUN
hls-12723	87	28	25	25	NUM
hls-12723	87	29	56.8	56.8	NUM
hls-12723	87	30	junior	junior	ADJ
hls-12723	87	31	high	high	ADJ
hls-12723	87	32	school	school	NOUN
hls-12723	87	33	6	6	NUM
hls-12723	87	34	13.6	13.6	NUM
hls-12723	87	35	senior	senior	ADJ
hls-12723	87	36	high	high	ADJ
hls-12723	87	37	school	school	NOUN
hls-12723	87	38	11	11	NUM
hls-12723	87	39	25.0	25.0	NUM
hls-12723	87	40	college	college	NOUN
hls-12723	87	41	2	2	NUM
hls-12723	87	42	4.5	4.5	NUM
hls-12723	87	43	employment	employment	NOUN
hls-12723	87	44	employee	employee	NOUN
hls-12723	87	45	2	2	NUM
hls-12723	87	46	4.5	4.5	NUM
hls-12723	87	47	farmer	farmer	NOUN
hls-12723	87	48	3	3	NUM
hls-12723	87	49	6.8	6.8	NUM
hls-12723	87	50	entrepreneur	entrepreneur	NOUN
hls-12723	87	51	4	4	NUM
hls-12723	87	52	9.1	9.1	NUM
hls-12723	87	53	not	not	PART
hls-12723	87	54	work	work	VERB
hls-12723	87	55	35	35	NUM
hls-12723	87	56	79.5	79.5	NUM
hls-12723	87	57	pcr	pcr	NOUN
hls-12723	87	58	positive	positive	ADJ
hls-12723	87	59	22	22	NUM
hls-12723	87	60	50.0	50.0	NUM
hls-12723	87	61	negative	negative	ADJ
hls-12723	87	62	22	22	NUM
hls-12723	87	63	50.0	50.0	NUM
hls-12723	87	64	table	table	NOUN
hls-12723	87	65	3	3	NUM
hls-12723	87	66	.	.	PUNCT
hls-12723	87	67	comparison	comparison	NOUN
hls-12723	87	68	positive	positive	ADJ
hls-12723	87	69	and	and	CCONJ
hls-12723	87	70	negative	negative	ADJ
hls-12723	87	71	syndrome	syndrome	NOUN
hls-12723	87	72	scale	scale	NOUN
hls-12723	87	73	(	(	PUNCT
hls-12723	87	74	panss	pans	NOUN
hls-12723	87	75	)	)	PUNCT
hls-12723	87	76	dan	dan	PROPN
hls-12723	87	77	il-6	il-6	X
hls-12723	87	78	pre	pre	PROPN
hls-12723	87	79	-	-	ADJ
hls-12723	87	80	post	post	ADJ
hls-12723	87	81	.	.	PUNCT
hls-12723	87	82	category	category	NOUN
hls-12723	87	83	n	n	PRON
hls-12723	87	84	mean	mean	VERB
hls-12723	87	85	sd	sd	NOUN
hls-12723	87	86	decrease	decrease	NOUN
hls-12723	87	87	(	(	PUNCT
hls-12723	87	88	%	%	INTJ
hls-12723	87	89	)	)	PUNCT
hls-12723	87	90	p	p	NOUN
hls-12723	87	91	panss	pans	NOUN
hls-12723	87	92	pre	pre	VERB
hls-12723	87	93	44	44	NUM
hls-12723	87	94	72.4	72.4	NUM
hls-12723	87	95	3.4	3.4	NUM
hls-12723	87	96	21.4	21.4	NUM
hls-12723	87	97	0.000	0.000	NUM
hls-12723	87	98	*	*	PUNCT
hls-12723	87	99	panss	pans	NOUN
hls-12723	87	100	post	post	VERB
hls-12723	87	101	44	44	NUM
hls-12723	87	102	56.9	56.9	NUM
hls-12723	87	103	6.3	6.3	NUM
hls-12723	87	104	il-6	il-6	NOUN
hls-12723	88	1	pre	pre	ADJ
hls-12723	88	2	(	(	PUNCT
hls-12723	88	3	pg	pg	NOUN
hls-12723	88	4	/	/	SYM
hls-12723	88	5	ml	ml	NOUN
hls-12723	88	6	)	)	PUNCT
hls-12723	88	7	44	44	NUM
hls-12723	88	8	23.6	23.6	NUM
hls-12723	88	9	4.1	4.1	NUM
hls-12723	88	10	10.6	10.6	NUM
hls-12723	88	11	0.000	0.000	NUM
hls-12723	88	12	*	*	PUNCT
hls-12723	88	13	*	*	X
hls-12723	88	14	il-6	il-6	CCONJ
hls-12723	88	15	post	post	NOUN
hls-12723	88	16	(	(	PUNCT
hls-12723	88	17	pg	pg	NOUN
hls-12723	88	18	/	/	SYM
hls-12723	88	19	ml	ml	VERB
hls-12723	88	20	)	)	PUNCT
hls-12723	88	21	44	44	NUM
hls-12723	88	22	21.1	21.1	NUM
hls-12723	88	23	3.4	3.4	NUM
hls-12723	88	24	*	*	PUNCT
hls-12723	88	25	wilcoxon	wilcoxon	PROPN
hls-12723	88	26	signed	sign	VERB
hls-12723	88	27	rank	rank	NOUN
hls-12723	88	28	test	test	NOUN
hls-12723	88	29	;	;	PUNCT
hls-12723	88	30	*	*	PUNCT
hls-12723	88	31	*	*	PUNCT
hls-12723	88	32	paired	pair	VERB
hls-12723	88	33	t	t	NOUN
hls-12723	88	34	-	-	PUNCT
hls-12723	88	35	test	test	NOUN
hls-12723	88	36	.	.	PUNCT
hls-12723	89	1	discussion	discussion	NOUN
hls-12723	89	2	this	this	DET
hls-12723	89	3	study	study	NOUN
hls-12723	89	4	was	be	AUX
hls-12723	89	5	conducted	conduct	VERB
hls-12723	89	6	to	to	PART
hls-12723	89	7	see	see	VERB
hls-12723	89	8	the	the	DET
hls-12723	89	9	effectiveness	effectiveness	NOUN
hls-12723	89	10	of	of	ADP
hls-12723	89	11	risperidone	risperidone	NOUN
hls-12723	89	12	administration	administration	NOUN
hls-12723	89	13	on	on	ADP
hls-12723	89	14	panss	pans	NOUN
hls-12723	89	15	scores	score	NOUN
hls-12723	89	16	and	and	CCONJ
hls-12723	89	17	interleukin	interleukin	NOUN
hls-12723	89	18	6	6	NUM
hls-12723	89	19	levels	level	NOUN
hls-12723	89	20	in	in	ADP
hls-12723	89	21	schizophrenia	schizophrenia	NOUN
hls-12723	89	22	patients	patient	NOUN
hls-12723	89	23	with	with	ADP
hls-12723	89	24	confirmed	confirm	VERB
hls-12723	89	25	covid-19	covid-19	PROPN
hls-12723	89	26	for	for	ADP
hls-12723	89	27	four	four	NUM
hls-12723	89	28	weeks	week	NOUN
hls-12723	89	29	,	,	PUNCT
hls-12723	89	30	from	from	ADP
hls-12723	89	31	july	july	PROPN
hls-12723	89	32	to	to	ADP
hls-12723	89	33	august	august	PROPN
hls-12723	89	34	2021	2021	NUM
hls-12723	89	35	,	,	PUNCT
hls-12723	89	36	with	with	ADP
hls-12723	89	37	a	a	DET
hls-12723	89	38	total	total	ADJ
hls-12723	89	39	sample	sample	NOUN
hls-12723	89	40	of	of	ADP
hls-12723	89	41	44	44	NUM
hls-12723	89	42	people	people	NOUN
hls-12723	89	43	,	,	PUNCT
hls-12723	89	44	divided	divide	VERB
hls-12723	89	45	into	into	ADP
hls-12723	89	46	two	two	NUM
hls-12723	89	47	groups	group	NOUN
hls-12723	89	48	,	,	PUNCT
hls-12723	89	49	namely	namely	ADV
hls-12723	89	50	the	the	DET
hls-12723	89	51	covid-19	covid-19	PROPN
hls-12723	89	52	positive	positive	ADJ
hls-12723	89	53	group	group	NOUN
hls-12723	89	54	and	and	CCONJ
hls-12723	89	55	control	control	NOUN
hls-12723	89	56	groups	group	NOUN
hls-12723	89	57	.	.	PUNCT
hls-12723	90	1	both	both	DET
hls-12723	90	2	groups	group	NOUN
hls-12723	90	3	received	receive	VERB
hls-12723	90	4	risperidone	risperidone	NOUN
hls-12723	90	5	therapy	therapy	NOUN
hls-12723	90	6	of	of	ADP
hls-12723	90	7	2	2	NUM
hls-12723	90	8	-	-	SYM
hls-12723	90	9	6	6	NUM
hls-12723	90	10	mg	mg	NOUN
hls-12723	90	11	per	per	ADP
hls-12723	90	12	day	day	NOUN
hls-12723	90	13	;	;	PUNCT
hls-12723	90	14	the	the	DET
hls-12723	90	15	covid-19	covid-19	PROPN
hls-12723	90	16	positive	positive	ADJ
hls-12723	90	17	group	group	NOUN
hls-12723	90	18	was	be	AUX
hls-12723	90	19	the	the	DET
hls-12723	90	20	schizophrenia	schizophrenia	NOUN
hls-12723	90	21	group	group	NOUN
hls-12723	90	22	with	with	ADP
hls-12723	90	23	covid-19	covid-19	PROPN
hls-12723	90	24	,	,	PUNCT
hls-12723	90	25	and	and	CCONJ
hls-12723	90	26	the	the	DET
hls-12723	90	27	control	control	NOUN
hls-12723	90	28	group	group	NOUN
hls-12723	90	29	was	be	AUX
hls-12723	90	30	the	the	DET
hls-12723	90	31	schizophrenia	schizophrenia	NOUN
hls-12723	90	32	group	group	NOUN
hls-12723	90	33	without	without	ADP
hls-12723	90	34	covid-19	covid-19	PROPN
hls-12723	90	35	.	.	PUNCT
hls-12723	91	1	patients	patient	NOUN
hls-12723	91	2	who	who	PRON
hls-12723	91	3	met	meet	VERB
hls-12723	91	4	the	the	DET
hls-12723	91	5	inclusion	inclusion	NOUN
hls-12723	91	6	criteria	criterion	NOUN
hls-12723	91	7	were	be	AUX
hls-12723	91	8	recorded	record	VERB
hls-12723	91	9	based	base	VERB
hls-12723	91	10	on	on	ADP
hls-12723	91	11	gender	gender	NOUN
hls-12723	91	12	,	,	PUNCT
hls-12723	91	13	age	age	NOUN
hls-12723	91	14	category	category	NOUN
hls-12723	91	15	,	,	PUNCT
hls-12723	91	16	education	education	NOUN
hls-12723	91	17	,	,	PUNCT
hls-12723	91	18	occupation	occupation	NOUN
hls-12723	91	19	,	,	PUNCT
hls-12723	91	20	and	and	CCONJ
hls-12723	91	21	pcr	pcr	NOUN
hls-12723	91	22	results	result	NOUN
hls-12723	91	23	.	.	PUNCT
hls-12723	92	1	schizophrenia	schizophrenia	PROPN
hls-12723	92	2	is	be	AUX
hls-12723	92	3	a	a	DET
hls-12723	92	4	chronic	chronic	ADJ
hls-12723	92	5	mental	mental	ADJ
hls-12723	92	6	disorder	disorder	NOUN
hls-12723	92	7	characterized	characterize	VERB
hls-12723	92	8	by	by	ADP
hls-12723	92	9	many	many	ADJ
hls-12723	92	10	symptoms	symptom	NOUN
hls-12723	92	11	,	,	PUNCT
hls-12723	92	12	such	such	ADJ
hls-12723	92	13	as	as	ADP
hls-12723	92	14	hallucinations	hallucination	NOUN
hls-12723	92	15	,	,	PUNCT
hls-12723	92	16	delusions	delusion	NOUN
hls-12723	92	17	,	,	PUNCT
hls-12723	92	18	confused	confused	ADJ
hls-12723	92	19	thoughts	thought	NOUN
hls-12723	92	20	,	,	PUNCT
hls-12723	92	21	and	and	CCONJ
hls-12723	92	22	impaired	impaired	ADJ
hls-12723	92	23	cognitive	cognitive	NOUN
hls-12723	92	24	function.9	function.9	PROPN
hls-12723	92	25	several	several	ADJ
hls-12723	92	26	processes	process	NOUN
hls-12723	92	27	,	,	PUNCT
hls-12723	92	28	such	such	ADJ
hls-12723	92	29	as	as	ADP
hls-12723	92	30	inflammation	inflammation	NOUN
hls-12723	92	31	,	,	PUNCT
hls-12723	92	32	oxidative	oxidative	ADJ
hls-12723	92	33	stress	stress	NOUN
hls-12723	92	34	,	,	PUNCT
hls-12723	92	35	and	and	CCONJ
hls-12723	92	36	complex	complex	ADJ
hls-12723	92	37	interactions	interaction	NOUN
hls-12723	92	38	of	of	ADP
hls-12723	92	39	neurotransmitters	neurotransmitter	NOUN
hls-12723	92	40	,	,	PUNCT
hls-12723	92	41	are	be	AUX
hls-12723	92	42	involved	involve	VERB
hls-12723	92	43	with	with	ADP
hls-12723	92	44	the	the	DET
hls-12723	92	45	pathophysiology	pathophysiology	NOUN
hls-12723	92	46	of	of	ADP
hls-12723	92	47	schizophrenia.10	schizophrenia.10	VERB
hls-12723	92	48	the	the	DET
hls-12723	92	49	release	release	NOUN
hls-12723	92	50	of	of	ADP
hls-12723	92	51	proinflammatory	proinflammatory	ADJ
hls-12723	92	52	cytokines	cytokine	NOUN
hls-12723	92	53	and	and	CCONJ
hls-12723	92	54	free	free	ADJ
hls-12723	92	55	radicals	radical	NOUN
hls-12723	92	56	associated	associate	VERB
hls-12723	92	57	with	with	ADP
hls-12723	92	58	activated	activate	VERB
hls-12723	92	59	microglia	microglia	NOUN
hls-12723	92	60	is	be	AUX
hls-12723	92	61	associated	associate	VERB
hls-12723	92	62	with	with	ADP
hls-12723	92	63	the	the	DET
hls-12723	92	64	pathophysiology	pathophysiology	NOUN
hls-12723	92	65	of	of	ADP
hls-12723	92	66	schizophrenia	schizophrenia	NOUN
hls-12723	92	67	.	.	PUNCT
hls-12723	93	1	it	it	PRON
hls-12723	93	2	is	be	AUX
hls-12723	93	3	also	also	ADV
hls-12723	93	4	found	find	VERB
hls-12723	93	5	in	in	ADP
hls-12723	93	6	postmortem	postmortem	NOUN
hls-12723	93	7	examination	examination	NOUN
hls-12723	93	8	of	of	ADP
hls-12723	93	9	brain	brain	NOUN
hls-12723	93	10	tissue.11	tissue.11	VERB
hls-12723	93	11	an	an	DET
hls-12723	93	12	increase	increase	NOUN
hls-12723	93	13	in	in	ADP
hls-12723	93	14	several	several	ADJ
hls-12723	93	15	markers	marker	NOUN
hls-12723	93	16	of	of	ADP
hls-12723	93	17	inflammation	inflammation	NOUN
hls-12723	93	18	in	in	ADP
hls-12723	93	19	serum	serum	NOUN
hls-12723	93	20	and	and	CCONJ
hls-12723	93	21	csf	csf	PROPN
hls-12723	93	22	,	,	PUNCT
hls-12723	93	23	such	such	ADJ
hls-12723	93	24	as	as	ADP
hls-12723	93	25	prostaglandin	prostaglandin	NOUN
hls-12723	93	26	e2	e2	PROPN
hls-12723	93	27	(	(	PUNCT
hls-12723	93	28	pge2	pge2	PROPN
hls-12723	93	29	)	)	PUNCT
hls-12723	93	30	,	,	PUNCT
hls-12723	93	31	creactive	creactive	ADJ
hls-12723	93	32	protein	protein	NOUN
hls-12723	93	33	(	(	PUNCT
hls-12723	93	34	crp	crp	PROPN
hls-12723	93	35	)	)	PUNCT
hls-12723	93	36	,	,	PUNCT
hls-12723	93	37	and	and	CCONJ
hls-12723	93	38	several	several	ADJ
hls-12723	93	39	proinflammatory	proinflammatory	ADJ
hls-12723	93	40	cytokines	cytokine	NOUN
hls-12723	93	41	such	such	ADJ
hls-12723	93	42	as	as	ADP
hls-12723	93	43	interleukin	interleukin	NOUN
hls-12723	93	44	(	(	PUNCT
hls-12723	93	45	il)-1β	il)-1β	PROPN
hls-12723	93	46	,	,	PUNCT
hls-12723	93	47	il-6	il-6	PRON
hls-12723	93	48	,	,	PUNCT
hls-12723	93	49	il-8	il-8	NOUN
hls-12723	93	50	,	,	PUNCT
hls-12723	93	51	and	and	CCONJ
hls-12723	93	52	tumor	tumor	NOUN
hls-12723	93	53	necrosis	necrosis	NOUN
hls-12723	93	54	factor	factor	NOUN
hls-12723	93	55	(	(	PUNCT
hls-12723	93	56	tnf	tnf	PROPN
hls-12723	93	57	)	)	PUNCT
hls-12723	93	58	α	α	PRON
hls-12723	93	59	also	also	ADV
hls-12723	93	60	observed	observe	VERB
hls-12723	93	61	in	in	ADP
hls-12723	93	62	schizophrenic	schizophrenic	ADJ
hls-12723	93	63	patients.12	patients.12	NOUN
hls-12723	93	64	involvement	involvement	NOUN
hls-12723	93	65	of	of	ADP
hls-12723	93	66	the	the	DET
hls-12723	93	67	immune	immune	ADJ
hls-12723	93	68	system	system	NOUN
hls-12723	93	69	is	be	AUX
hls-12723	93	70	related	relate	VERB
hls-12723	93	71	to	to	ADP
hls-12723	93	72	the	the	DET
hls-12723	93	73	pathogenesis	pathogenesis	NOUN
hls-12723	93	74	of	of	ADP
hls-12723	93	75	schizophrenia	schizophrenia	NOUN
hls-12723	93	76	,	,	PUNCT
hls-12723	93	77	especially	especially	ADV
hls-12723	93	78	negative	negative	ADJ
hls-12723	93	79	symptoms	symptom	NOUN
hls-12723	93	80	and	and	CCONJ
hls-12723	93	81	cognitive	cognitive	ADJ
hls-12723	93	82	dysfunction.13	dysfunction.13	NOUN
hls-12723	93	83	this	this	DET
hls-12723	93	84	immune	immune	ADJ
hls-12723	93	85	system	system	NOUN
hls-12723	93	86	dysregulation	dysregulation	NOUN
hls-12723	93	87	can	can	AUX
hls-12723	93	88	be	be	AUX
hls-12723	93	89	connected	connect	VERB
hls-12723	93	90	to	to	ADP
hls-12723	93	91	events	event	NOUN
hls-12723	93	92	,	,	PUNCT
hls-12723	93	93	risk	risk	NOUN
hls-12723	93	94	factors	factor	NOUN
hls-12723	93	95	,	,	PUNCT
hls-12723	93	96	or	or	CCONJ
hls-12723	93	97	responses	response	NOUN
hls-12723	93	98	to	to	ADP
hls-12723	93	99	therapy	therapy	NOUN
hls-12723	93	100	in	in	ADP
hls-12723	93	101	schizophrenic	schizophrenic	ADJ
hls-12723	93	102	patients.14	patients.14	PROPN
hls-12723	93	103	national	national	ADJ
hls-12723	93	104	patient	patient	NOUN
hls-12723	93	105	databases	database	NOUN
hls-12723	93	106	in	in	ADP
hls-12723	93	107	the	the	DET
hls-12723	93	108	uk16	uk16	PROPN
hls-12723	93	109	and	and	CCONJ
hls-12723	93	110	south	south	PROPN
hls-12723	93	111	korea17	korea17	PROPN
hls-12723	93	112	found	find	VERB
hls-12723	93	113	that	that	SCONJ
hls-12723	93	114	patients	patient	NOUN
hls-12723	93	115	with	with	ADP
hls-12723	93	116	psychotic	psychotic	ADJ
hls-12723	93	117	disorders	disorder	NOUN
hls-12723	93	118	are	be	AUX
hls-12723	93	119	at	at	ADP
hls-12723	93	120	increased	increase	VERB
hls-12723	93	121	risk	risk	NOUN
hls-12723	93	122	of	of	ADP
hls-12723	93	123	severe	severe	ADJ
hls-12723	93	124	complications	complication	NOUN
hls-12723	93	125	of	of	ADP
hls-12723	93	126	covid-19	covid-19	PROPN
hls-12723	93	127	.	.	PUNCT
hls-12723	94	1	patients	patient	NOUN
hls-12723	94	2	with	with	ADP
hls-12723	94	3	severe	severe	ADJ
hls-12723	94	4	mental	mental	ADJ
hls-12723	94	5	illnesses	illness	NOUN
hls-12723	94	6	are	be	AUX
hls-12723	94	7	more	more	ADV
hls-12723	94	8	susceptible	susceptible	ADJ
hls-12723	94	9	to	to	ADP
hls-12723	94	10	infection	infection	NOUN
hls-12723	94	11	for	for	ADP
hls-12723	94	12	various	various	ADJ
hls-12723	94	13	reasons	reason	NOUN
hls-12723	94	14	,	,	PUNCT
hls-12723	94	15	some	some	PRON
hls-12723	94	16	related	related	ADJ
hls-12723	94	17	to	to	ADP
hls-12723	94	18	the	the	DET
hls-12723	94	19	presence	presence	NOUN
hls-12723	94	20	of	of	ADP
hls-12723	94	21	an	an	DET
hls-12723	94	22	underlying	underlie	VERB
hls-12723	94	23	disease	disease	NOUN
hls-12723	94	24	and	and	CCONJ
hls-12723	94	25	some	some	PRON
hls-12723	94	26	due	due	ADJ
hls-12723	94	27	to	to	ADP
hls-12723	94	28	environmental	environmental	ADJ
hls-12723	94	29	factors	factor	NOUN
hls-12723	94	30	,	,	PUNCT
hls-12723	94	31	including	include	VERB
hls-12723	94	32	housing	housing	NOUN
hls-12723	94	33	insecurity	insecurity	NOUN
hls-12723	94	34	,	,	PUNCT
hls-12723	94	35	smoking	smoking	NOUN
hls-12723	94	36	,	,	PUNCT
hls-12723	94	37	poor	poor	ADJ
hls-12723	94	38	access	access	NOUN
hls-12723	94	39	to	to	ADP
hls-12723	94	40	health	health	NOUN
hls-12723	94	41	facilities	facility	NOUN
hls-12723	94	42	,	,	PUNCT
hls-12723	94	43	and	and	CCONJ
hls-12723	94	44	the	the	DET
hls-12723	94	45	effects	effect	NOUN
hls-12723	94	46	of	of	ADP
hls-12723	94	47	medications	medication	NOUN
hls-12723	94	48	used	use	VERB
hls-12723	94	49	to	to	PART
hls-12723	94	50	treat	treat	VERB
hls-12723	94	51	the	the	DET
hls-12723	94	52	disorder	disorder	NOUN
hls-12723	94	53	.	.	PUNCT
hls-12723	95	1	this	this	PRON
hls-12723	95	2	increased	increase	VERB
hls-12723	95	3	susceptibility	susceptibility	NOUN
hls-12723	95	4	to	to	ADP
hls-12723	95	5	respiratory	respiratory	ADJ
hls-12723	95	6	tract	tract	NOUN
hls-12723	95	7	infections	infection	NOUN
hls-12723	95	8	may	may	AUX
hls-12723	95	9	contribute	contribute	VERB
hls-12723	95	10	to	to	ADP
hls-12723	95	11	the	the	DET
hls-12723	95	12	risk	risk	NOUN
hls-12723	95	13	of	of	ADP
hls-12723	95	14	covid-19	covid-19	PROPN
hls-12723	95	15	in	in	ADP
hls-12723	95	16	patients	patient	NOUN
hls-12723	95	17	with	with	ADP
hls-12723	95	18	severe	severe	ADJ
hls-12723	95	19	mental	mental	ADJ
hls-12723	95	20	illness	illness	NOUN
hls-12723	95	21	or	or	CCONJ
hls-12723	95	22	who	who	PRON
hls-12723	95	23	are	be	AUX
hls-12723	95	24	in	in	ADP
hls-12723	95	25	inpatient	inpatient	NOUN
hls-12723	96	1	care.8	care.8	NOUN
hls-12723	96	2	schizophrenia	schizophrenia	NOUN
hls-12723	96	3	subjects	subject	NOUN
hls-12723	96	4	in	in	ADP
hls-12723	96	5	the	the	DET
hls-12723	96	6	covid-19	covid-19	PROPN
hls-12723	96	7	positive	positive	ADJ
hls-12723	96	8	group	group	NOUN
hls-12723	96	9	and	and	CCONJ
hls-12723	96	10	control	control	NOUN
hls-12723	96	11	groups	group	NOUN
hls-12723	96	12	were	be	AUX
hls-12723	96	13	more	more	ADV
hls-12723	96	14	male	male	ADJ
hls-12723	96	15	than	than	ADP
hls-12723	96	16	female	female	ADJ
hls-12723	96	17	;	;	PUNCT
hls-12723	96	18	male	male	ADJ
hls-12723	96	19	subjects	subject	NOUN
hls-12723	96	20	were	be	AUX
hls-12723	96	21	34	34	NUM
hls-12723	96	22	subjects	subject	NOUN
hls-12723	96	23	(	(	PUNCT
hls-12723	96	24	77.3	77.3	NUM
hls-12723	96	25	%	%	NOUN
hls-12723	96	26	)	)	PUNCT
hls-12723	96	27	,	,	PUNCT
hls-12723	96	28	and	and	CCONJ
hls-12723	96	29	female	female	ADJ
hls-12723	96	30	subjects	subject	NOUN
hls-12723	96	31	were	be	AUX
hls-12723	96	32	10	10	NUM
hls-12723	96	33	subjects	subject	NOUN
hls-12723	96	34	(	(	PUNCT
hls-12723	96	35	22.7	22.7	NUM
hls-12723	96	36	%	%	NOUN
hls-12723	96	37	)	)	PUNCT
hls-12723	96	38	.	.	PUNCT
hls-12723	97	1	based	base	VERB
hls-12723	97	2	on	on	ADP
hls-12723	97	3	the	the	DET
hls-12723	97	4	age	age	NOUN
hls-12723	97	5	,	,	PUNCT
hls-12723	97	6	18	18	NUM
hls-12723	97	7	-	-	SYM
hls-12723	97	8	29	29	NUM
hls-12723	97	9	years	year	NOUN
hls-12723	97	10	was	be	AUX
hls-12723	97	11	12	12	NUM
hls-12723	97	12	subjects	subject	NOUN
hls-12723	97	13	(	(	PUNCT
hls-12723	97	14	27.3	27.3	NUM
hls-12723	97	15	%	%	NOUN
hls-12723	97	16	)	)	PUNCT
hls-12723	97	17	,	,	PUNCT
hls-12723	97	18	30	30	NUM
hls-12723	97	19	-	-	SYM
hls-12723	97	20	39	39	NUM
hls-12723	97	21	years	year	NOUN
hls-12723	97	22	was	be	AUX
hls-12723	97	23	19	19	NUM
hls-12723	97	24	subjects	subject	NOUN
hls-12723	97	25	(	(	PUNCT
hls-12723	97	26	43.2	43.2	NUM
hls-12723	97	27	%	%	NOUN
hls-12723	97	28	)	)	PUNCT
hls-12723	97	29	,	,	PUNCT
hls-12723	97	30	40	40	NUM
hls-12723	97	31	-	-	SYM
hls-12723	97	32	53	53	NUM
hls-12723	97	33	years	year	NOUN
hls-12723	97	34	was	be	AUX
hls-12723	97	35	13	13	NUM
hls-12723	97	36	subjects	subject	NOUN
hls-12723	97	37	(	(	PUNCT
hls-12723	97	38	29.5	29.5	NUM
hls-12723	97	39	%	%	NOUN
hls-12723	97	40	)	)	PUNCT
hls-12723	97	41	(	(	PUNCT
hls-12723	97	42	table	table	NOUN
hls-12723	97	43	2	2	NUM
hls-12723	97	44	)	)	PUNCT
hls-12723	97	45	.	.	PUNCT
hls-12723	98	1	schizophrenia	schizophrenia	PROPN
hls-12723	98	2	is	be	AUX
hls-12723	98	3	more	more	ADV
hls-12723	98	4	common	common	ADJ
hls-12723	98	5	in	in	ADP
hls-12723	98	6	men	man	NOUN
hls-12723	98	7	than	than	ADP
hls-12723	98	8	women.10	women.10	VERB
hls-12723	98	9	men	man	NOUN
hls-12723	98	10	have	have	VERB
hls-12723	98	11	an	an	DET
hls-12723	98	12	earlier	early	ADJ
hls-12723	98	13	onset	onset	NOUN
hls-12723	98	14	of	of	ADP
hls-12723	98	15	schizophrenia	schizophrenia	NOUN
hls-12723	98	16	than	than	ADP
hls-12723	98	17	women	woman	NOUN
hls-12723	98	18	;	;	PUNCT
hls-12723	98	19	the	the	DET
hls-12723	98	20	peak	peak	NOUN
hls-12723	98	21	age	age	NOUN
hls-12723	98	22	is	be	AUX
hls-12723	98	23	25	25	NUM
hls-12723	98	24	to	to	PART
hls-12723	98	25	35	35	NUM
hls-12723	98	26	years	year	NOUN
hls-12723	98	27	,	,	PUNCT
hls-12723	98	28	approximately	approximately	ADV
hls-12723	98	29	15	15	NUM
hls-12723	98	30	-	-	SYM
hls-12723	98	31	55	55	NUM
hls-12723	98	32	years	year	NOUN
hls-12723	98	33	of	of	ADP
hls-12723	98	34	age	age	NOUN
hls-12723	98	35	for	for	ADP
hls-12723	98	36	patients	patient	NOUN
hls-12723	98	37	on	on	ADP
hls-12723	98	38	schizophrenia	schizophrenia	NOUN
hls-12723	98	39	treatment.9	treatment.9	PROPN
hls-12723	98	40	in	in	ADP
hls-12723	98	41	this	this	DET
hls-12723	98	42	study	study	NOUN
hls-12723	98	43	,	,	PUNCT
hls-12723	98	44	the	the	DET
hls-12723	98	45	samples	sample	NOUN
hls-12723	98	46	were	be	AUX
hls-12723	98	47	30	30	NUM
hls-12723	98	48	-	-	SYM
hls-12723	98	49	39	39	NUM
hls-12723	98	50	years	year	NOUN
hls-12723	98	51	old	old	ADJ
hls-12723	98	52	(	(	PUNCT
hls-12723	98	53	43.2	43.2	NUM
hls-12723	98	54	%	%	NOUN
hls-12723	98	55	)	)	PUNCT
hls-12723	98	56	.	.	PUNCT
hls-12723	99	1	the	the	DET
hls-12723	99	2	education	education	NOUN
hls-12723	99	3	level	level	NOUN
hls-12723	99	4	in	in	ADP
hls-12723	99	5	this	this	DET
hls-12723	99	6	study	study	NOUN
hls-12723	99	7	was	be	AUX
hls-12723	99	8	56.8	56.8	NUM
hls-12723	99	9	%	%	NOUN
hls-12723	99	10	elementary	elementary	ADJ
hls-12723	99	11	school	school	NOUN
hls-12723	99	12	.	.	PUNCT
hls-12723	100	1	a	a	DET
hls-12723	100	2	deficit	deficit	NOUN
hls-12723	100	3	in	in	ADP
hls-12723	100	4	social	social	ADJ
hls-12723	100	5	functioning	function	VERB
hls-12723	100	6	mode	mode	NOUN
hls-12723	100	7	made	make	VERB
hls-12723	100	8	it	it	PRON
hls-12723	100	9	difficult	difficult	ADJ
hls-12723	100	10	for	for	SCONJ
hls-12723	100	11	subjects	subject	NOUN
hls-12723	100	12	with	with	ADP
hls-12723	100	13	schizophrenia	schizophrenia	NOUN
hls-12723	100	14	to	to	PART
hls-12723	100	15	continue	continue	VERB
hls-12723	100	16	their	their	PRON
hls-12723	100	17	education	education	NOUN
hls-12723	100	18	to	to	ADP
hls-12723	100	19	a	a	DET
hls-12723	100	20	higher	high	ADJ
hls-12723	100	21	level	level	NOUN
hls-12723	100	22	.	.	PUNCT
hls-12723	101	1	this	this	DET
hls-12723	101	2	deficit	deficit	NOUN
hls-12723	101	3	was	be	AUX
hls-12723	101	4	in	in	ADP
hls-12723	101	5	the	the	DET
hls-12723	101	6	form	form	NOUN
hls-12723	101	7	of	of	ADP
hls-12723	101	8	social	social	ADJ
hls-12723	101	9	isolation	isolation	NOUN
hls-12723	101	10	,	,	PUNCT
hls-12723	101	11	often	often	ADV
hls-12723	101	12	indicated	indicate	VERB
hls-12723	101	13	by	by	ADP
hls-12723	101	14	inadequate	inadequate	ADJ
hls-12723	101	15	and	and	CCONJ
hls-12723	101	16	inappropriate	inappropriate	ADJ
hls-12723	101	17	emotional	emotional	ADJ
hls-12723	101	18	responses	response	NOUN
hls-12723	101	19	,	,	PUNCT
hls-12723	101	20	poor	poor	ADJ
hls-12723	101	21	interpersonal	interpersonal	ADJ
hls-12723	101	22	relationships	relationship	NOUN
hls-12723	101	23	,	,	PUNCT
hls-12723	101	24	feelings	feeling	NOUN
hls-12723	101	25	of	of	ADP
hls-12723	101	26	threat	threat	NOUN
hls-12723	101	27	in	in	ADP
hls-12723	101	28	social	social	ADJ
hls-12723	101	29	situations	situation	NOUN
hls-12723	101	30	,	,	PUNCT
hls-12723	101	31	difficulty	difficulty	NOUN
hls-12723	101	32	communicating	communicate	VERB
hls-12723	101	33	verbally	verbally	ADV
hls-12723	101	34	,	,	PUNCT
hls-12723	101	35	and	and	CCONJ
hls-12723	101	36	reactions	reaction	NOUN
hls-12723	101	37	to	to	ADP
hls-12723	101	38	excessive	excessive	ADJ
hls-12723	101	39	stimuli.18	stimuli.18	PROPN
hls-12723	101	40	the	the	DET
hls-12723	101	41	subject	subject	NOUN
hls-12723	101	42	’s	’s	PART
hls-12723	101	43	initial	initial	ADJ
hls-12723	101	44	panss	pans	NOUN
hls-12723	101	45	scores	score	NOUN
hls-12723	101	46	varied	vary	VERB
hls-12723	101	47	between	between	ADP
hls-12723	101	48	68–81	68–81	PROPN
hls-12723	101	49	,	,	PUNCT
hls-12723	101	50	with	with	ADP
hls-12723	101	51	a	a	DET
hls-12723	101	52	mean	mean	NOUN
hls-12723	101	53	of	of	ADP
hls-12723	101	54	72.4±3.4	72.4±3.4	NUM
hls-12723	101	55	.	.	PUNCT
hls-12723	102	1	the	the	DET
hls-12723	102	2	distribution	distribution	NOUN
hls-12723	102	3	of	of	ADP
hls-12723	102	4	pre	pre	ADJ
hls-12723	102	5	-	-	ADJ
hls-12723	102	6	panss	pans	NOUN
hls-12723	102	7	data	datum	NOUN
hls-12723	102	8	was	be	AUX
hls-12723	102	9	not	not	PART
hls-12723	102	10	normal	normal	ADJ
hls-12723	102	11	.	.	PUNCT
hls-12723	103	1	post	post	ADJ
hls-12723	103	2	-	-	ADJ
hls-12723	103	3	subject	subject	ADJ
hls-12723	103	4	panss	pans	NOUN
hls-12723	103	5	scores	score	NOUN
hls-12723	103	6	ranged	range	VERB
hls-12723	103	7	between	between	ADP
hls-12723	103	8	43–69	43–69	NUM
hls-12723	103	9	,	,	PUNCT
hls-12723	103	10	with	with	ADP
hls-12723	103	11	a	a	DET
hls-12723	103	12	mean	mean	NOUN
hls-12723	103	13	of	of	ADP
hls-12723	103	14	56.9±6.3	56.9±6.3	NUM
hls-12723	103	15	.	.	PUNCT
hls-12723	104	1	the	the	DET
hls-12723	104	2	distribution	distribution	NOUN
hls-12723	104	3	of	of	ADP
hls-12723	104	4	panss	pans	NOUN
hls-12723	104	5	post	post	NOUN
hls-12723	104	6	data	datum	NOUN
hls-12723	104	7	was	be	AUX
hls-12723	104	8	not	not	PART
hls-12723	104	9	normal	normal	ADJ
hls-12723	104	10	.	.	PUNCT
hls-12723	105	1	the	the	DET
hls-12723	105	2	difference	difference	NOUN
hls-12723	105	3	scores	score	NOUN
hls-12723	105	4	of	of	ADP
hls-12723	105	5	panss	pans	NOUN
hls-12723	105	6	(	(	PUNCT
hls-12723	105	7	pre	pre	ADJ
hls-12723	105	8	-	-	ADJ
hls-12723	105	9	post	post	ADJ
hls-12723	105	10	)	)	PUNCT
hls-12723	105	11	subjects	subject	NOUN
hls-12723	105	12	varied	varied	ADJ
hls-12723	105	13	between	between	ADP
hls-12723	105	14	7–34	7–34	PROPN
hls-12723	105	15	,	,	PUNCT
hls-12723	105	16	with	with	ADP
hls-12723	105	17	a	a	DET
hls-12723	105	18	mean	mean	NOUN
hls-12723	105	19	of	of	ADP
hls-12723	105	20	15.6±5.9	15.6±5.9	NUM
hls-12723	105	21	(	(	PUNCT
hls-12723	105	22	table	table	NOUN
hls-12723	105	23	1	1	NUM
hls-12723	105	24	)	)	PUNCT
hls-12723	105	25	.	.	PUNCT
hls-12723	106	1	the	the	DET
hls-12723	106	2	difference	difference	NOUN
hls-12723	106	3	in	in	ADP
hls-12723	106	4	panss	pans	NOUN
hls-12723	106	5	scores	score	NOUN
hls-12723	106	6	showed	show	VERB
hls-12723	106	7	a	a	DET
hls-12723	106	8	decrease	decrease	NOUN
hls-12723	106	9	in	in	ADP
hls-12723	106	10	the	the	DET
hls-12723	106	11	post	post	NOUN
hls-12723	106	12	-	-	NOUN
hls-12723	106	13	measurement	measurement	NOUN
hls-12723	106	14	compared	compare	VERB
hls-12723	106	15	to	to	ADP
hls-12723	106	16	pre	pre	VERB
hls-12723	106	17	-	-	VERB
hls-12723	106	18	measurement	measurement	NOUN
hls-12723	106	19	.	.	PUNCT
hls-12723	107	1	the	the	DET
hls-12723	107	2	distribution	distribution	NOUN
hls-12723	107	3	of	of	ADP
hls-12723	107	4	panss	pans	NOUN
hls-12723	107	5	difference	difference	NOUN
hls-12723	107	6	data	datum	NOUN
hls-12723	107	7	was	be	AUX
hls-12723	107	8	not	not	PART
hls-12723	107	9	normal	normal	ADJ
hls-12723	107	10	,	,	PUNCT
hls-12723	107	11	possibly	possibly	ADV
hls-12723	107	12	due	due	ADP
hls-12723	107	13	to	to	ADP
hls-12723	107	14	clinical	clinical	ADJ
hls-12723	107	15	improvement	improvement	NOUN
hls-12723	107	16	before	before	ADV
hls-12723	107	17	and	and	CCONJ
hls-12723	107	18	after	after	ADP
hls-12723	107	19	risperidone	risperidone	NOUN
hls-12723	107	20	antipsychotic	antipsychotic	ADJ
hls-12723	107	21	therapy	therapy	NOUN
hls-12723	107	22	.	.	PUNCT
hls-12723	108	1	there	there	PRON
hls-12723	108	2	are	be	VERB
hls-12723	108	3	several	several	ADJ
hls-12723	108	4	mechanisms	mechanism	NOUN
hls-12723	108	5	by	by	ADP
hls-12723	108	6	which	which	PRON
hls-12723	108	7	risperidone	risperidone	NOUN
hls-12723	108	8	may	may	AUX
hls-12723	108	9	decrease	decrease	VERB
hls-12723	108	10	il-6	il-6	PRON
hls-12723	108	11	levels	level	NOUN
hls-12723	108	12	.	.	PUNCT
hls-12723	109	1	the	the	DET
hls-12723	109	2	study	study	NOUN
hls-12723	109	3	conducted	conduct	VERB
hls-12723	109	4	by	by	ADP
hls-12723	109	5	de	de	PROPN
hls-12723	109	6	souza	souza	PROPN
hls-12723	109	7	et	et	PROPN
hls-12723	109	8	al	al	PROPN
hls-12723	109	9	.	.	PROPN
hls-12723	109	10	found	find	VERB
hls-12723	109	11	that	that	SCONJ
hls-12723	109	12	risperidone	risperidone	NOUN
hls-12723	109	13	inhibited	inhibit	VERB
hls-12723	109	14	il-6	il-6	NOUN
hls-12723	109	15	-	-	PUNCT
hls-12723	109	16	induced	induce	VERB
hls-12723	109	17	s100b	s100b	PROPN
hls-12723	109	18	secretion	secretion	NOUN
hls-12723	109	19	,	,	PUNCT
hls-12723	109	20	reducing	reduce	VERB
hls-12723	109	21	the	the	DET
hls-12723	109	22	rate	rate	NOUN
hls-12723	109	23	of	of	ADP
hls-12723	109	24	secretion	secretion	NOUN
hls-12723	109	25	below	below	ADP
hls-12723	109	26	the	the	DET
hls-12723	109	27	basal	basal	PROPN
hls-12723	109	28	level.19	level.19	NOUN
hls-12723	109	29	circulating	circulate	VERB
hls-12723	109	30	levels	level	NOUN
hls-12723	109	31	of	of	ADP
hls-12723	109	32	il-6	il-6	NOUN
hls-12723	109	33	and	and	CCONJ
hls-12723	109	34	il-10	il-10	PRON
hls-12723	109	35	may	may	AUX
hls-12723	109	36	regulate	regulate	VERB
hls-12723	109	37	the	the	DET
hls-12723	109	38	expression	expression	NOUN
hls-12723	109	39	of	of	ADP
hls-12723	109	40	the	the	DET
hls-12723	109	41	akt1	akt1	NOUN
hls-12723	109	42	,	,	PUNCT
hls-12723	109	43	drosha	drosha	PROPN
hls-12723	109	44	,	,	PUNCT
hls-12723	109	45	ndel1	ndel1	PROPN
hls-12723	109	46	,	,	PUNCT
hls-12723	109	47	disc1	disc1	NOUN
hls-12723	109	48	,	,	PUNCT
hls-12723	109	49	and	and	CCONJ
hls-12723	109	50	mbp	mbp	AUX
hls-12723	109	51	genes.20	genes.20	PROPN
hls-12723	109	52	thus	thus	ADV
hls-12723	109	53	,	,	PUNCT
hls-12723	109	54	risperidone	risperidone	NOUN
hls-12723	109	55	treatment	treatment	NOUN
hls-12723	109	56	may	may	AUX
hls-12723	109	57	modulate	modulate	VERB
hls-12723	109	58	gene	gene	NOUN
hls-12723	109	59	expression	expression	NOUN
hls-12723	109	60	during	during	ADP
hls-12723	109	61	the	the	DET
hls-12723	109	62	treatment	treatment	NOUN
hls-12723	109	63	of	of	ADP
hls-12723	109	64	schizophrenia	schizophrenia	NOUN
hls-12723	109	65	.	.	PUNCT
hls-12723	110	1	in	in	ADP
hls-12723	110	2	recent	recent	ADJ
hls-12723	110	3	years	year	NOUN
hls-12723	110	4	,	,	PUNCT
hls-12723	110	5	scientists	scientist	NOUN
hls-12723	110	6	have	have	AUX
hls-12723	110	7	discovered	discover	VERB
hls-12723	110	8	in	in	ADP
hls-12723	110	9	biochemical	biochemical	ADJ
hls-12723	110	10	studies	study	NOUN
hls-12723	110	11	of	of	ADP
hls-12723	110	12	the	the	DET
hls-12723	110	13	central	central	ADJ
hls-12723	110	14	nervous	nervous	ADJ
hls-12723	110	15	system	system	NOUN
hls-12723	110	16	that	that	PRON
hls-12723	110	17	il-6	il-6	PRON
hls-12723	110	18	is	be	AUX
hls-12723	110	19	produced	produce	VERB
hls-12723	110	20	by	by	ADP
hls-12723	110	21	neurons	neuron	NOUN
hls-12723	110	22	,	,	PUNCT
hls-12723	110	23	astrocytes	astrocyte	NOUN
hls-12723	110	24	,	,	PUNCT
hls-12723	110	25	and	and	CCONJ
hls-12723	110	26	microglia	microglia	NOUN
hls-12723	110	27	and	and	CCONJ
hls-12723	110	28	acts	act	VERB
hls-12723	110	29	as	as	ADP
hls-12723	110	30	a	a	DET
hls-12723	110	31	neurotrophic	neurotrophic	ADJ
hls-12723	110	32	factor	factor	NOUN
hls-12723	110	33	in	in	ADP
hls-12723	110	34	the	the	DET
hls-12723	110	35	central	central	ADJ
hls-12723	110	36	nervous	nervous	ADJ
hls-12723	110	37	system	system	NOUN
hls-12723	110	38	.	.	PUNCT
hls-12723	111	1	however	however	ADV
hls-12723	111	2	,	,	PUNCT
hls-12723	111	3	recent	recent	ADJ
hls-12723	111	4	studies	study	NOUN
hls-12723	111	5	suggest	suggest	VERB
hls-12723	111	6	that	that	SCONJ
hls-12723	111	7	risperidone	risperidone	NOUN
hls-12723	111	8	can	can	AUX
hls-12723	111	9	attenuate	attenuate	VERB
hls-12723	111	10	microglia	microglia	ADJ
hls-12723	111	11	activation	activation	NOUN
hls-12723	111	12	in	in	ADP
hls-12723	111	13	the	the	DET
hls-12723	111	14	brain	brain	NOUN
hls-12723	111	15	,	,	PUNCT
hls-12723	111	16	reducing	reduce	VERB
hls-12723	111	17	il-6	il-6	NUM
hls-12723	111	18	levels	level	NOUN
hls-12723	111	19	and	and	CCONJ
hls-12723	111	20	suggesting	suggest	VERB
hls-12723	111	21	risperidone	risperidone	NOUN
hls-12723	111	22	may	may	AUX
hls-12723	111	23	improve	improve	VERB
hls-12723	111	24	brain	brain	NOUN
hls-12723	111	25	disease.21	disease.21	PROPN
hls-12723	111	26	a	a	DET
hls-12723	111	27	meta	meta	ADJ
hls-12723	111	28	-	-	PUNCT
hls-12723	111	29	analysis	analysis	NOUN
hls-12723	111	30	study	study	NOUN
hls-12723	111	31	that	that	PRON
hls-12723	111	32	found	find	VERB
hls-12723	111	33	a	a	DET
hls-12723	111	34	decrease	decrease	NOUN
hls-12723	111	35	in	in	ADP
hls-12723	111	36	il-6	il-6	NOUN
hls-12723	111	37	levels	level	NOUN
hls-12723	111	38	after	after	ADP
hls-12723	111	39	short	short	ADJ
hls-12723	111	40	-	-	PUNCT
hls-12723	111	41	term	term	NOUN
hls-12723	111	42	risperidone	risperidone	NOUN
hls-12723	111	43	treatment	treatment	NOUN
hls-12723	111	44	saw	see	VERB
hls-12723	111	45	a	a	DET
hls-12723	111	46	significant	significant	ADJ
hls-12723	111	47	reduction	reduction	NOUN
hls-12723	111	48	after	after	ADP
hls-12723	111	49	four	four	NUM
hls-12723	111	50	weeks	week	NOUN
hls-12723	111	51	of	of	ADP
hls-12723	111	52	antipsychotic	antipsychotic	ADJ
hls-12723	111	53	administration.22	administration.22	NOUN
hls-12723	111	54	in	in	ADP
hls-12723	111	55	another	another	DET
hls-12723	111	56	study	study	NOUN
hls-12723	111	57	that	that	PRON
hls-12723	111	58	observed	observe	VERB
hls-12723	111	59	a	a	DET
hls-12723	111	60	decrease	decrease	NOUN
hls-12723	111	61	in	in	ADP
hls-12723	111	62	il-6	il-6	NOUN
hls-12723	111	63	levels	level	NOUN
hls-12723	111	64	within	within	ADP
hls-12723	111	65	nine	nine	NUM
hls-12723	111	66	days	day	NOUN
hls-12723	111	67	of	of	ADP
hls-12723	111	68	antipsychotic	antipsychotic	ADJ
hls-12723	111	69	treatment	treatment	NOUN
hls-12723	111	70	and	and	CCONJ
hls-12723	111	71	at	at	ADP
hls-12723	111	72	eight	eight	NUM
hls-12723	111	73	weeks	week	NOUN
hls-12723	111	74	showed	show	VERB
hls-12723	111	75	no	no	DET
hls-12723	111	76	significant	significant	ADJ
hls-12723	111	77	symptoms	symptom	NOUN
hls-12723	111	78	,	,	PUNCT
hls-12723	111	79	there	there	PRON
hls-12723	111	80	was	be	VERB
hls-12723	111	81	no	no	DET
hls-12723	111	82	difference	difference	NOUN
hls-12723	111	83	between	between	ADP
hls-12723	111	84	patients	patient	NOUN
hls-12723	111	85	and	and	CCONJ
hls-12723	111	86	control	control	VERB
hls-12723	111	87	subjects.23	subjects.23	PROPN
hls-12723	111	88	overall	overall	ADV
hls-12723	111	89	,	,	PUNCT
hls-12723	111	90	il-6	il-6	NUM
hls-12723	111	91	levels	level	NOUN
hls-12723	111	92	were	be	AUX
hls-12723	111	93	normalized	normalize	VERB
hls-12723	111	94	to	to	ADP
hls-12723	111	95	some	some	DET
hls-12723	111	96	extent	extent	NOUN
hls-12723	111	97	immediately	immediately	ADV
hls-12723	111	98	after	after	ADP
hls-12723	111	99	risperidone	risperidone	NOUN
hls-12723	111	100	treatment	treatment	NOUN
hls-12723	111	101	.	.	PUNCT
hls-12723	112	1	evidence	evidence	NOUN
hls-12723	112	2	that	that	SCONJ
hls-12723	112	3	cytokines	cytokine	NOUN
hls-12723	112	4	can	can	AUX
hls-12723	112	5	be	be	AUX
hls-12723	112	6	affected	affect	VERB
hls-12723	112	7	by	by	ADP
hls-12723	112	8	antipsychotic	antipsychotic	ADJ
hls-12723	112	9	treatment	treatment	NOUN
hls-12723	112	10	,	,	PUNCT
hls-12723	112	11	possibly	possibly	ADV
hls-12723	112	12	in	in	ADP
hls-12723	112	13	a	a	DET
hls-12723	112	14	dual	dual	ADJ
hls-12723	112	15	mode	mode	NOUN
hls-12723	112	16	(	(	PUNCT
hls-12723	112	17	short	short	ADJ
hls-12723	112	18	-	-	PUNCT
hls-12723	112	19	term	term	NOUN
hls-12723	112	20	and	and	CCONJ
hls-12723	112	21	long	long	ADJ
hls-12723	112	22	-	-	PUNCT
hls-12723	112	23	term	term	NOUN
hls-12723	112	24	)	)	PUNCT
hls-12723	112	25	,	,	PUNCT
hls-12723	112	26	antiinflammatory	antiinflammatory	NOUN
hls-12723	112	27	in	in	ADP
hls-12723	112	28	antipsychotics	antipsychotic	NOUN
hls-12723	112	29	may	may	AUX
hls-12723	112	30	contribute	contribute	VERB
hls-12723	112	31	to	to	ADP
hls-12723	112	32	the	the	DET
hls-12723	112	33	treatment	treatment	NOUN
hls-12723	112	34	of	of	ADP
hls-12723	112	35	schizophrenia	schizophrenia	NOUN
hls-12723	112	36	.	.	PUNCT
hls-12723	113	1	anti	anti	ADJ
hls-12723	113	2	-	-	ADJ
hls-12723	113	3	inflammatory	inflammatory	ADJ
hls-12723	113	4	effects	effect	NOUN
hls-12723	113	5	of	of	ADP
hls-12723	113	6	antipsychotics	antipsychotic	NOUN
hls-12723	113	7	may	may	AUX
hls-12723	113	8	play	play	VERB
hls-12723	113	9	a	a	DET
hls-12723	113	10	role	role	NOUN
hls-12723	113	11	in	in	ADP
hls-12723	113	12	treating	treat	VERB
hls-12723	113	13	psychotic	psychotic	ADJ
hls-12723	113	14	symptoms.24,25	symptoms.24,25	NOUN
hls-12723	113	15	in	in	ADP
hls-12723	113	16	a	a	DET
hls-12723	113	17	recent	recent	ADJ
hls-12723	113	18	metaanalysis	metaanalysis	NOUN
hls-12723	113	19	of	of	ADP
hls-12723	113	20	12	12	NUM
hls-12723	113	21	studies	study	NOUN
hls-12723	113	22	(	(	PUNCT
hls-12723	113	23	961	961	NUM
hls-12723	113	24	patients	patient	NOUN
hls-12723	113	25	with	with	ADP
hls-12723	113	26	schizophrenia	schizophrenia	NOUN
hls-12723	113	27	and	and	CCONJ
hls-12723	113	28	729	729	NUM
hls-12723	113	29	controls	control	NOUN
hls-12723	113	30	)	)	PUNCT
hls-12723	113	31	on	on	ADP
hls-12723	113	32	the	the	DET
hls-12723	113	33	effect	effect	NOUN
hls-12723	113	34	of	of	ADP
hls-12723	113	35	antipsychotics	antipsychotic	NOUN
hls-12723	113	36	on	on	ADP
hls-12723	113	37	serum	serum	NOUN
hls-12723	113	38	production	production	NOUN
hls-12723	113	39	of	of	ADP
hls-12723	113	40	interleukin-6	interleukin-6	PROPN
hls-12723	113	41	(	(	PUNCT
hls-12723	113	42	il-6	il-6	NUM
hls-12723	113	43	)	)	PUNCT
hls-12723	113	44	,	,	PUNCT
hls-12723	113	45	a	a	DET
hls-12723	113	46	proinflammatory	proinflammatory	ADJ
hls-12723	113	47	cytokine	cytokine	NOUN
hls-12723	113	48	,	,	PUNCT
hls-12723	113	49	they	they	PRON
hls-12723	113	50	found	find	VERB
hls-12723	113	51	that	that	SCONJ
hls-12723	113	52	antipsychotic	antipsychotic	ADJ
hls-12723	113	53	treatment	treatment	NOUN
hls-12723	113	54	was	be	AUX
hls-12723	113	55	associated	associate	VERB
hls-12723	113	56	with	with	ADP
hls-12723	113	57	a	a	DET
hls-12723	113	58	decrease	decrease	NOUN
hls-12723	113	59	in	in	ADP
hls-12723	113	60	il-6	il-6	NOUN
hls-12723	113	61	on	on	ADP
hls-12723	113	62	the	the	DET
hls-12723	113	63	patient	patient	NOUN
hls-12723	113	64	.	.	PUNCT
hls-12723	114	1	in	in	ADP
hls-12723	114	2	contrast	contrast	NOUN
hls-12723	114	3	,	,	PUNCT
hls-12723	114	4	trifluoperazine	trifluoperazine	NOUN
hls-12723	114	5	,	,	PUNCT
hls-12723	114	6	a	a	DET
hls-12723	114	7	conventional	conventional	ADJ
hls-12723	114	8	antipsychotic	antipsychotic	NOUN
hls-12723	114	9	,	,	PUNCT
hls-12723	114	10	has	have	AUX
hls-12723	114	11	been	be	AUX
hls-12723	114	12	identified	identify	VERB
hls-12723	114	13	as	as	ADP
hls-12723	114	14	a	a	DET
hls-12723	114	15	potential	potential	ADJ
hls-12723	114	16	treatment	treatment	NOUN
hls-12723	114	17	option	option	NOUN
hls-12723	114	18	for	for	ADP
hls-12723	114	19	microbial	microbial	ADJ
hls-12723	114	20	-	-	PUNCT
hls-12723	114	21	induced	induce	VERB
hls-12723	114	22	septic	septic	ADJ
hls-12723	114	23	shock	shock	NOUN
hls-12723	114	24	after	after	SCONJ
hls-12723	114	25	it	it	PRON
hls-12723	114	26	reduced	reduce	VERB
hls-12723	114	27	the	the	DET
hls-12723	114	28	inflammatory	inflammatory	ADJ
hls-12723	114	29	response	response	NOUN
hls-12723	114	30	by	by	ADP
hls-12723	114	31	suppressing	suppress	VERB
hls-12723	114	32	proinflammatory	proinflammatory	ADJ
hls-12723	114	33	cytokines	cytokine	NOUN
hls-12723	114	34	in	in	ADP
hls-12723	114	35	mice.26	mice.26	NOUN
hls-12723	114	36	recently	recently	ADV
hls-12723	114	37	,	,	PUNCT
hls-12723	114	38	crespo	crespo	PROPN
hls-12723	114	39	-	-	PUNCT
hls-12723	114	40	facorro	facorro	PROPN
hls-12723	114	41	et	et	PROPN
hls-12723	114	42	al	al	PROPN
hls-12723	114	43	.	.	PROPN
hls-12723	114	44	suggested	suggest	VERB
hls-12723	114	45	that	that	SCONJ
hls-12723	114	46	aripiprazole	aripiprazole	NOUN
hls-12723	114	47	,	,	PUNCT
hls-12723	114	48	an	an	DET
hls-12723	114	49	atypical	atypical	ADJ
hls-12723	114	50	antipsychotic	antipsychotic	NOUN
hls-12723	114	51	,	,	PUNCT
hls-12723	114	52	could	could	AUX
hls-12723	114	53	also	also	ADV
hls-12723	114	54	be	be	AUX
hls-12723	114	55	reused	reuse	VERB
hls-12723	114	56	as	as	ADP
hls-12723	114	57	a	a	DET
hls-12723	114	58	treatment	treatment	NOUN
hls-12723	114	59	for	for	ADP
hls-12723	114	60	covid-19	covid-19	PROPN
hls-12723	114	61	after	after	SCONJ
hls-12723	114	62	transcriptomic	transcriptomic	ADJ
hls-12723	114	63	analysis	analysis	NOUN
hls-12723	114	64	revealed	reveal	VERB
hls-12723	114	65	that	that	SCONJ
hls-12723	114	66	it	it	PRON
hls-12723	114	67	could	could	AUX
hls-12723	114	68	reverse	reverse	VERB
hls-12723	114	69	the	the	DET
hls-12723	114	70	effects	effect	NOUN
hls-12723	114	71	caused	cause	VERB
hls-12723	114	72	by	by	ADP
hls-12723	114	73	covid-19	covid-19	PROPN
hls-12723	114	74	on	on	ADP
hls-12723	114	75	gene	gene	NOUN
hls-12723	114	76	expression	expression	NOUN
hls-12723	114	77	in	in	ADP
hls-12723	114	78	patients.27	patients.27	PROPN
hls-12723	114	79	in	in	ADP
hls-12723	114	80	this	this	DET
hls-12723	114	81	study	study	NOUN
hls-12723	114	82	,	,	PUNCT
hls-12723	114	83	in	in	ADP
hls-12723	114	84	the	the	DET
hls-12723	114	85	covid-19	covid-19	PROPN
hls-12723	114	86	positive	positive	ADJ
hls-12723	114	87	group	group	NOUN
hls-12723	114	88	,	,	PUNCT
hls-12723	114	89	the	the	DET
hls-12723	114	90	mean	mean	NOUN
hls-12723	114	91	of	of	ADP
hls-12723	114	92	il-6	il-6	NOUN
hls-12723	114	93	post	post	NOUN
hls-12723	114	94	was	be	AUX
hls-12723	114	95	significantly	significantly	ADV
hls-12723	114	96	lower	low	ADJ
hls-12723	114	97	than	than	ADP
hls-12723	114	98	pre	pre	ADJ
hls-12723	114	99	,	,	PUNCT
hls-12723	114	100	which	which	PRON
hls-12723	114	101	was	be	AUX
hls-12723	114	102	23.0	23.0	NUM
hls-12723	114	103	compared	compare	VERB
hls-12723	114	104	to	to	ADP
hls-12723	114	105	26.1	26.1	NUM
hls-12723	114	106	(	(	PUNCT
hls-12723	114	107	p<0.001	p<0.001	PROPN
hls-12723	114	108	)	)	PUNCT
hls-12723	114	109	.	.	PUNCT
hls-12723	115	1	while	while	SCONJ
hls-12723	115	2	in	in	ADP
hls-12723	115	3	the	the	DET
hls-12723	115	4	control	control	NOUN
hls-12723	115	5	group	group	NOUN
hls-12723	115	6	,	,	PUNCT
hls-12723	115	7	the	the	DET
hls-12723	115	8	mean	mean	NOUN
hls-12723	115	9	of	of	ADP
hls-12723	115	10	il-6	il-6	NOUN
hls-12723	115	11	post	post	NOUN
hls-12723	115	12	was	be	AUX
hls-12723	115	13	considerably	considerably	ADV
hls-12723	115	14	lower	low	ADJ
hls-12723	115	15	than	than	ADP
hls-12723	115	16	pre	pre	ADJ
hls-12723	115	17	,	,	PUNCT
hls-12723	115	18	which	which	PRON
hls-12723	115	19	was	be	AUX
hls-12723	115	20	19.3	19.3	NUM
hls-12723	115	21	versus	versus	ADP
hls-12723	115	22	21.0	21.0	NUM
hls-12723	115	23	(	(	PUNCT
hls-12723	115	24	p<0.001	p<0.001	PROPN
hls-12723	115	25	)	)	PUNCT
hls-12723	115	26	(	(	PUNCT
hls-12723	115	27	table	table	NOUN
hls-12723	115	28	6	6	NUM
hls-12723	115	29	)	)	PUNCT
hls-12723	115	30	.	.	PUNCT
hls-12723	116	1	the	the	DET
hls-12723	116	2	covid-19	covid-19	PROPN
hls-12723	116	3	-	-	PUNCT
hls-12723	116	4	positive	positive	ADJ
hls-12723	116	5	group	group	NOUN
hls-12723	116	6	and	and	CCONJ
hls-12723	116	7	control	control	NOUN
hls-12723	116	8	groups	group	NOUN
hls-12723	116	9	might	might	AUX
hls-12723	116	10	had	have	VERB
hls-12723	116	11	lower	low	ADJ
hls-12723	116	12	il-6	il-6	NOUN
hls-12723	116	13	values	value	NOUN
hls-12723	116	14	below	below	ADP
hls-12723	116	15	the	the	DET
hls-12723	116	16	cut	cut	NOUN
hls-12723	116	17	-	-	PUNCT
hls-12723	116	18	off	off	NOUN
hls-12723	116	19	(	(	PUNCT
hls-12723	116	20	35pg	35pg	NOUN
hls-12723	116	21	/	/	SYM
hls-12723	116	22	ml	ml	NOUN
hls-12723	116	23	)	)	PUNCT
hls-12723	116	24	even	even	ADV
hls-12723	116	25	before	before	ADP
hls-12723	116	26	in	in	ADP
hls-12723	116	27	treatment	treatment	NOUN
hls-12723	116	28	antiviral	antiviral	NOUN
hls-12723	116	29	.	.	PUNCT
hls-12723	117	1	the	the	DET
hls-12723	117	2	phenomena	phenomenon	NOUN
hls-12723	117	3	could	could	AUX
hls-12723	117	4	be	be	AUX
hls-12723	117	5	the	the	DET
hls-12723	117	6	effect	effect	NOUN
hls-12723	117	7	of	of	ADP
hls-12723	117	8	risperidone	risperidone	NOUN
hls-12723	117	9	and	and	CCONJ
hls-12723	117	10	antivirals	antiviral	NOUN
hls-12723	117	11	made	make	VERB
hls-12723	117	12	the	the	DET
hls-12723	117	13	covid19	covid19	NOUN
hls-12723	117	14	positive	positive	ADJ
hls-12723	117	15	group	group	NOUN
hls-12723	117	16	asymptomatic	asymptomatic	NOUN
hls-12723	117	17	and	and	CCONJ
hls-12723	117	18	the	the	DET
hls-12723	117	19	il-6	il-6	NOUN
hls-12723	117	20	value	value	NOUN
hls-12723	117	21	below	below	ADP
hls-12723	117	22	the	the	DET
hls-12723	117	23	cutoff	cutoff	NOUN
hls-12723	117	24	.	.	PUNCT
hls-12723	118	1	serum	serum	PROPN
hls-12723	118	2	il-6	il-6	NOUN
hls-12723	118	3	levels	level	NOUN
hls-12723	118	4	appeared	appear	VERB
hls-12723	118	5	to	to	PART
hls-12723	118	6	be	be	AUX
hls-12723	118	7	a	a	DET
hls-12723	118	8	useful	useful	ADJ
hls-12723	118	9	prognostic	prognostic	ADJ
hls-12723	118	10	biomarker	biomarker	NOUN
hls-12723	118	11	in	in	ADP
hls-12723	118	12	patients	patient	NOUN
hls-12723	118	13	with	with	ADP
hls-12723	118	14	a	a	DET
hls-12723	118	15	diagnosis	diagnosis	NOUN
hls-12723	118	16	of	of	ADP
hls-12723	118	17	covid-19	covid-19	PROPN
hls-12723	118	18	disease	disease	NOUN
hls-12723	118	19	.	.	PUNCT
hls-12723	119	1	the	the	PRON
hls-12723	119	2	35	35	NUM
hls-12723	119	3	pg	pg	NOUN
hls-12723	119	4	/	/	SYM
hls-12723	119	5	ml	ml	VERB
hls-12723	119	6	cut	cut	VERB
hls-12723	119	7	-	-	PUNCT
hls-12723	119	8	off	off	ADP
hls-12723	119	9	point	point	NOUN
hls-12723	119	10	could	could	AUX
hls-12723	119	11	clearly	clearly	ADV
hls-12723	119	12	distinguish	distinguish	VERB
hls-12723	119	13	the	the	DET
hls-12723	119	14	patients	patient	NOUN
hls-12723	119	15	with	with	ADP
hls-12723	119	16	more	more	ADV
hls-12723	119	17	severe	severe	ADJ
hls-12723	119	18	disease	disease	NOUN
hls-12723	119	19	.	.	PUNCT
hls-12723	120	1	serum	serum	PROPN
hls-12723	120	2	il-6	il-6	NOUN
hls-12723	120	3	levels	level	NOUN
hls-12723	120	4	in	in	ADP
hls-12723	120	5	patients	patient	NOUN
hls-12723	120	6	with	with	ADP
hls-12723	120	7	covid19	covid19	NOUN
hls-12723	120	8	:	:	PUNCT
hls-12723	120	9	and	and	CCONJ
hls-12723	120	10	non	non	PROPN
hls-12723	120	11	-	-	ADJ
hls-12723	120	12	covid-19	covid-19	PROPN
hls-12723	120	13	,	,	PUNCT
hls-12723	120	14	covid-19	covid-19	PROPN
hls-12723	120	15	:	:	PUNCT
hls-12723	120	16	7.56	7.56	NUM
hls-12723	120	17	,	,	PUNCT
hls-12723	120	18	non	non	ADJ
hls-12723	120	19	-	-	NOUN
hls-12723	120	20	covid	covid	ADJ
hls-12723	120	21	:	:	PUNCT
hls-12723	120	22	0.03	0.03	NUM
hls-12723	120	23	,	,	PUNCT
hls-12723	120	24	other	other	ADJ
hls-12723	120	25	diseases	disease	NOUN
hls-12723	120	26	9.12.28	9.12.28	NUM
hls-12723	120	27	a	a	DET
hls-12723	120	28	study	study	NOUN
hls-12723	120	29	in	in	ADP
hls-12723	120	30	shanghai	shanghai	PROPN
hls-12723	120	31	,	,	PUNCT
hls-12723	120	32	china	china	PROPN
hls-12723	120	33	,	,	PUNCT
hls-12723	120	34	found	find	VERB
hls-12723	120	35	that	that	SCONJ
hls-12723	120	36	in	in	ADP
hls-12723	120	37	hospitalized	hospitalize	VERB
hls-12723	120	38	covid-19	covid-19	PROPN
hls-12723	120	39	patients	patient	NOUN
hls-12723	120	40	,	,	PUNCT
hls-12723	120	41	the	the	DET
hls-12723	120	42	normal	normal	ADJ
hls-12723	120	43	concentration	concentration	NOUN
hls-12723	120	44	ranges	range	VERB
hls-12723	120	45	article	article	NOUN
hls-12723	120	46	[	[	X
hls-12723	120	47	page	page	NOUN
hls-12723	120	48	102	102	NUM
hls-12723	120	49	]	]	PUNCT
hls-12723	121	1	[	[	X
hls-12723	121	2	healthcare	healthcare	NOUN
hls-12723	121	3	in	in	ADP
hls-12723	121	4	low	low	ADJ
hls-12723	121	5	-	-	PUNCT
hls-12723	121	6	resource	resource	NOUN
hls-12723	121	7	settings	setting	NOUN
hls-12723	121	8	2025;13:12723	2025;13:12723	NUM
hls-12723	121	9	]	]	PUNCT
hls-12723	121	10	for	for	ADP
hls-12723	121	11	il-1β	il-1β	PROPN
hls-12723	121	12	,	,	PUNCT
hls-12723	121	13	il-8	il-8	NOUN
hls-12723	121	14	,	,	PUNCT
hls-12723	121	15	il-10	il-10	PRON
hls-12723	121	16	,	,	PUNCT
hls-12723	121	17	and	and	CCONJ
hls-12723	121	18	tumor	tumor	NOUN
hls-12723	121	19	necrosis	necrosis	NOUN
hls-12723	121	20	factor	factor	NOUN
hls-12723	121	21	-	-	PUNCT
hls-12723	121	22	alpha	alpha	NOUN
hls-12723	121	23	(	(	PUNCT
hls-12723	121	24	tnfα	tnfα	NOUN
hls-12723	121	25	)	)	PUNCT
hls-12723	121	26	were	be	AUX
hls-12723	121	27	below	below	ADP
hls-12723	121	28	5	5	NUM
hls-12723	121	29	,	,	PUNCT
hls-12723	121	30	62	62	NUM
hls-12723	121	31	,	,	PUNCT
hls-12723	121	32	9.1	9.1	NUM
hls-12723	121	33	,	,	PUNCT
hls-12723	121	34	respectively	respectively	ADV
hls-12723	121	35	,	,	PUNCT
hls-12723	121	36	and	and	CCONJ
hls-12723	121	37	8.1	8.1	NUM
hls-12723	121	38	pg	pg	NOUN
hls-12723	121	39	/	/	SYM
hls-12723	121	40	ml.29	ml.29	PROPN
hls-12723	121	41	the	the	DET
hls-12723	121	42	normal	normal	ADJ
hls-12723	121	43	concentration	concentration	NOUN
hls-12723	121	44	range	range	NOUN
hls-12723	121	45	of	of	ADP
hls-12723	121	46	il-6	il-6	NOUN
hls-12723	121	47	is	be	AUX
hls-12723	121	48	between	between	ADP
hls-12723	121	49	0	0	NUM
hls-12723	121	50	-	-	SYM
hls-12723	121	51	7	7	NUM
hls-12723	121	52	pg	pg	NOUN
hls-12723	121	53	/	/	SYM
hls-12723	121	54	ml	ml	ADP
hls-12723	121	55	,	,	PUNCT
hls-12723	121	56	and	and	CCONJ
hls-12723	121	57	the	the	DET
hls-12723	121	58	normal	normal	ADJ
hls-12723	121	59	il-2	il-2	ADJ
hls-12723	121	60	receptor	receptor	NOUN
hls-12723	121	61	(	(	PUNCT
hls-12723	121	62	il-2r	il-2r	NOUN
hls-12723	121	63	)	)	PUNCT
hls-12723	121	64	ranges	range	VERB
hls-12723	121	65	from	from	ADP
hls-12723	121	66	223	223	NUM
hls-12723	121	67	to	to	PART
hls-12723	121	68	710	710	NUM
hls-12723	121	69	u	u	NOUN
hls-12723	121	70	/	/	SYM
hls-12723	121	71	ml	ml	NOUN
hls-12723	121	72	.	.	PUNCT
hls-12723	122	1	the	the	DET
hls-12723	122	2	lower	low	ADJ
hls-12723	122	3	limit	limit	NOUN
hls-12723	122	4	of	of	ADP
hls-12723	122	5	detection	detection	NOUN
hls-12723	122	6	of	of	ADP
hls-12723	122	7	the	the	DET
hls-12723	122	8	kit	kit	NOUN
hls-12723	122	9	was	be	AUX
hls-12723	122	10	1.5	1.5	NUM
hls-12723	122	11	pg	pg	NOUN
hls-12723	122	12	/	/	SYM
hls-12723	122	13	ml	ml	ADP
hls-12723	122	14	,	,	PUNCT
hls-12723	122	15	and	and	CCONJ
hls-12723	122	16	the	the	DET
hls-12723	122	17	upper	upper	ADJ
hls-12723	122	18	limit	limit	NOUN
hls-12723	122	19	of	of	ADP
hls-12723	122	20	detection	detection	NOUN
hls-12723	122	21	was	be	AUX
hls-12723	122	22	5000	5000	NUM
hls-12723	122	23	pg	pg	NOUN
hls-12723	122	24	/	/	SYM
hls-12723	122	25	ml	ml	NOUN
hls-12723	122	26	without	without	ADP
hls-12723	122	27	dilution	dilution	NOUN
hls-12723	122	28	.	.	PUNCT
hls-12723	123	1	the	the	DET
hls-12723	123	2	upper	upper	ADJ
hls-12723	123	3	limit	limit	NOUN
hls-12723	123	4	of	of	ADP
hls-12723	123	5	normal	normal	ADJ
hls-12723	123	6	is	be	AUX
hls-12723	123	7	7	7	NUM
hls-12723	123	8	pg	pg	NOUN
hls-12723	123	9	/	/	SYM
hls-12723	123	10	ml	ml	PROPN
hls-12723	123	11	.	.	PUNCT
hls-12723	123	12	baseline	baseline	PROPN
hls-12723	123	13	il-6	il-6	NOUN
hls-12723	124	1	concentrations	concentration	NOUN
hls-12723	124	2	are	be	AUX
hls-12723	124	3	highly	highly	ADV
hls-12723	124	4	predictive	predictive	ADJ
hls-12723	124	5	of	of	ADP
hls-12723	124	6	in	in	ADP
hls-12723	124	7	-	-	PUNCT
hls-12723	124	8	hospital	hospital	NOUN
hls-12723	124	9	mortality	mortality	NOUN
hls-12723	124	10	for	for	ADP
hls-12723	124	11	covid-19	covid-19	PROPN
hls-12723	124	12	patients	patient	NOUN
hls-12723	124	13	.	.	PUNCT
hls-12723	125	1	the	the	DET
hls-12723	125	2	mean	mean	ADJ
hls-12723	125	3	concentration	concentration	NOUN
hls-12723	125	4	of	of	ADP
hls-12723	125	5	il-6	il-6	NUM
hls-12723	125	6	was	be	AUX
hls-12723	125	7	<	<	X
hls-12723	125	8	0.001	0.001	NUM
hls-12723	125	9	.	.	PUNCT
hls-12723	126	1	serum	serum	PROPN
hls-12723	126	2	il-6	il-6	NOUN
hls-12723	126	3	remains	remain	VERB
hls-12723	126	4	high	high	ADJ
hls-12723	126	5	in	in	ADP
hls-12723	126	6	critically	critically	ADV
hls-12723	126	7	ill	ill	ADJ
hls-12723	126	8	patients	patient	NOUN
hls-12723	126	9	even	even	ADV
hls-12723	126	10	after	after	ADP
hls-12723	126	11	recovery	recovery	NOUN
hls-12723	126	12	.	.	PUNCT
hls-12723	127	1	an	an	DET
hls-12723	127	2	il-6	il-6	NOUN
hls-12723	127	3	concentration	concentration	NOUN
hls-12723	127	4	higher	high	ADJ
hls-12723	127	5	than	than	ADP
hls-12723	127	6	37.65	37.65	NUM
hls-12723	127	7	pg	pg	NOUN
hls-12723	127	8	/	/	SYM
hls-12723	127	9	ml	ml	PROPN
hls-12723	127	10	was	be	AUX
hls-12723	127	11	predictive	predictive	ADJ
hls-12723	127	12	of	of	ADP
hls-12723	127	13	in	in	ADP
hls-12723	127	14	-	-	PUNCT
hls-12723	127	15	hospital	hospital	NOUN
hls-12723	127	16	mortality	mortality	NOUN
hls-12723	127	17	(	(	PUNCT
hls-12723	128	1	auc	auc	NOUN
hls-12723	128	2	0.97	0.97	NUM
hls-12723	129	1	[	[	SYM
hls-12723	129	2	95	95	NUM
hls-12723	129	3	%	%	NOUN
hls-12723	129	4	ci	ci	NOUN
hls-12723	129	5	0.95–0.99	0.95–0.99	PROPN
hls-12723	129	6	]	]	X
hls-12723	129	7	,	,	PUNCT
hls-12723	129	8	p	p	X
hls-12723	129	9	<	<	X
hls-12723	129	10	0.001	0.001	NUM
hls-12723	129	11	)	)	PUNCT
hls-12723	129	12	with	with	ADP
hls-12723	129	13	a	a	DET
hls-12723	129	14	sensitivity	sensitivity	NOUN
hls-12723	129	15	of	of	ADP
hls-12723	129	16	91.7	91.7	NUM
hls-12723	129	17	%	%	NOUN
hls-12723	129	18	and	and	CCONJ
hls-12723	129	19	a	a	DET
hls-12723	129	20	specificity	specificity	NOUN
hls-12723	129	21	of	of	ADP
hls-12723	129	22	91.7	91.7	NUM
hls-12723	129	23	%	%	NOUN
hls-12723	129	24	.	.	PUNCT
hls-12723	130	1	95.7%.30	95.7%.30	NOUN
hls-12723	130	2	a	a	DET
hls-12723	130	3	study	study	NOUN
hls-12723	130	4	mentions	mention	VERB
hls-12723	130	5	the	the	DET
hls-12723	130	6	effect	effect	NOUN
hls-12723	130	7	of	of	ADP
hls-12723	130	8	antipsychotic	antipsychotic	ADJ
hls-12723	130	9	therapy	therapy	NOUN
hls-12723	130	10	on	on	ADP
hls-12723	130	11	disease	disease	NOUN
hls-12723	130	12	progression	progression	NOUN
hls-12723	130	13	and	and	CCONJ
hls-12723	130	14	the	the	DET
hls-12723	130	15	correlation	correlation	NOUN
hls-12723	130	16	between	between	ADP
hls-12723	130	17	cytokine	cytokine	NOUN
hls-12723	130	18	levels	level	NOUN
hls-12723	130	19	and	and	CCONJ
hls-12723	130	20	clinical	clinical	ADJ
hls-12723	130	21	characteristics.31	characteristics.31	NOUN
hls-12723	130	22	later	later	ADV
hls-12723	130	23	the	the	DET
hls-12723	130	24	results	result	NOUN
hls-12723	130	25	of	of	ADP
hls-12723	130	26	this	this	DET
hls-12723	130	27	study	study	NOUN
hls-12723	130	28	showed	show	VERB
hls-12723	130	29	that	that	SCONJ
hls-12723	130	30	the	the	DET
hls-12723	130	31	cytokine	cytokine	NOUN
hls-12723	130	32	changes	change	NOUN
hls-12723	130	33	in	in	ADP
hls-12723	130	34	schizophrenia	schizophrenia	NOUN
hls-12723	130	35	may	may	AUX
hls-12723	130	36	differ	differ	VERB
hls-12723	130	37	from	from	ADP
hls-12723	130	38	the	the	DET
hls-12723	130	39	clinical	clinical	ADJ
hls-12723	130	40	status	status	NOUN
hls-12723	130	41	.	.	PUNCT
hls-12723	131	1	in	in	ADP
hls-12723	131	2	this	this	DET
hls-12723	131	3	study	study	NOUN
hls-12723	131	4	,	,	PUNCT
hls-12723	131	5	schizophrenic	schizophrenic	ADJ
hls-12723	131	6	patients	patient	NOUN
hls-12723	131	7	with	with	ADP
hls-12723	131	8	confirmed	confirm	VERB
hls-12723	131	9	covid-19	covid-19	PROPN
hls-12723	131	10	received	receive	VERB
hls-12723	131	11	covid-19	covid-19	PROPN
hls-12723	131	12	therapy	therapy	NOUN
hls-12723	131	13	with	with	ADP
hls-12723	131	14	an	an	DET
hls-12723	131	15	administration	administration	NOUN
hls-12723	131	16	of	of	ADP
hls-12723	131	17	antivirals	antiviral	NOUN
hls-12723	131	18	.	.	PUNCT
hls-12723	132	1	conclusions	conclusion	NOUN
hls-12723	132	2	the	the	DET
hls-12723	132	3	panss	pans	NOUN
hls-12723	132	4	scores	score	NOUN
hls-12723	132	5	in	in	ADP
hls-12723	132	6	both	both	CCONJ
hls-12723	132	7	the	the	DET
hls-12723	132	8	covid-19	covid-19	PROPN
hls-12723	132	9	positive	positive	ADJ
hls-12723	132	10	group	group	NOUN
hls-12723	132	11	and	and	CCONJ
hls-12723	132	12	control	control	NOUN
hls-12723	132	13	groups	group	NOUN
hls-12723	132	14	at	at	ADP
hls-12723	132	15	the	the	DET
hls-12723	132	16	end	end	NOUN
hls-12723	132	17	of	of	ADP
hls-12723	132	18	the	the	DET
hls-12723	132	19	study	study	NOUN
hls-12723	132	20	were	be	AUX
hls-12723	132	21	significantly	significantly	ADV
hls-12723	132	22	lower	low	ADJ
hls-12723	132	23	than	than	ADP
hls-12723	132	24	at	at	ADP
hls-12723	132	25	the	the	DET
hls-12723	132	26	initial	initial	ADJ
hls-12723	132	27	treatment	treatment	NOUN
hls-12723	132	28	,	,	PUNCT
hls-12723	132	29	and	and	CCONJ
hls-12723	132	30	the	the	DET
hls-12723	132	31	same	same	ADJ
hls-12723	132	32	trend	trend	NOUN
hls-12723	132	33	was	be	AUX
hls-12723	132	34	observed	observe	VERB
hls-12723	132	35	for	for	ADP
hls-12723	132	36	the	the	DET
hls-12723	132	37	il6	il6	NOUN
hls-12723	132	38	scores	score	NOUN
hls-12723	132	39	in	in	ADP
hls-12723	132	40	both	both	DET
hls-12723	132	41	groups	group	NOUN
hls-12723	132	42	.	.	PUNCT
hls-12723	133	1	the	the	DET
hls-12723	133	2	decreases	decrease	NOUN
hls-12723	133	3	in	in	ADP
hls-12723	133	4	panss	pans	NOUN
hls-12723	133	5	and	and	CCONJ
hls-12723	133	6	il-6	il-6	NOUN
hls-12723	133	7	scores	score	NOUN
hls-12723	133	8	were	be	AUX
hls-12723	133	9	not	not	PART
hls-12723	133	10	affected	affect	VERB
hls-12723	133	11	by	by	ADP
hls-12723	133	12	gender	gender	NOUN
hls-12723	133	13	,	,	PUNCT
hls-12723	133	14	age	age	NOUN
hls-12723	133	15	,	,	PUNCT
hls-12723	133	16	or	or	CCONJ
hls-12723	133	17	pcr	pcr	NOUN
hls-12723	133	18	results	result	NOUN
hls-12723	133	19	.	.	PUNCT
hls-12723	134	1	notably	notably	ADV
hls-12723	134	2	,	,	PUNCT
hls-12723	134	3	both	both	CCONJ
hls-12723	134	4	the	the	DET
hls-12723	134	5	covid-19	covid-19	PROPN
hls-12723	134	6	positive	positive	ADJ
hls-12723	134	7	group	group	NOUN
hls-12723	134	8	and	and	CCONJ
hls-12723	134	9	control	control	NOUN
hls-12723	134	10	groups	group	NOUN
hls-12723	134	11	had	have	VERB
hls-12723	134	12	a	a	DET
hls-12723	134	13	lower	low	ADJ
hls-12723	134	14	value	value	NOUN
hls-12723	134	15	of	of	ADP
hls-12723	134	16	il-6	il-6	NOUN
hls-12723	134	17	(	(	PUNCT
hls-12723	134	18	35pg	35pg	NOUN
hls-12723	134	19	/	/	SYM
hls-12723	134	20	ml	ml	NOUN
hls-12723	134	21	)	)	PUNCT
hls-12723	134	22	at	at	ADP
hls-12723	134	23	the	the	DET
hls-12723	134	24	beginning	beginning	NOUN
hls-12723	134	25	of	of	ADP
hls-12723	134	26	the	the	DET
hls-12723	134	27	study	study	NOUN
hls-12723	134	28	,	,	PUNCT
hls-12723	134	29	suggesting	suggest	VERB
hls-12723	134	30	that	that	SCONJ
hls-12723	134	31	risperidone	risperidone	NOUN
hls-12723	134	32	may	may	AUX
hls-12723	134	33	have	have	AUX
hls-12723	134	34	influenced	influence	VERB
hls-12723	134	35	the	the	DET
hls-12723	134	36	il-6	il-6	NUM
hls-12723	134	37	levels	level	NOUN
hls-12723	134	38	before	before	SCONJ
hls-12723	134	39	the	the	DET
hls-12723	134	40	covid-19	covid-19	PROPN
hls-12723	134	41	diagnosis	diagnosis	NOUN
hls-12723	134	42	was	be	AUX
hls-12723	134	43	confirmed	confirm	VERB
hls-12723	134	44	.	.	PUNCT
hls-12723	135	1	additionally	additionally	ADV
hls-12723	135	2	,	,	PUNCT
hls-12723	135	3	a	a	DET
hls-12723	135	4	combination	combination	NOUN
hls-12723	135	5	of	of	ADP
hls-12723	135	6	the	the	DET
hls-12723	135	7	antipsychotic	antipsychotic	ADJ
hls-12723	135	8	risperidone	risperidone	NOUN
hls-12723	135	9	and	and	CCONJ
hls-12723	135	10	antivirals	antiviral	NOUN
hls-12723	135	11	was	be	AUX
hls-12723	135	12	found	find	VERB
hls-12723	135	13	to	to	PART
hls-12723	135	14	lower	lower	VERB
hls-12723	135	15	the	the	DET
hls-12723	135	16	il-6	il-6	NUM
hls-12723	135	17	levels	level	NOUN
hls-12723	135	18	below	below	ADP
hls-12723	135	19	the	the	DET
hls-12723	135	20	cutoff	cutoff	NOUN
hls-12723	135	21	point	point	NOUN
hls-12723	135	22	.	.	PUNCT
hls-12723	136	1	article	article	NOUN
hls-12723	137	1	[	[	X
hls-12723	137	2	healthcare	healthcare	NOUN
hls-12723	137	3	in	in	ADP
hls-12723	137	4	low	low	ADJ
hls-12723	137	5	-	-	PUNCT
hls-12723	137	6	resource	resource	NOUN
hls-12723	137	7	settings	setting	NOUN
hls-12723	137	8	2025;13:12723	2025;13:12723	NUM
hls-12723	137	9	]	]	X
hls-12723	138	1	[	[	X
hls-12723	138	2	page	page	NOUN
hls-12723	138	3	103	103	NUM
hls-12723	138	4	]	]	PUNCT
hls-12723	138	5	table	table	NOUN
hls-12723	138	6	4	4	NUM
hls-12723	138	7	.	.	PUNCT
hls-12723	138	8	comparison	comparison	NOUN
hls-12723	138	9	positive	positive	ADJ
hls-12723	138	10	and	and	CCONJ
hls-12723	138	11	negative	negative	ADJ
hls-12723	138	12	syndrome	syndrome	NOUN
hls-12723	138	13	scale	scale	NOUN
hls-12723	138	14	(	(	PUNCT
hls-12723	138	15	panss	pans	NOUN
hls-12723	138	16	)	)	PUNCT
hls-12723	138	17	dan	dan	PROPN
hls-12723	138	18	il-6	il-6	X
hls-12723	138	19	pre	pre	PROPN
hls-12723	138	20	-	-	NOUN
hls-12723	138	21	post	post	ADJ
hls-12723	138	22	(	(	PUNCT
hls-12723	138	23	by	by	ADP
hls-12723	138	24	gender	gender	NOUN
hls-12723	138	25	)	)	PUNCT
hls-12723	138	26	.	.	PUNCT
hls-12723	139	1	category	category	NOUN
hls-12723	139	2	variables	variable	VERB
hls-12723	139	3	n	n	ADV
hls-12723	139	4	mean	mean	VERB
hls-12723	139	5	sd	sd	ADP
hls-12723	139	6	p	p	PROPN
hls-12723	139	7	man	man	NOUN
hls-12723	139	8	panss	pans	NOUN
hls-12723	139	9	pre	pre	VERB
hls-12723	139	10	34	34	NUM
hls-12723	139	11	72.1	72.1	NUM
hls-12723	139	12	3.2	3.2	NUM
hls-12723	139	13	0.000	0.000	NUM
hls-12723	139	14	*	*	PUNCT
hls-12723	139	15	panss	pans	NOUN
hls-12723	139	16	post	post	VERB
hls-12723	139	17	34	34	NUM
hls-12723	139	18	56.5	56.5	NUM
hls-12723	139	19	5.9	5.9	NUM
hls-12723	139	20	il-6	il-6	NOUN
hls-12723	139	21	pre	pre	X
hls-12723	139	22	(	(	PUNCT
hls-12723	139	23	pg	pg	NOUN
hls-12723	139	24	/	/	SYM
hls-12723	139	25	ml	ml	VERB
hls-12723	139	26	)	)	PUNCT
hls-12723	139	27	34	34	NUM
hls-12723	139	28	23.6	23.6	NUM
hls-12723	139	29	4.4	4.4	NUM
hls-12723	139	30	0.000	0.000	NUM
hls-12723	139	31	*	*	PUNCT
hls-12723	139	32	*	*	X
hls-12723	139	33	il-6	il-6	CCONJ
hls-12723	139	34	post	post	NOUN
hls-12723	139	35	(	(	PUNCT
hls-12723	139	36	pg	pg	NOUN
hls-12723	139	37	/	/	SYM
hls-12723	139	38	ml	ml	VERB
hls-12723	139	39	)	)	PUNCT
hls-12723	139	40	34	34	NUM
hls-12723	139	41	21.1	21.1	NUM
hls-12723	139	42	3.6	3.6	NUM
hls-12723	139	43	women	woman	NOUN
hls-12723	139	44	panss	pans	NOUN
hls-12723	139	45	pre	pre	VERB
hls-12723	139	46	10	10	NUM
hls-12723	139	47	73.6	73.6	NUM
hls-12723	139	48	4.0	4.0	NUM
hls-12723	139	49	0.000	0.000	NUM
hls-12723	139	50	*	*	PUNCT
hls-12723	139	51	panss	pans	NOUN
hls-12723	139	52	post	post	VERB
hls-12723	139	53	10	10	NUM
hls-12723	139	54	58.2	58.2	NUM
hls-12723	139	55	7.7	7.7	NUM
hls-12723	139	56	il-6	il-6	NOUN
hls-12723	140	1	pre	pre	ADJ
hls-12723	140	2	(	(	PUNCT
hls-12723	140	3	pg	pg	NOUN
hls-12723	140	4	/	/	SYM
hls-12723	140	5	ml	ml	NOUN
hls-12723	140	6	)	)	PUNCT
hls-12723	140	7	10	10	NUM
hls-12723	140	8	23.4	23.4	NUM
hls-12723	140	9	3.3	3.3	NUM
hls-12723	140	10	0.000	0.000	NUM
hls-12723	140	11	*	*	PUNCT
hls-12723	140	12	*	*	X
hls-12723	140	13	il-6	il-6	CCONJ
hls-12723	140	14	post	post	NOUN
hls-12723	140	15	(	(	PUNCT
hls-12723	140	16	pg	pg	NOUN
hls-12723	140	17	/	/	SYM
hls-12723	140	18	ml	ml	NOUN
hls-12723	140	19	)	)	PUNCT
hls-12723	140	20	10	10	NUM
hls-12723	140	21	21.0	21.0	NUM
hls-12723	140	22	3.0	3.0	NUM
hls-12723	140	23	*	*	PUNCT
hls-12723	140	24	wilcoxon	wilcoxon	PROPN
hls-12723	140	25	signed	sign	VERB
hls-12723	140	26	rank	rank	NOUN
hls-12723	140	27	test	test	NOUN
hls-12723	140	28	;	;	PUNCT
hls-12723	141	1	*	*	PUNCT
hls-12723	141	2	*	*	PUNCT
hls-12723	141	3	paired	pair	VERB
hls-12723	141	4	t	t	NOUN
hls-12723	141	5	-	-	PUNCT
hls-12723	141	6	test	test	NOUN
hls-12723	141	7	.	.	PUNCT
hls-12723	142	1	table	table	NOUN
hls-12723	142	2	5	5	NUM
hls-12723	142	3	.	.	PUNCT
hls-12723	143	1	comparison	comparison	NOUN
hls-12723	143	2	positive	positive	ADJ
hls-12723	143	3	and	and	CCONJ
hls-12723	143	4	negative	negative	ADJ
hls-12723	143	5	syndrome	syndrome	NOUN
hls-12723	143	6	scale	scale	NOUN
hls-12723	143	7	(	(	PUNCT
hls-12723	143	8	panss	pans	NOUN
hls-12723	143	9	)	)	PUNCT
hls-12723	143	10	dan	dan	PROPN
hls-12723	143	11	il-6	il-6	X
hls-12723	143	12	pre	pre	PROPN
hls-12723	143	13	-	-	NOUN
hls-12723	143	14	post	post	ADJ
hls-12723	143	15	(	(	PUNCT
hls-12723	143	16	by	by	ADP
hls-12723	143	17	age	age	NOUN
hls-12723	143	18	)	)	PUNCT
hls-12723	143	19	.	.	PUNCT
hls-12723	144	1	category	category	NOUN
hls-12723	144	2	variables	variable	VERB
hls-12723	144	3	n	n	ADV
hls-12723	144	4	mean	mean	VERB
hls-12723	144	5	sd	sd	ADP
hls-12723	144	6	p	p	DET
hls-12723	144	7	18	18	NUM
hls-12723	144	8	-	-	SYM
hls-12723	144	9	29	29	NUM
hls-12723	144	10	years	year	NOUN
hls-12723	144	11	panss	pans	NOUN
hls-12723	144	12	pre	pre	VERB
hls-12723	144	13	12	12	NUM
hls-12723	144	14	72.3	72.3	NUM
hls-12723	144	15	3.6	3.6	NUM
hls-12723	144	16	0.000	0.000	NUM
hls-12723	144	17	*	*	PUNCT
hls-12723	144	18	panss	pans	NOUN
hls-12723	144	19	post	post	VERB
hls-12723	144	20	12	12	NUM
hls-12723	144	21	56.9	56.9	NUM
hls-12723	144	22	6.2	6.2	NUM
hls-12723	144	23	il-6	il-6	NOUN
hls-12723	144	24	pre	pre	ADJ
hls-12723	144	25	(	(	PUNCT
hls-12723	144	26	pg	pg	NOUN
hls-12723	144	27	/	/	SYM
hls-12723	144	28	ml	ml	VERB
hls-12723	144	29	)	)	PUNCT
hls-12723	144	30	12	12	NUM
hls-12723	144	31	24.5	24.5	NUM
hls-12723	144	32	3.7	3.7	NUM
hls-12723	144	33	0.000	0.000	NUM
hls-12723	144	34	*	*	PUNCT
hls-12723	144	35	*	*	X
hls-12723	144	36	il-6	il-6	CCONJ
hls-12723	144	37	post	post	NOUN
hls-12723	144	38	(	(	PUNCT
hls-12723	144	39	pg	pg	NOUN
hls-12723	144	40	/	/	SYM
hls-12723	144	41	ml	ml	VERB
hls-12723	144	42	)	)	PUNCT
hls-12723	144	43	12	12	NUM
hls-12723	144	44	21.9	21.9	NUM
hls-12723	144	45	3.2	3.2	NUM
hls-12723	144	46	30	30	NUM
hls-12723	144	47	-	-	SYM
hls-12723	144	48	39	39	NUM
hls-12723	144	49	years	year	NOUN
hls-12723	144	50	panss	pans	NOUN
hls-12723	144	51	pre	pre	VERB
hls-12723	144	52	19	19	NUM
hls-12723	144	53	71.3	71.3	NUM
hls-12723	144	54	2.6	2.6	NUM
hls-12723	144	55	0.000	0.000	NUM
hls-12723	144	56	*	*	PUNCT
hls-12723	144	57	panss	pans	NOUN
hls-12723	144	58	post	post	VERB
hls-12723	144	59	19	19	NUM
hls-12723	144	60	56.4	56.4	NUM
hls-12723	144	61	6.4	6.4	NUM
hls-12723	144	62	il-6	il-6	NOUN
hls-12723	145	1	pre	pre	ADJ
hls-12723	145	2	(	(	PUNCT
hls-12723	145	3	pg	pg	NOUN
hls-12723	145	4	/	/	SYM
hls-12723	145	5	ml	ml	NOUN
hls-12723	145	6	)	)	PUNCT
hls-12723	145	7	19	19	NUM
hls-12723	145	8	23.0	23.0	NUM
hls-12723	145	9	4.7	4.7	NUM
hls-12723	145	10	0.000	0.000	NUM
hls-12723	145	11	*	*	PUNCT
hls-12723	145	12	*	*	X
hls-12723	145	13	il-6	il-6	CCONJ
hls-12723	145	14	post	post	NOUN
hls-12723	145	15	(	(	PUNCT
hls-12723	145	16	pg	pg	NOUN
hls-12723	145	17	/	/	SYM
hls-12723	145	18	ml	ml	NOUN
hls-12723	145	19	)	)	PUNCT
hls-12723	145	20	19	19	NUM
hls-12723	145	21	20.8	20.8	NUM
hls-12723	145	22	3.9	3.9	NUM
hls-12723	145	23	40	40	NUM
hls-12723	145	24	-	-	SYM
hls-12723	145	25	53	53	NUM
hls-12723	145	26	years	year	NOUN
hls-12723	145	27	panss	pans	NOUN
hls-12723	145	28	pre	pre	VERB
hls-12723	145	29	13	13	NUM
hls-12723	145	30	74.2	74.2	NUM
hls-12723	145	31	3.9	3.9	NUM
hls-12723	145	32	0.000	0.000	NUM
hls-12723	145	33	*	*	PUNCT
hls-12723	145	34	panss	pans	NOUN
hls-12723	145	35	post	post	VERB
hls-12723	145	36	13	13	NUM
hls-12723	145	37	57.5	57.5	NUM
hls-12723	145	38	6.8	6.8	NUM
hls-12723	145	39	il-6	il-6	NOUN
hls-12723	145	40	pre	pre	X
hls-12723	145	41	(	(	PUNCT
hls-12723	145	42	pg	pg	NOUN
hls-12723	145	43	/	/	SYM
hls-12723	145	44	ml	ml	NOUN
hls-12723	145	45	)	)	PUNCT
hls-12723	145	46	13	13	NUM
hls-12723	145	47	23.5	23.5	NUM
hls-12723	145	48	3.8	3.8	NUM
hls-12723	145	49	0.000	0.000	NUM
hls-12723	145	50	*	*	PUNCT
hls-12723	145	51	*	*	X
hls-12723	145	52	il-6	il-6	CCONJ
hls-12723	145	53	post	post	NOUN
hls-12723	145	54	(	(	PUNCT
hls-12723	145	55	pg	pg	NOUN
hls-12723	145	56	/	/	SYM
hls-12723	145	57	ml	ml	VERB
hls-12723	145	58	)	)	PUNCT
hls-12723	145	59	13	13	NUM
hls-12723	145	60	20.9	20.9	NUM
hls-12723	145	61	2.9	2.9	NUM
hls-12723	145	62	*	*	PUNCT
hls-12723	145	63	wilcoxon	wilcoxon	PROPN
hls-12723	145	64	signed	sign	VERB
hls-12723	145	65	rank	rank	NOUN
hls-12723	145	66	test	test	NOUN
hls-12723	145	67	;	;	PUNCT
hls-12723	145	68	*	*	PUNCT
hls-12723	145	69	*	*	PUNCT
hls-12723	145	70	paired	pair	VERB
hls-12723	145	71	t	t	NOUN
hls-12723	145	72	-	-	PUNCT
hls-12723	145	73	test	test	NOUN
hls-12723	145	74	.	.	PUNCT
hls-12723	146	1	table	table	NOUN
hls-12723	146	2	6	6	NUM
hls-12723	146	3	.	.	PUNCT
hls-12723	147	1	comparison	comparison	NOUN
hls-12723	147	2	positive	positive	ADJ
hls-12723	147	3	and	and	CCONJ
hls-12723	147	4	negative	negative	ADJ
hls-12723	147	5	syndrome	syndrome	NOUN
hls-12723	147	6	scale	scale	NOUN
hls-12723	147	7	(	(	PUNCT
hls-12723	147	8	panss	pans	NOUN
hls-12723	147	9	)	)	PUNCT
hls-12723	147	10	dan	dan	PROPN
hls-12723	147	11	il-6	il-6	X
hls-12723	147	12	pre	pre	PROPN
hls-12723	147	13	-	-	NOUN
hls-12723	147	14	post	post	ADJ
hls-12723	147	15	(	(	PUNCT
hls-12723	147	16	by	by	ADP
hls-12723	147	17	pcr	pcr	ADJ
hls-12723	147	18	testing	testing	NOUN
hls-12723	147	19	)	)	PUNCT
hls-12723	147	20	.	.	PUNCT
hls-12723	148	1	pcr	pcr	PROPN
hls-12723	148	2	variables	variable	NOUN
hls-12723	148	3	n	n	ADV
hls-12723	148	4	mean	mean	VERB
hls-12723	148	5	sd	sd	NOUN
hls-12723	148	6	decrease	decrease	NOUN
hls-12723	148	7	(	(	PUNCT
hls-12723	148	8	%	%	INTJ
hls-12723	148	9	)	)	PUNCT
hls-12723	148	10	p	p	DET
hls-12723	148	11	positive	positive	ADJ
hls-12723	148	12	panss	pans	NOUN
hls-12723	148	13	pre	pre	VERB
hls-12723	148	14	22	22	NUM
hls-12723	148	15	73.5	73.5	NUM
hls-12723	148	16	3.9	3.9	NUM
hls-12723	148	17	22.4	22.4	NUM
hls-12723	148	18	0.000	0.000	NUM
hls-12723	148	19	*	*	PUNCT
hls-12723	148	20	panss	pans	NOUN
hls-12723	148	21	post	post	VERB
hls-12723	148	22	22	22	NUM
hls-12723	148	23	57.0	57.0	NUM
hls-12723	148	24	6.9	6.9	NUM
hls-12723	148	25	il-6	il-6	NOUN
hls-12723	149	1	pre	pre	ADJ
hls-12723	149	2	(	(	PUNCT
hls-12723	149	3	pg	pg	NOUN
hls-12723	149	4	/	/	SYM
hls-12723	149	5	ml	ml	VERB
hls-12723	149	6	)	)	PUNCT
hls-12723	149	7	22	22	NUM
hls-12723	149	8	26.1	26.1	NUM
hls-12723	149	9	2.4	2.4	NUM
hls-12723	149	10	11.8	11.8	NUM
hls-12723	149	11	0.000	0.000	NUM
hls-12723	149	12	*	*	PUNCT
hls-12723	149	13	*	*	X
hls-12723	149	14	il-6	il-6	CCONJ
hls-12723	149	15	post	post	NOUN
hls-12723	149	16	(	(	PUNCT
hls-12723	149	17	pg	pg	NOUN
hls-12723	149	18	/	/	SYM
hls-12723	149	19	ml	ml	VERB
hls-12723	149	20	)	)	PUNCT
hls-12723	149	21	22	22	NUM
hls-12723	149	22	23.0	23.0	NUM
hls-12723	149	23	2.1	2.1	NUM
hls-12723	149	24	negative	negative	ADJ
hls-12723	149	25	panss	pans	NOUN
hls-12723	149	26	beginning	begin	VERB
hls-12723	149	27	22	22	NUM
hls-12723	149	28	71.4	71.4	NUM
hls-12723	149	29	2.6	2.6	NUM
hls-12723	149	30	20.6	20.6	NUM
hls-12723	149	31	0.000	0.000	NUM
hls-12723	149	32	*	*	PUNCT
hls-12723	149	33	panss	pans	NOUN
hls-12723	149	34	end	end	VERB
hls-12723	149	35	22	22	NUM
hls-12723	149	36	56.7	56.7	NUM
hls-12723	149	37	5.9	5.9	NUM
hls-12723	149	38	il-6	il-6	NOUN
hls-12723	149	39	pre	pre	ADJ
hls-12723	149	40	(	(	PUNCT
hls-12723	149	41	pg	pg	NOUN
hls-12723	149	42	/	/	SYM
hls-12723	149	43	ml	ml	VERB
hls-12723	149	44	)	)	PUNCT
hls-12723	149	45	22	22	NUM
hls-12723	149	46	21.0	21.0	NUM
hls-12723	149	47	3.9	3.9	NUM
hls-12723	149	48	8.1	8.1	NUM
hls-12723	149	49	0.000	0.000	NUM
hls-12723	149	50	*	*	PUNCT
hls-12723	149	51	*	*	X
hls-12723	149	52	il-6	il-6	CCONJ
hls-12723	149	53	post	post	NOUN
hls-12723	149	54	(	(	PUNCT
hls-12723	149	55	pg	pg	NOUN
hls-12723	149	56	/	/	SYM
hls-12723	149	57	ml	ml	NOUN
hls-12723	149	58	)	)	PUNCT
hls-12723	149	59	22	22	NUM
hls-12723	149	60	19.3	19.3	NUM
hls-12723	149	61	3.4	3.4	NUM
hls-12723	149	62	*	*	PUNCT
hls-12723	149	63	wilcoxon	wilcoxon	PROPN
hls-12723	149	64	signed	sign	VERB
hls-12723	149	65	rank	rank	NOUN
hls-12723	149	66	test	test	NOUN
hls-12723	149	67	;	;	PUNCT
hls-12723	150	1	*	*	PUNCT
hls-12723	150	2	*	*	PUNCT
hls-12723	150	3	paired	pair	VERB
hls-12723	150	4	t	t	NOUN
hls-12723	150	5	-	-	PUNCT
hls-12723	150	6	test	test	NOUN
hls-12723	150	7	.	.	PUNCT
hls-12723	151	1	references	reference	NOUN
hls-12723	151	2	1	1	NUM
hls-12723	151	3	.	.	PUNCT
hls-12723	151	4	badan	badan	PROPN
hls-12723	151	5	pusat	pusat	PROPN
hls-12723	151	6	statistik	statistik	PROPN
hls-12723	151	7	provinsi	provinsi	PROPN
hls-12723	151	8	sulawesi	sulawesi	PROPN
hls-12723	151	9	selatan	selatan	PROPN
hls-12723	151	10	.	.	PUNCT
hls-12723	152	1	perilaku	perilaku	PROPN
hls-12723	152	2	masyarakat	masyarakat	PROPN
hls-12723	152	3	pada	pada	PROPN
hls-12723	152	4	masa	masa	PROPN
hls-12723	152	5	pandemi	pandemi	ADP
hls-12723	152	6	covid-19	covid-19	PROPN
hls-12723	152	7	provinsi	provinsi	PROPN
hls-12723	152	8	sulawesi	sulawesi	PROPN
hls-12723	152	9	selatan	selatan	PROPN
hls-12723	152	10	.	.	PUNCT
hls-12723	153	1	2022	2022	NUM
hls-12723	153	2	;	;	PUNCT
hls-12723	153	3	1–53	1–53	NOUN
hls-12723	153	4	2	2	NUM
hls-12723	153	5	.	.	PUNCT
hls-12723	153	6	felsenstein	felsenstein	PROPN
hls-12723	153	7	s	s	PROPN
hls-12723	153	8	,	,	PUNCT
hls-12723	153	9	herbert	herbert	PROPN
hls-12723	153	10	ja	ja	PROPN
hls-12723	153	11	,	,	PUNCT
hls-12723	153	12	mcnamara	mcnamara	PROPN
hls-12723	153	13	ps	ps	PROPN
hls-12723	153	14	,	,	PUNCT
hls-12723	153	15	hedrich	hedrich	X
hls-12723	153	16	cm	cm	NOUN
hls-12723	153	17	.	.	PUNCT
hls-12723	154	1	covid-19	covid-19	PROPN
hls-12723	154	2	:	:	PUNCT
hls-12723	154	3	immunology	immunology	NOUN
hls-12723	154	4	and	and	CCONJ
hls-12723	154	5	treatment	treatment	NOUN
hls-12723	154	6	options	option	NOUN
hls-12723	154	7	.	.	PUNCT
hls-12723	155	1	clin	clin	PROPN
hls-12723	155	2	immunol	immunol	NOUN
hls-12723	155	3	2020;215:108448	2020;215:108448	NUM
hls-12723	155	4	.	.	PROPN
hls-12723	156	1	3	3	X
hls-12723	156	2	.	.	X
hls-12723	156	3	diao	diao	PROPN
hls-12723	156	4	b	b	PROPN
hls-12723	156	5	,	,	PUNCT
hls-12723	156	6	wang	wang	PROPN
hls-12723	156	7	c	c	PROPN
hls-12723	156	8	,	,	PUNCT
hls-12723	156	9	wang	wang	PROPN
hls-12723	156	10	r	r	PROPN
hls-12723	156	11	,	,	PUNCT
hls-12723	156	12	et	et	PROPN
hls-12723	156	13	al	al	PROPN
hls-12723	156	14	.	.	PUNCT
hls-12723	157	1	human	human	ADJ
hls-12723	157	2	kidney	kidney	PROPN
hls-12723	157	3	is	be	AUX
hls-12723	157	4	a	a	DET
hls-12723	157	5	target	target	NOUN
hls-12723	157	6	for	for	ADP
hls-12723	157	7	novel	novel	ADJ
hls-12723	157	8	severe	severe	ADJ
hls-12723	157	9	acute	acute	ADJ
hls-12723	157	10	respiratory	respiratory	ADJ
hls-12723	157	11	syndrome	syndrome	NOUN
hls-12723	157	12	coronavirus	coronavirus	NOUN
hls-12723	157	13	2	2	NUM
hls-12723	157	14	(	(	PUNCT
hls-12723	157	15	sars	sar	NOUN
hls-12723	157	16	-	-	PUNCT
hls-12723	157	17	cov-2	cov-2	NOUN
hls-12723	157	18	)	)	PUNCT
hls-12723	157	19	infection	infection	NOUN
hls-12723	157	20	running	run	VERB
hls-12723	157	21	title	title	NOUN
hls-12723	157	22	:	:	PUNCT
hls-12723	157	23	sars	sars	PROPN
hls-12723	157	24	-	-	PUNCT
hls-12723	157	25	cov-2	cov-2	PART
hls-12723	157	26	infects	infect	VERB
hls-12723	157	27	human	human	ADJ
hls-12723	157	28	kidney	kidney	NOUN
hls-12723	157	29	.	.	PUNCT
hls-12723	158	1	medrxivorg	medrxivorg	PROPN
hls-12723	158	2	2020;12:2506	2020;12:2506	NUM
hls-12723	158	3	.	.	PROPN
hls-12723	159	1	4	4	NUM
hls-12723	159	2	.	.	X
hls-12723	159	3	sokolowska	sokolowska	PROPN
hls-12723	159	4	m	m	PROPN
hls-12723	159	5	,	,	PUNCT
hls-12723	159	6	lukasik	lukasik	PROPN
hls-12723	159	7	zm	zm	PROPN
hls-12723	159	8	,	,	PUNCT
hls-12723	159	9	agache	agache	PROPN
hls-12723	159	10	i	i	PRON
hls-12723	159	11	,	,	PUNCT
hls-12723	159	12	et	et	PROPN
hls-12723	159	13	al	al	PROPN
hls-12723	159	14	.	.	PUNCT
hls-12723	159	15	immunology	immunology	NOUN
hls-12723	159	16	of	of	ADP
hls-12723	159	17	covid-19	covid-19	PROPN
hls-12723	159	18	:	:	PUNCT
hls-12723	159	19	mechanisms	mechanism	NOUN
hls-12723	159	20	,	,	PUNCT
hls-12723	159	21	clinical	clinical	ADJ
hls-12723	159	22	outcome	outcome	NOUN
hls-12723	159	23	,	,	PUNCT
hls-12723	159	24	diagnostics	diagnostic	NOUN
hls-12723	159	25	,	,	PUNCT
hls-12723	159	26	and	and	CCONJ
hls-12723	159	27	perspectives	perspective	NOUN
hls-12723	159	28	—	—	PUNCT
hls-12723	159	29	a	a	DET
hls-12723	159	30	report	report	NOUN
hls-12723	159	31	of	of	ADP
hls-12723	159	32	the	the	DET
hls-12723	159	33	european	european	PROPN
hls-12723	159	34	academy	academy	PROPN
hls-12723	159	35	of	of	ADP
hls-12723	159	36	allergy	allergy	PROPN
hls-12723	159	37	and	and	CCONJ
hls-12723	159	38	clinical	clinical	ADJ
hls-12723	159	39	immunology	immunology	NOUN
hls-12723	159	40	(	(	PUNCT
hls-12723	159	41	eaaci	eaaci	NOUN
hls-12723	159	42	)	)	PUNCT
hls-12723	159	43	.	.	PUNCT
hls-12723	160	1	allergy	allergy	PROPN
hls-12723	160	2	eur	eur	PROPN
hls-12723	160	3	j	j	PROPN
hls-12723	160	4	allergy	allergy	PROPN
hls-12723	160	5	clin	clin	PROPN
hls-12723	160	6	immunol	immunol	PROPN
hls-12723	160	7	2020;75:2445–76	2020;75:2445–76	PROPN
hls-12723	160	8	.	.	PUNCT
hls-12723	161	1	5	5	NUM
hls-12723	161	2	.	.	PUNCT
hls-12723	161	3	guo	guo	PROPN
hls-12723	161	4	q	q	PROPN
hls-12723	161	5	,	,	PUNCT
hls-12723	161	6	zheng	zheng	PROPN
hls-12723	161	7	y	y	PROPN
hls-12723	161	8	,	,	PUNCT
hls-12723	161	9	shi	shi	PROPN
hls-12723	161	10	j	j	PROPN
hls-12723	161	11	,	,	PUNCT
hls-12723	161	12	et	et	PROPN
hls-12723	161	13	al	al	PROPN
hls-12723	161	14	.	.	PUNCT
hls-12723	161	15	immediate	immediate	ADJ
hls-12723	161	16	psychological	psychological	ADJ
hls-12723	161	17	distress	distress	NOUN
hls-12723	161	18	in	in	ADP
hls-12723	161	19	quarantined	quarantine	VERB
hls-12723	161	20	patients	patient	NOUN
hls-12723	161	21	with	with	ADP
hls-12723	161	22	covid-19	covid-19	PROPN
hls-12723	161	23	and	and	CCONJ
hls-12723	161	24	its	its	PRON
hls-12723	161	25	association	association	NOUN
hls-12723	161	26	with	with	ADP
hls-12723	161	27	peripheral	peripheral	ADJ
hls-12723	161	28	inflammation	inflammation	NOUN
hls-12723	161	29	:	:	PUNCT
hls-12723	161	30	a	a	DET
hls-12723	161	31	mixed	mix	VERB
hls-12723	161	32	-	-	PUNCT
hls-12723	161	33	method	method	NOUN
hls-12723	161	34	study	study	NOUN
hls-12723	161	35	.	.	PUNCT
hls-12723	162	1	brain	brain	NOUN
hls-12723	162	2	behav	behav	PROPN
hls-12723	162	3	immun	immun	PROPN
hls-12723	162	4	2020;88:17–27	2020;88:17–27	NUM
hls-12723	162	5	.	.	PROPN
hls-12723	163	1	6	6	NUM
hls-12723	163	2	.	.	X
hls-12723	163	3	guirao	guirao	PROPN
hls-12723	163	4	jj	jj	PROPN
hls-12723	163	5	,	,	PUNCT
hls-12723	163	6	cabrera	cabrera	PROPN
hls-12723	163	7	cm	cm	PROPN
hls-12723	163	8	,	,	PUNCT
hls-12723	163	9	jiménez	jiménez	PROPN
hls-12723	163	10	n	n	CCONJ
hls-12723	163	11	,	,	PUNCT
hls-12723	163	12	et	et	PROPN
hls-12723	163	13	al	al	PROPN
hls-12723	163	14	.	.	PROPN
hls-12723	163	15	high	high	PROPN
hls-12723	163	16	serum	serum	PROPN
hls-12723	163	17	il-6	il-6	NOUN
hls-12723	163	18	values	value	NOUN
hls-12723	163	19	increase	increase	VERB
hls-12723	163	20	the	the	DET
hls-12723	163	21	risk	risk	NOUN
hls-12723	163	22	of	of	ADP
hls-12723	163	23	mortality	mortality	NOUN
hls-12723	163	24	and	and	CCONJ
hls-12723	163	25	the	the	DET
hls-12723	163	26	severity	severity	NOUN
hls-12723	163	27	of	of	ADP
hls-12723	163	28	pneumonia	pneumonia	NOUN
hls-12723	163	29	in	in	ADP
hls-12723	163	30	patients	patient	NOUN
hls-12723	163	31	diagnosed	diagnose	VERB
hls-12723	163	32	with	with	ADP
hls-12723	163	33	covid-19	covid-19	PROPN
hls-12723	163	34	.	.	PROPN
hls-12723	163	35	mol	mol	ADP
hls-12723	163	36	immunol	immunol	NOUN
hls-12723	163	37	2020;128:64	2020;128:64	NUM
hls-12723	163	38	-	-	SYM
hls-12723	163	39	8	8	NUM
hls-12723	163	40	.	.	NOUN
hls-12723	164	1	7	7	X
hls-12723	164	2	.	.	X
hls-12723	164	3	world	world	PROPN
hls-12723	164	4	health	health	PROPN
hls-12723	164	5	organization	organization	PROPN
hls-12723	164	6	.	.	PUNCT
hls-12723	165	1	global	global	ADJ
hls-12723	165	2	surveillance	surveillance	NOUN
hls-12723	165	3	for	for	ADP
hls-12723	165	4	covid19	covid19	NOUN
hls-12723	165	5	caused	cause	VERB
hls-12723	165	6	by	by	ADP
hls-12723	165	7	human	human	ADJ
hls-12723	165	8	infection	infection	NOUN
hls-12723	165	9	with	with	ADP
hls-12723	165	10	covid-19	covid-19	PROPN
hls-12723	165	11	virus	virus	NOUN
hls-12723	165	12	:	:	PUNCT
hls-12723	165	13	interim	interim	ADJ
hls-12723	165	14	guidance	guidance	NOUN
hls-12723	165	15	,	,	PUNCT
hls-12723	165	16	20	20	NUM
hls-12723	165	17	march	march	NOUN
hls-12723	165	18	2020	2020	NUM
hls-12723	165	19	.	.	PUNCT
hls-12723	166	1	world	world	PROPN
hls-12723	166	2	health	health	PROPN
hls-12723	166	3	organization	organization	PROPN
hls-12723	166	4	.	.	PUNCT
hls-12723	167	1	2020	2020	NUM
hls-12723	167	2	.	.	PUNCT
hls-12723	168	1	avaiable	avaiable	ADJ
hls-12723	168	2	from	from	ADP
hls-12723	168	3	:	:	PUNCT
hls-12723	168	4	https://iris.who.int/handle/10665/331506	https://iris.who.int/handle/10665/331506	NOUN
hls-12723	168	5	8	8	NUM
hls-12723	168	6	.	.	PUNCT
hls-12723	169	1	may	may	AUX
hls-12723	169	2	m	m	PRON
hls-12723	169	3	,	,	PUNCT
hls-12723	169	4	slitzky	slitzky	PROPN
hls-12723	169	5	m	m	NOUN
hls-12723	169	6	,	,	PUNCT
hls-12723	169	7	rostama	rostama	PROPN
hls-12723	169	8	b	b	X
hls-12723	169	9	,	,	PUNCT
hls-12723	169	10	et	et	PROPN
hls-12723	169	11	al	al	PROPN
hls-12723	169	12	.	.	PUNCT
hls-12723	169	13	antipsychotic	antipsychotic	ADJ
hls-12723	169	14	-	-	PUNCT
hls-12723	169	15	induced	induce	VERB
hls-12723	169	16	immune	immune	ADJ
hls-12723	169	17	dysfunction	dysfunction	NOUN
hls-12723	169	18	:	:	PUNCT
hls-12723	169	19	a	a	DET
hls-12723	169	20	consideration	consideration	NOUN
hls-12723	169	21	for	for	ADP
hls-12723	169	22	covid-19	covid-19	PROPN
hls-12723	169	23	risk	risk	NOUN
hls-12723	169	24	.	.	PUNCT
hls-12723	170	1	brain	brain	NOUN
hls-12723	170	2	,	,	PUNCT
hls-12723	170	3	behav	behav	PROPN
hls-12723	170	4	immun	immun	PROPN
hls-12723	170	5	heal	heal	PROPN
hls-12723	170	6	2020;6:100097	2020;6:100097	NOUN
hls-12723	170	7	.	.	PUNCT
hls-12723	171	1	9	9	X
hls-12723	171	2	.	.	X
hls-12723	171	3	patel	patel	PROPN
hls-12723	171	4	kr	kr	PROPN
hls-12723	171	5	,	,	PUNCT
hls-12723	171	6	cherian	cherian	PROPN
hls-12723	171	7	j	j	PROPN
hls-12723	171	8	,	,	PUNCT
hls-12723	171	9	gohil	gohil	PROPN
hls-12723	171	10	k	k	PROPN
hls-12723	171	11	,	,	PUNCT
hls-12723	171	12	et	et	PROPN
hls-12723	171	13	al	al	PROPN
hls-12723	171	14	.	.	PUNCT
hls-12723	171	15	schizophrenia	schizophrenia	PROPN
hls-12723	171	16	:	:	PUNCT
hls-12723	171	17	overview	overview	NOUN
hls-12723	171	18	and	and	CCONJ
hls-12723	171	19	treatment	treatment	NOUN
hls-12723	171	20	options	option	NOUN
hls-12723	171	21	.	.	PUNCT
hls-12723	172	1	p	p	X
hls-12723	172	2	t	t	PROPN
hls-12723	172	3	2014;39:638–645	2014;39:638–645	NUM
hls-12723	172	4	10	10	NUM
hls-12723	172	5	.	.	PUNCT
hls-12723	173	1	fitrikasari	fitrikasari	VERB
hls-12723	173	2	a	a	DET
hls-12723	173	3	,	,	PUNCT
hls-12723	173	4	kartikasari	kartikasari	PROPN
hls-12723	173	5	l.	l.	PROPN
hls-12723	173	6	buku	buku	PROPN
hls-12723	173	7	ajar	ajar	PROPN
hls-12723	173	8	skizofrenia	skizofrenia	PROPN
hls-12723	173	9	.	.	PUNCT
hls-12723	174	1	undip	undip	PROPN
hls-12723	174	2	press	press	PROPN
hls-12723	174	3	semarang	semarang	PROPN
hls-12723	174	4	;	;	PUNCT
hls-12723	174	5	2022	2022	NUM
hls-12723	174	6	.	.	PUNCT
hls-12723	175	1	available	available	ADJ
hls-12723	175	2	from	from	ADP
hls-12723	175	3	:	:	PUNCT
hls-12723	175	4	https://docpak.undip.ac.id/id/eprint/18409/1/buku%20ajar%20skizofre	https://docpak.undip.ac.id/id/eprint/18409/1/buku%20ajar%20skizofre	PROPN
hls-12723	175	5	nia%20final.pdf	nia%20final.pdf	PROPN
hls-12723	175	6	11	11	NUM
hls-12723	175	7	.	.	PUNCT
hls-12723	175	8	monji	monji	PROPN
hls-12723	176	1	a	a	PRON
hls-12723	176	2	,	,	PUNCT
hls-12723	176	3	kato	kato	PROPN
hls-12723	176	4	ta	ta	PROPN
hls-12723	176	5	,	,	PUNCT
hls-12723	176	6	mizoguchi	mizoguchi	PROPN
hls-12723	176	7	y	y	PROPN
hls-12723	176	8	,	,	PUNCT
hls-12723	176	9	et	et	PROPN
hls-12723	176	10	al	al	PROPN
hls-12723	176	11	.	.	PUNCT
hls-12723	176	12	neuroinflammation	neuroinflammation	NOUN
hls-12723	176	13	in	in	ADP
hls-12723	176	14	schizophrenia	schizophrenia	NOUN
hls-12723	176	15	especially	especially	ADV
hls-12723	176	16	focused	focus	VERB
hls-12723	176	17	on	on	ADP
hls-12723	176	18	the	the	DET
hls-12723	176	19	role	role	NOUN
hls-12723	176	20	of	of	ADP
hls-12723	176	21	microglia	microglia	NOUN
hls-12723	176	22	.	.	PUNCT
hls-12723	177	1	prog	prog	PROPN
hls-12723	177	2	neuro	neuro	NOUN
hls-12723	177	3	-	-	PUNCT
hls-12723	177	4	psychopharmacology	psychopharmacology	NOUN
hls-12723	177	5	biol	biol	NOUN
hls-12723	177	6	psychiatry	psychiatry	NOUN
hls-12723	177	7	2013;42:115	2013;42:115	NOUN
hls-12723	177	8	–	–	PUNCT
hls-12723	177	9	121	121	NUM
hls-12723	177	10	.	.	PUNCT
hls-12723	177	11	12	12	NUM
hls-12723	177	12	.	.	PUNCT
hls-12723	178	1	müller	müller	PROPN
hls-12723	178	2	n	n	PROPN
hls-12723	178	3	,	,	PUNCT
hls-12723	178	4	weidinger	weidinger	NOUN
hls-12723	178	5	e	e	NOUN
hls-12723	178	6	,	,	PUNCT
hls-12723	178	7	leitner	leitner	NOUN
hls-12723	178	8	b	b	NOUN
hls-12723	178	9	,	,	PUNCT
hls-12723	178	10	schwarz	schwarz	PROPN
hls-12723	178	11	mj	mj	PROPN
hls-12723	178	12	.	.	PUNCT
hls-12723	179	1	the	the	DET
hls-12723	179	2	role	role	NOUN
hls-12723	179	3	of	of	ADP
hls-12723	179	4	inflammation	inflammation	NOUN
hls-12723	179	5	in	in	ADP
hls-12723	179	6	schizophrenia	schizophrenia	NOUN
hls-12723	179	7	.	.	PUNCT
hls-12723	180	1	front	front	ADJ
hls-12723	180	2	neurosci	neurosci	NOUN
hls-12723	180	3	2015;9:372	2015;9:372	NOUN
hls-12723	180	4	.	.	PROPN
hls-12723	180	5	13	13	NUM
hls-12723	180	6	.	.	PUNCT
hls-12723	181	1	meyer	meyer	PROPN
hls-12723	181	2	u.	u.	PROPN
hls-12723	181	3	developmental	developmental	PROPN
hls-12723	181	4	neuroinflammation	neuroinflammation	NOUN
hls-12723	181	5	and	and	CCONJ
hls-12723	181	6	schizophrenia	schizophrenia	NOUN
hls-12723	181	7	.	.	PUNCT
hls-12723	182	1	prog	prog	PROPN
hls-12723	182	2	neuro	neuro	NOUN
hls-12723	182	3	-	-	PUNCT
hls-12723	182	4	psychopharmacology	psychopharmacology	NOUN
hls-12723	182	5	biol	biol	NOUN
hls-12723	182	6	psychiatry	psychiatry	NOUN
hls-12723	182	7	2013;42:20–34	2013;42:20–34	NUM
hls-12723	182	8	.	.	PUNCT
hls-12723	183	1	14	14	NUM
hls-12723	183	2	.	.	PUNCT
hls-12723	184	1	radtke	radtke	PROPN
hls-12723	184	2	fa	fa	PROPN
hls-12723	184	3	,	,	PUNCT
hls-12723	184	4	chapman	chapman	PROPN
hls-12723	184	5	g	g	PROPN
hls-12723	184	6	,	,	PUNCT
hls-12723	184	7	hall	hall	PROPN
hls-12723	184	8	j	j	PROPN
hls-12723	184	9	,	,	PUNCT
hls-12723	184	10	et	et	PROPN
hls-12723	184	11	al	al	PROPN
hls-12723	184	12	.	.	PUNCT
hls-12723	185	1	modulating	modulate	VERB
hls-12723	185	2	neuroinflammation	neuroinflammation	NOUN
hls-12723	185	3	to	to	PART
hls-12723	185	4	treat	treat	VERB
hls-12723	185	5	neuropsychiatric	neuropsychiatric	ADJ
hls-12723	185	6	disorders	disorder	NOUN
hls-12723	185	7	.	.	PUNCT
hls-12723	186	1	biomed	biome	VERB
hls-12723	186	2	res	re	NOUN
hls-12723	186	3	int	int	NOUN
hls-12723	186	4	2017;2017:5071786	2017;2017:5071786	NUM
hls-12723	186	5	.	.	PUNCT
hls-12723	187	1	15	15	NUM
hls-12723	187	2	.	.	PUNCT
hls-12723	188	1	quincozes	quincoze	NOUN
hls-12723	188	2	-	-	PUNCT
hls-12723	188	3	santos	santos	PROPN
hls-12723	188	4	a	a	PRON
hls-12723	188	5	,	,	PUNCT
hls-12723	188	6	abib	abib	PROPN
hls-12723	188	7	rt	rt	PROPN
hls-12723	188	8	,	,	PUNCT
hls-12723	188	9	leite	leite	PROPN
hls-12723	188	10	mc	mc	PROPN
hls-12723	188	11	,	,	PUNCT
hls-12723	188	12	et	et	PROPN
hls-12723	188	13	al	al	PROPN
hls-12723	188	14	.	.	PROPN
hls-12723	188	15	effect	effect	NOUN
hls-12723	188	16	of	of	ADP
hls-12723	188	17	the	the	DET
hls-12723	188	18	atypical	atypical	ADJ
hls-12723	188	19	neuroleptic	neuroleptic	ADJ
hls-12723	188	20	risperidone	risperidone	NOUN
hls-12723	188	21	on	on	ADP
hls-12723	188	22	morphology	morphology	NOUN
hls-12723	188	23	and	and	CCONJ
hls-12723	188	24	s100b	s100b	PROPN
hls-12723	188	25	secretion	secretion	NOUN
hls-12723	188	26	in	in	ADP
hls-12723	188	27	c6	c6	PROPN
hls-12723	188	28	astroglial	astroglial	ADJ
hls-12723	188	29	lineage	lineage	NOUN
hls-12723	188	30	cells	cell	NOUN
hls-12723	188	31	.	.	PUNCT
hls-12723	189	1	mol	mol	ADP
hls-12723	189	2	cell	cell	NOUN
hls-12723	189	3	biochem	biochem	NOUN
hls-12723	189	4	2008;314:59–63	2008;314:59–63	NUM
hls-12723	189	5	.	.	PROPN
hls-12723	189	6	16	16	NUM
hls-12723	189	7	.	.	PUNCT
hls-12723	190	1	yang	yang	PROPN
hls-12723	190	2	l	l	PROPN
hls-12723	190	3	,	,	PUNCT
hls-12723	190	4	liu	liu	PROPN
hls-12723	190	5	s	s	PROPN
hls-12723	190	6	,	,	PUNCT
hls-12723	190	7	liu	liu	PROPN
hls-12723	190	8	j	j	PROPN
hls-12723	190	9	,	,	PUNCT
hls-12723	190	10	et	et	PROPN
hls-12723	190	11	al	al	PROPN
hls-12723	190	12	.	.	PUNCT
hls-12723	191	1	covid-19	covid-19	PROPN
hls-12723	191	2	:	:	PUNCT
hls-12723	191	3	immunopathogenesis	immunopathogenesis	NOUN
hls-12723	191	4	and	and	CCONJ
hls-12723	191	5	immunotherapeutics	immunotherapeutic	NOUN
hls-12723	191	6	.	.	PUNCT
hls-12723	192	1	signal	signal	PROPN
hls-12723	192	2	transduct	transduct	NOUN
hls-12723	192	3	target	target	NOUN
hls-12723	192	4	ther	ther	ADV
hls-12723	192	5	2020;5:1–8	2020;5:1–8	NUM
hls-12723	192	6	.	.	PROPN
hls-12723	192	7	17	17	NUM
hls-12723	192	8	.	.	PUNCT
hls-12723	193	1	lee	lee	PROPN
hls-12723	193	2	sw	sw	PROPN
hls-12723	193	3	,	,	PUNCT
hls-12723	193	4	yang	yang	PROPN
hls-12723	193	5	jm	jm	PROPN
hls-12723	193	6	,	,	PUNCT
hls-12723	193	7	moon	moon	PROPN
hls-12723	193	8	sy	sy	PROPN
hls-12723	193	9	,	,	PUNCT
hls-12723	193	10	et	et	PROPN
hls-12723	193	11	al	al	PROPN
hls-12723	193	12	.	.	PROPN
hls-12723	193	13	association	association	PROPN
hls-12723	193	14	between	between	ADP
hls-12723	193	15	mental	mental	ADJ
hls-12723	193	16	illness	illness	NOUN
hls-12723	193	17	and	and	CCONJ
hls-12723	193	18	covid-19	covid-19	PROPN
hls-12723	193	19	susceptibility	susceptibility	NOUN
hls-12723	193	20	and	and	CCONJ
hls-12723	193	21	clinical	clinical	ADJ
hls-12723	193	22	outcomes	outcome	NOUN
hls-12723	193	23	in	in	ADP
hls-12723	193	24	south	south	PROPN
hls-12723	193	25	korea	korea	PROPN
hls-12723	193	26	:	:	PUNCT
hls-12723	193	27	a	a	DET
hls-12723	193	28	nationwide	nationwide	ADJ
hls-12723	193	29	cohort	cohort	NOUN
hls-12723	193	30	study	study	NOUN
hls-12723	193	31	.	.	PUNCT
hls-12723	194	1	lancet	lancet	PROPN
hls-12723	194	2	psychiatry	psychiatry	PROPN
hls-12723	194	3	2020;7:1025–31	2020;7:1025–31	PROPN
hls-12723	194	4	.	.	PROPN
hls-12723	195	1	18	18	NUM
hls-12723	195	2	.	.	X
hls-12723	195	3	videbeck	videbeck	PROPN
hls-12723	195	4	sl	sl	INTJ
hls-12723	195	5	.	.	PUNCT
hls-12723	196	1	the	the	DET
hls-12723	196	2	eighth	eighth	ADJ
hls-12723	196	3	edition	edition	NOUN
hls-12723	196	4	of	of	ADP
hls-12723	196	5	psychiatric	psychiatric	ADJ
hls-12723	196	6	–	–	PUNCT
hls-12723	196	7	mental	mental	ADJ
hls-12723	196	8	health	health	NOUN
hls-12723	196	9	nursing	nursing	NOUN
hls-12723	196	10	.	.	PUNCT
hls-12723	197	1	lww	lww	PROPN
hls-12723	197	2	;	;	PUNCT
hls-12723	197	3	2020	2020	NUM
hls-12723	197	4	.	.	PUNCT
hls-12723	198	1	19	19	NUM
hls-12723	198	2	.	.	X
hls-12723	198	3	de	de	PROPN
hls-12723	198	4	souza	souza	PROPN
hls-12723	198	5	df	df	PROPN
hls-12723	198	6	,	,	PUNCT
hls-12723	198	7	wartchow	wartchow	X
hls-12723	198	8	k	k	X
hls-12723	198	9	,	,	PUNCT
hls-12723	198	10	hansen	hansen	PROPN
hls-12723	198	11	f	f	PROPN
hls-12723	198	12	,	,	PUNCT
hls-12723	198	13	et	et	PROPN
hls-12723	198	14	al	al	PROPN
hls-12723	198	15	.	.	PROPN
hls-12723	199	1	interleukin-6induced	interleukin-6induce	VERB
hls-12723	199	2	s100b	s100b	PROPN
hls-12723	199	3	secretion	secretion	NOUN
hls-12723	199	4	is	be	AUX
hls-12723	199	5	inhibited	inhibit	VERB
hls-12723	199	6	by	by	ADP
hls-12723	199	7	haloperidol	haloperidol	NOUN
hls-12723	199	8	and	and	CCONJ
hls-12723	199	9	risperidone	risperidone	NOUN
hls-12723	199	10	.	.	PUNCT
hls-12723	200	1	prog	prog	PROPN
hls-12723	200	2	neuro	neuro	NOUN
hls-12723	200	3	-	-	PUNCT
hls-12723	200	4	psychopharmacology	psychopharmacology	NOUN
hls-12723	200	5	biol	biol	NOUN
hls-12723	200	6	psychiatry	psychiatry	NOUN
hls-12723	200	7	2013;43:14–22	2013;43:14–22	NUM
hls-12723	200	8	.	.	PUNCT
hls-12723	201	1	20	20	NUM
hls-12723	201	2	.	.	PUNCT
hls-12723	201	3	noto	noto	PROPN
hls-12723	201	4	mn	mn	PROPN
hls-12723	201	5	,	,	PUNCT
hls-12723	201	6	maes	maes	PROPN
hls-12723	201	7	m	m	PROPN
hls-12723	201	8	,	,	PUNCT
hls-12723	201	9	nunes	nunes	PROPN
hls-12723	201	10	sov	sov	PROPN
hls-12723	201	11	,	,	PUNCT
hls-12723	201	12	et	et	PROPN
hls-12723	201	13	al	al	PROPN
hls-12723	201	14	.	.	PUNCT
hls-12723	201	15	activation	activation	NOUN
hls-12723	201	16	of	of	ADP
hls-12723	201	17	the	the	DET
hls-12723	201	18	immune	immune	NOUN
hls-12723	201	19	-	-	PUNCT
hls-12723	201	20	inflammatory	inflammatory	ADJ
hls-12723	201	21	response	response	NOUN
hls-12723	201	22	system	system	NOUN
hls-12723	201	23	and	and	CCONJ
hls-12723	201	24	the	the	DET
hls-12723	201	25	compensatory	compensatory	ADJ
hls-12723	201	26	immune	immune	NOUN
hls-12723	201	27	-	-	PUNCT
hls-12723	201	28	regulatory	regulatory	ADJ
hls-12723	201	29	system	system	NOUN
hls-12723	201	30	in	in	ADP
hls-12723	201	31	antipsychotic	antipsychotic	ADJ
hls-12723	201	32	naive	naive	ADJ
hls-12723	201	33	first	first	ADJ
hls-12723	201	34	episode	episode	NOUN
hls-12723	201	35	psychosis	psychosis	NOUN
hls-12723	201	36	.	.	PUNCT
hls-12723	202	1	eur	eur	PROPN
hls-12723	202	2	neuropsychopharmacol	neuropsychopharmacol	PROPN
hls-12723	203	1	2019;29:416–31	2019;29:416–31	PROPN
hls-12723	203	2	.	.	PROPN
hls-12723	204	1	21	21	NUM
hls-12723	204	2	.	.	PUNCT
hls-12723	205	1	al	al	PROPN
hls-12723	205	2	-	-	PUNCT
hls-12723	205	3	amin	amin	PROPN
hls-12723	205	4	mm	mm	PROPN
hls-12723	205	5	,	,	PUNCT
hls-12723	205	6	choudhury	choudhury	PROPN
hls-12723	205	7	mfr	mfr	PROPN
hls-12723	205	8	,	,	PUNCT
hls-12723	205	9	chowdhury	chowdhury	VERB
hls-12723	205	10	as	as	ADP
hls-12723	205	11	,	,	PUNCT
hls-12723	205	12	et	et	PROPN
hls-12723	205	13	al	al	PROPN
hls-12723	205	14	.	.	PUNCT
hls-12723	205	15	pretreatment	pretreatment	NOUN
hls-12723	205	16	with	with	ADP
hls-12723	205	17	risperidone	risperidone	NOUN
hls-12723	205	18	ameliorates	ameliorate	VERB
hls-12723	205	19	systemic	systemic	ADJ
hls-12723	205	20	lpsinduced	lpsinduce	VERB
hls-12723	205	21	oxidative	oxidative	ADJ
hls-12723	205	22	stress	stress	NOUN
hls-12723	205	23	in	in	ADP
hls-12723	205	24	the	the	DET
hls-12723	205	25	cortex	cortex	NOUN
hls-12723	205	26	and	and	CCONJ
hls-12723	205	27	hippocampus	hippocampus	NOUN
hls-12723	205	28	.	.	PUNCT
hls-12723	206	1	front	front	ADJ
hls-12723	206	2	neurosci	neurosci	PROPN
hls-12723	206	3	2018;12:1–9	2018;12:1–9	PROPN
hls-12723	206	4	.	.	PUNCT
hls-12723	207	1	22	22	NUM
hls-12723	207	2	.	.	PUNCT
hls-12723	207	3	song	song	PROPN
hls-12723	207	4	x	x	PROPN
hls-12723	207	5	,	,	PUNCT
hls-12723	207	6	fan	fan	PROPN
hls-12723	207	7	x	x	PROPN
hls-12723	207	8	,	,	PUNCT
hls-12723	207	9	li	li	PROPN
hls-12723	207	10	x	x	PROPN
hls-12723	207	11	,	,	PUNCT
hls-12723	207	12	et	et	PROPN
hls-12723	207	13	al	al	PROPN
hls-12723	207	14	.	.	PROPN
hls-12723	207	15	changes	change	NOUN
hls-12723	207	16	in	in	ADP
hls-12723	207	17	pro	pro	ADJ
hls-12723	207	18	-	-	ADJ
hls-12723	207	19	inflammatory	inflammatory	ADJ
hls-12723	207	20	cytokines	cytokine	NOUN
hls-12723	207	21	and	and	CCONJ
hls-12723	207	22	body	body	NOUN
hls-12723	207	23	weight	weight	NOUN
hls-12723	207	24	during	during	ADP
hls-12723	207	25	6	6	NUM
hls-12723	207	26	-	-	PUNCT
hls-12723	207	27	month	month	NOUN
hls-12723	207	28	risperidone	risperidone	NOUN
hls-12723	207	29	treatment	treatment	NOUN
hls-12723	207	30	in	in	ADP
hls-12723	207	31	drug	drug	NOUN
hls-12723	207	32	naïve	naïve	ADJ
hls-12723	207	33	,	,	PUNCT
hls-12723	207	34	first	first	ADJ
hls-12723	207	35	-	-	PUNCT
hls-12723	207	36	episode	episode	NOUN
hls-12723	207	37	schizophrenia	schizophrenia	NOUN
hls-12723	207	38	.	.	PUNCT
hls-12723	208	1	psychopharmacology	psychopharmacology	NOUN
hls-12723	208	2	(	(	PUNCT
hls-12723	208	3	berl	berl	PROPN
hls-12723	208	4	)	)	PUNCT
hls-12723	208	5	2014;231:319–25	2014;231:319–25	NUM
hls-12723	208	6	.	.	X
hls-12723	208	7	23	23	NUM
hls-12723	208	8	.	.	X
hls-12723	209	1	frommberger	frommberger	ADJ
hls-12723	209	2	uh	uh	INTJ
hls-12723	209	3	,	,	PUNCT
hls-12723	209	4	bauer	bauer	PROPN
hls-12723	209	5	j	j	PROPN
hls-12723	209	6	,	,	PUNCT
hls-12723	209	7	haselbauer	haselbauer	PROPN
hls-12723	209	8	p	p	PROPN
hls-12723	209	9	,	,	PUNCT
hls-12723	209	10	et	et	PROPN
hls-12723	210	1	al	al	PROPN
hls-12723	210	2	.	.	PUNCT
hls-12723	210	3	interleukin-6(il-6	interleukin-6(il-6	PROPN
hls-12723	210	4	)	)	PUNCT
hls-12723	210	5	plasma	plasma	NOUN
hls-12723	210	6	levels	level	NOUN
hls-12723	210	7	in	in	ADP
hls-12723	210	8	depression	depression	NOUN
hls-12723	210	9	and	and	CCONJ
hls-12723	210	10	schizophrenia	schizophrenia	NOUN
hls-12723	210	11	:	:	PUNCT
hls-12723	210	12	comparison	comparison	NOUN
hls-12723	210	13	between	between	ADP
hls-12723	210	14	the	the	DET
hls-12723	210	15	acute	acute	ADJ
hls-12723	210	16	state	state	NOUN
hls-12723	210	17	and	and	CCONJ
hls-12723	210	18	after	after	ADP
hls-12723	210	19	remission	remission	NOUN
hls-12723	210	20	.	.	PUNCT
hls-12723	211	1	eur	eur	PROPN
hls-12723	211	2	arch	arch	PROPN
hls-12723	211	3	psychiatry	psychiatry	PROPN
hls-12723	211	4	clin	clin	PROPN
hls-12723	211	5	neurosci	neurosci	PROPN
hls-12723	211	6	1997;247:228–33	1997;247:228–33	PROPN
hls-12723	211	7	.	.	PROPN
hls-12723	211	8	24	24	NUM
hls-12723	211	9	.	.	PUNCT
hls-12723	212	1	zajkowska	zajkowska	PROPN
hls-12723	212	2	z	z	PROPN
hls-12723	212	3	,	,	PUNCT
hls-12723	212	4	mondelli	mondelli	PROPN
hls-12723	212	5	v.	v.	CCONJ
hls-12723	212	6	first	first	ADJ
hls-12723	212	7	-	-	PUNCT
hls-12723	212	8	episode	episode	NOUN
hls-12723	212	9	psychosis	psychosis	NOUN
hls-12723	212	10	:	:	PUNCT
hls-12723	212	11	an	an	DET
hls-12723	212	12	inflammatory	inflammatory	ADJ
hls-12723	212	13	state	state	NOUN
hls-12723	212	14	?	?	PUNCT
hls-12723	213	1	neuroimmunomodulation	neuroimmunomodulation	PROPN
hls-12723	213	2	2014;21:102–8	2014;21:102–8	NUM
hls-12723	213	3	.	.	PUNCT
hls-12723	214	1	25	25	NUM
hls-12723	214	2	.	.	PUNCT
hls-12723	215	1	zhou	zhou	PROPN
hls-12723	215	2	x	x	PROPN
hls-12723	215	3	,	,	PUNCT
hls-12723	215	4	tian	tian	PROPN
hls-12723	215	5	b	b	PROPN
hls-12723	215	6	,	,	PUNCT
hls-12723	215	7	han	han	PROPN
hls-12723	215	8	h	h	PROPN
hls-12723	215	9	bin	bin	PROPN
hls-12723	215	10	.	.	PUNCT
hls-12723	215	11	serum	serum	VERB
hls-12723	215	12	interleukin-6	interleukin-6	NUM
hls-12723	215	13	in	in	ADP
hls-12723	215	14	schizophrenia	schizophrenia	NOUN
hls-12723	215	15	:	:	PUNCT
hls-12723	215	16	a	a	DET
hls-12723	215	17	system	system	NOUN
hls-12723	215	18	review	review	NOUN
hls-12723	215	19	and	and	CCONJ
hls-12723	215	20	meta	meta	ADJ
hls-12723	215	21	-	-	PUNCT
hls-12723	215	22	analysis	analysis	NOUN
hls-12723	215	23	.	.	PUNCT
hls-12723	216	1	cytokine	cytokine	VERB
hls-12723	216	2	2021;141:155441	2021;141:155441	NUM
hls-12723	216	3	.	.	PUNCT
hls-12723	217	1	26	26	NUM
hls-12723	217	2	.	.	PUNCT
hls-12723	217	3	park	park	PROPN
hls-12723	217	4	jh	jh	PROPN
hls-12723	217	5	,	,	PUNCT
hls-12723	217	6	park	park	PROPN
hls-12723	217	7	hj	hj	PROPN
hls-12723	217	8	,	,	PUNCT
hls-12723	217	9	lee	lee	PROPN
hls-12723	217	10	se	se	PROPN
hls-12723	217	11	,	,	PUNCT
hls-12723	217	12	et	et	PROPN
hls-12723	217	13	al	al	PROPN
hls-12723	217	14	.	.	PUNCT
hls-12723	218	1	repositioning	reposition	VERB
hls-12723	218	2	of	of	ADP
hls-12723	218	3	the	the	DET
hls-12723	218	4	antipsychotic	antipsychotic	ADJ
hls-12723	218	5	drug	drug	NOUN
hls-12723	218	6	tfp	tfp	PROPN
hls-12723	218	7	for	for	ADP
hls-12723	218	8	sepsis	sepsis	NOUN
hls-12723	218	9	treatment	treatment	NOUN
hls-12723	218	10	.	.	PUNCT
hls-12723	219	1	j	j	PROPN
hls-12723	219	2	mol	mol	ADP
hls-12723	219	3	med	med	PROPN
hls-12723	219	4	2019;97:64758	2019;97:64758	NUM
hls-12723	219	5	.	.	PROPN
hls-12723	219	6	27	27	NUM
hls-12723	219	7	.	.	PUNCT
hls-12723	219	8	crespo	crespo	PROPN
hls-12723	219	9	-	-	PUNCT
hls-12723	219	10	facorro	facorro	PROPN
hls-12723	219	11	b	b	PROPN
hls-12723	219	12	,	,	PUNCT
hls-12723	219	13	ruiz	ruiz	NOUN
hls-12723	219	14	-	-	PUNCT
hls-12723	219	15	veguilla	veguilla	NOUN
hls-12723	219	16	m	m	PROPN
hls-12723	219	17	,	,	PUNCT
hls-12723	219	18	vázquez	vázquez	ADJ
hls-12723	219	19	-	-	PUNCT
hls-12723	219	20	bourgon	bourgon	PROPN
hls-12723	219	21	j	j	PROPN
hls-12723	219	22	,	,	PUNCT
hls-12723	219	23	et	et	PROPN
hls-12723	219	24	al	al	PROPN
hls-12723	219	25	.	.	PROPN
hls-12723	219	26	aripiprazole	aripiprazole	PROPN
hls-12723	219	27	as	as	ADP
hls-12723	219	28	a	a	DET
hls-12723	219	29	candidate	candidate	NOUN
hls-12723	219	30	treatment	treatment	NOUN
hls-12723	219	31	of	of	ADP
hls-12723	219	32	covid-19	covid-19	PROPN
hls-12723	219	33	identified	identify	VERB
hls-12723	219	34	through	through	ADP
hls-12723	219	35	genomic	genomic	ADJ
hls-12723	219	36	analysis	analysis	NOUN
hls-12723	219	37	.	.	PUNCT
hls-12723	220	1	front	front	ADJ
hls-12723	220	2	pharmacol	pharmacol	PROPN
hls-12723	220	3	2021;12:1–8	2021;12:1–8	NUM
hls-12723	220	4	.	.	PUNCT
hls-12723	221	1	28	28	NUM
hls-12723	221	2	.	.	PUNCT
hls-12723	222	1	lu	lu	PROPN
hls-12723	223	1	q	q	NOUN
hls-12723	223	2	,	,	PUNCT
hls-12723	223	3	zhu	zhu	PROPN
hls-12723	224	1	z	z	X
hls-12723	224	2	,	,	PUNCT
hls-12723	224	3	tan	tan	PROPN
hls-12723	224	4	c	c	AUX
hls-12723	224	5	,	,	PUNCT
hls-12723	224	6	et	et	PROPN
hls-12723	224	7	al	al	PROPN
hls-12723	224	8	.	.	PUNCT
hls-12723	224	9	changes	change	NOUN
hls-12723	224	10	of	of	ADP
hls-12723	224	11	serum	serum	NOUN
hls-12723	224	12	il-10	il-10	PRON
hls-12723	224	13	,	,	PUNCT
hls-12723	224	14	il-1β	il-1β	PROPN
hls-12723	224	15	,	,	PUNCT
hls-12723	224	16	il6	il6	NOUN
hls-12723	224	17	,	,	PUNCT
hls-12723	224	18	mcp-1	mcp-1	NOUN
hls-12723	224	19	,	,	PUNCT
hls-12723	224	20	tnf	tnf	PROPN
hls-12723	224	21	-	-	PUNCT
hls-12723	224	22	α	α	PROPN
hls-12723	224	23	,	,	PUNCT
hls-12723	224	24	ip-10	ip-10	NOUN
hls-12723	224	25	and	and	CCONJ
hls-12723	224	26	il-4	il-4	PRON
hls-12723	224	27	in	in	ADP
hls-12723	224	28	covid-19	covid-19	PROPN
hls-12723	224	29	patients	patient	NOUN
hls-12723	224	30	.	.	PUNCT
hls-12723	225	1	int	int	PROPN
hls-12723	226	1	j	j	PROPN
hls-12723	226	2	clin	clin	PROPN
hls-12723	226	3	pract	pract	PROPN
hls-12723	226	4	2021;75:1–8	2021;75:1–8	PROPN
hls-12723	226	5	.	.	PUNCT
hls-12723	227	1	29	29	NUM
hls-12723	227	2	.	.	PUNCT
hls-12723	228	1	li	li	PROPN
hls-12723	228	2	j	j	PROPN
hls-12723	228	3	,	,	PUNCT
hls-12723	228	4	rong	rong	PROPN
hls-12723	228	5	l	l	PROPN
hls-12723	228	6	,	,	PUNCT
hls-12723	228	7	cui	cui	NOUN
hls-12723	228	8	r	r	NOUN
hls-12723	228	9	,	,	PUNCT
hls-12723	228	10	et	et	PROPN
hls-12723	228	11	al	al	PROPN
hls-12723	228	12	.	.	PUNCT
hls-12723	228	13	dynamic	dynamic	ADJ
hls-12723	228	14	changes	change	NOUN
hls-12723	228	15	in	in	ADP
hls-12723	228	16	serum	serum	PROPN
hls-12723	228	17	il-6	il-6	NOUN
hls-12723	228	18	,	,	PUNCT
hls-12723	228	19	il8	il8	PROPN
hls-12723	228	20	,	,	PUNCT
hls-12723	228	21	and	and	CCONJ
hls-12723	228	22	il-10	il-10	PRON
hls-12723	228	23	predict	predict	VERB
hls-12723	228	24	the	the	DET
hls-12723	228	25	outcome	outcome	NOUN
hls-12723	228	26	of	of	ADP
hls-12723	228	27	icu	icu	PROPN
hls-12723	228	28	patients	patient	NOUN
hls-12723	228	29	with	with	ADP
hls-12723	228	30	severe	severe	ADJ
hls-12723	228	31	covid-19	covid-19	PROPN
hls-12723	228	32	.	.	PUNCT
hls-12723	229	1	ann	ann	PROPN
hls-12723	229	2	palliat	palliat	PROPN
hls-12723	229	3	med	med	PROPN
hls-12723	229	4	2021;10:3706–14	2021;10:3706–14	NUM
hls-12723	229	5	.	.	PUNCT
hls-12723	230	1	30	30	NUM
hls-12723	230	2	.	.	PUNCT
hls-12723	231	1	zhang	zhang	PROPN
hls-12723	231	2	j	j	PROPN
hls-12723	231	3	,	,	PUNCT
hls-12723	231	4	hao	hao	PROPN
hls-12723	231	5	y	y	PROPN
hls-12723	231	6	,	,	PUNCT
hls-12723	231	7	ou	ou	PROPN
hls-12723	231	8	w	w	PROPN
hls-12723	231	9	,	,	PUNCT
hls-12723	231	10	et	et	PROPN
hls-12723	231	11	al	al	PROPN
hls-12723	231	12	.	.	PROPN
hls-12723	231	13	serum	serum	PROPN
hls-12723	231	14	interleukin-6	interleukin-6	PROPN
hls-12723	231	15	is	be	AUX
hls-12723	231	16	an	an	DET
hls-12723	231	17	indicator	indicator	NOUN
hls-12723	231	18	for	for	ADP
hls-12723	231	19	severity	severity	NOUN
hls-12723	231	20	in	in	ADP
hls-12723	231	21	901	901	NUM
hls-12723	231	22	patients	patient	NOUN
hls-12723	231	23	with	with	ADP
hls-12723	231	24	sars	sar	NOUN
hls-12723	231	25	-	-	PUNCT
hls-12723	231	26	cov-2	cov-2	PART
hls-12723	231	27	infection	infection	NOUN
hls-12723	231	28	:	:	PUNCT
hls-12723	231	29	a	a	DET
hls-12723	231	30	cohort	cohort	NOUN
hls-12723	231	31	study	study	NOUN
hls-12723	231	32	.	.	PUNCT
hls-12723	232	1	j	j	PROPN
hls-12723	232	2	transl	transl	PROPN
hls-12723	232	3	med	me	VERB
hls-12723	232	4	2020;18:1–8	2020;18:1–8	PROPN
hls-12723	232	5	.	.	PUNCT
hls-12723	233	1	31	31	NUM
hls-12723	233	2	.	.	PUNCT
hls-12723	234	1	miller	miller	PROPN
hls-12723	234	2	bj	bj	PROPN
hls-12723	234	3	,	,	PUNCT
hls-12723	234	4	gassama	gassama	PROPN
hls-12723	234	5	b	b	NOUN
hls-12723	234	6	,	,	PUNCT
hls-12723	234	7	sebastian	sebastian	PROPN
hls-12723	234	8	d	d	PROPN
hls-12723	234	9	,	,	PUNCT
hls-12723	234	10	et	et	PROPN
hls-12723	234	11	al	al	PROPN
hls-12723	234	12	.	.	PUNCT
hls-12723	235	1	meta	meta	VERB
hls-12723	235	2	-	-	PUNCT
hls-12723	235	3	analysis	analysis	NOUN
hls-12723	235	4	of	of	ADP
hls-12723	235	5	lymphocytes	lymphocyte	NOUN
hls-12723	235	6	in	in	ADP
hls-12723	235	7	schizophrenia	schizophrenia	NOUN
hls-12723	235	8	:	:	PUNCT
hls-12723	235	9	clinical	clinical	ADJ
hls-12723	235	10	status	status	NOUN
hls-12723	235	11	and	and	CCONJ
hls-12723	235	12	antipsychotic	antipsychotic	ADJ
hls-12723	235	13	effects	effect	NOUN
hls-12723	235	14	brian	brian	PROPN
hls-12723	235	15	.	.	PUNCT
hls-12723	236	1	bone	bone	PROPN
hls-12723	236	2	2008;23:1–7	2008;23:1–7	NUM
hls-12723	236	3	.	.	PUNCT
hls-12723	237	1	article	article	NOUN
hls-12723	237	2	[	[	X
hls-12723	237	3	page	page	NOUN
hls-12723	237	4	104	104	NUM
hls-12723	237	5	]	]	PUNCT
hls-12723	238	1	[	[	X
hls-12723	238	2	healthcare	healthcare	NOUN
hls-12723	238	3	in	in	ADP
hls-12723	238	4	low	low	ADJ
hls-12723	238	5	-	-	PUNCT
hls-12723	238	6	resource	resource	NOUN
hls-12723	238	7	settings	setting	NOUN
hls-12723	238	8	2025;13:12723	2025;13:12723	NUM
hls-12723	238	9	]	]	PUNCT